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Summary 
Macrophages are an indispensable part of the innate immune system which mediate various 
functions including host defense against pathogens, metabolism, tissue homeostasis and 
even developmental processes. These extremely heterogeneous cells can adapt their 
transcriptional program upon a plethora of stimulatory cues and thus exist in different 
activation states to facilitate their diverse roles in the body. Corresponding transcriptional 
changes are established amongst others by transcriptional regulators (TRs) with diverse 
functions or by complex epigenetic alterations. Next generation sequencing technologies 
provide excellent experimental methods like ChIP- or RNA-sequencing, with which one can 
analyze genome wide enrichment properties of DNA binding proteins or the transcriptional 
activity of genes to elucidate in detail the activation of macrophages on the transcriptional 
level. 
Integrating the KO implemented normalization method (KOIN) into the standard peak calling 
procedure revealed multiple enhancements for ChIP-seq data analysis. False-positive 
signals can be eliminated in a tremendous amount, while signal-to-noise ratios are increased 
in low and even high quality ChIP-seq data sets. Besides the identification and removal of a 
recently identified special type of false-positive signal called “hyper-ChIPable regions”, the 
biological interpretation can profoundly benefit from KOIN. Overall, the KOIN method 
demonstrated its value as new possible gold standard control with various advantages 
compared to the currently established Input chromatin and IgG ChIP-seq controls. 
Furthermore, the ChIP-seq technology allows the definition of 1) different activity states for 
promoters or cis-regulatory regions and 2) important regulators in the establishment and 
maintenance of the transcriptional landscape by the detection of different covalent 
posttranslational histone modifications (HM), like acetylation or methylation. Four 
differentially activated primary human macrophages demonstrated a common epigenetic 
core program, maintained by various promoter sites. Simultaneously, activation state specific 
epigenetic differences at promoters, super-enhancer regions and especially at enhancer sites 
could mediate their specialization upon employed stimulatory signals. Finally, despite the 
detected epigenetic differences an astonishing fraction of genomic loci was defined by 
accessible promoter and enhancer markings in macrophage activation states. This was 
especially demonstrated in co-regulation networks for TRs and revealed an uncoupling of 
epigenetic and transcriptional control in monocyte-derived activated macrophages 
associated with cellular plasticity in response to microenvironmental signals. Other additional 
levels of transcriptional fine-tuning like enhancer RNAs, repressor proteins or the cross-talk 
between HMs could play an important role in fine-tuning macrophage transcription. 
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Especially, the cooperative binding of pioneer transcription factors (TF) like PU.1 with other 
secondary TFs like STAT proteins to these open genomic macrophage loci could represent 
an additional important switch in macrophage transcription in concert with HMs. 
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1. Introduction 
 
1.1 The innate immune system 
Throughout life an individual faces constant threats by infections with microbial pathogens 
and viruses or other dangerous biological compounds. Survival depends on the recognition 
of infectious microbes and an appropriate defense response. Two fundamental parts of the 
immune system are responsible for this recognition to ensure host survival (1,2). The 
adaptive immunity, an evolutionary achievement of vertebrates creates specialized and 
highly specific antigen receptors de novo in each organism, which are not-germ line encoded 
(3). In contrast, the innate immune system is the evolutionary more ancient form of host 
defense, found in most multicellular organisms and recognizes threats with a defined set of 
germ line encoded pathogen recognition receptors (PPR) (4). Mainly pathogen associated 
molecular patterns (PAMPs) but also abnormal self-antigens are recognized by PPRs. They 
can induce in their secreted form the complement system and lead to the phagocytosis of 
bound microorganisms by macrophages. Transmembrane receptors like Toll-like receptors 
(TLRs) recognize specific microbial compounds (5). In humans, ten different members of the 
TLR family can recognize intra- or extracellular PAMPs. Extracellular TLRs can identify 
lipotheichoic acid (TLR1/2), lipoproteins (TLR2/6), lipopolysaccharide (TLR4) or flagelin 
(TLR5). In the membrane of phagocytic compartments localized intracellular TLRs 
(TLR3/7/9) can recognize nucleic acids (6). All TLR signaling pathways ultimately lead to the 
expression and activation of the TFs nuclear factor kB (NFkB) and activation protein-1 (AP-1) 
inducing the transcription of genes necessary for microbial immune defense. If the innate 
immune system is not able to eliminate microbial infections, the adaptive immunity activates 
T and B cell mediated immunity, providing specific recognition by clonal amplification of 
antigen specific receptors and additionally provides memory for faster resolution of repeated 
challenges with the same microbial antigen. But in most cases, innate immune cells like 
neutrophils, granulocytes, mast cells, dendritic cells or macrophages respond very rapidly 
upon a challenge compared to adaptive immune cells and resolve the threat. 
 
1.2 Macrophage activation and plasticity 
Macrophages, fundamental effectors of the innate immune system, fulfill many specialized 
roles in the defense against pathogens, in developmental processes of the body, in tissue 
homeostasis and even in metabolic functions (7-9). They originate from circulating 
monocytes or tissue-resident precursors (10,11). Depending on their tissue localization 
Introduction 
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macrophages also play different roles in homeostasis (12). For example, Kupffer cells in the 
liver phagocytize erythrocytes and recycle hemoglobin together with red pulp macrophages 
of the spleen to maintain iron homeostasis (13,14), whereas microglia cells in the brain aid in 
synaptic pruning (15,16). Alveolar macrophages in the lung clear mucus and take up 
surfactant lipids (17). These are only some examples of various macrophage types with 
distinct specialized functions (18). Thus, macrophages are defined by their outstanding 
diversity and plasticity reacting to environmental cues like cytokines, microbial antigens or 
damaged cells finally emerging into different functional states. 
Importantly, despite their common monocytic origin tissue resident macrophages and 
monocytic-derived circulating macrophages show substantial differences. Tissue 
macrophages for example display a general immunomodulatory phenotype, while infiltrating 
recruited monocytes are activated into a pro- or anti-inflammatory phenotype depending on 
the tissue conditions (19). In steady state conditions the discrimination between tissue-
resident and monocyte-derived macrophages is not possible, but alternatively activated 
tissue macrophages revealed different transcriptional and phenotypic profiles from 
alternatively activated monocyte-derived macrophages (20). 
For many years, the classical paradigm of macrophage polarization into two major subtypes, 
classically activated (M1) and alternatively activated (M2) macrophages was established in 
the scientific community (7). In this model, the in vitro stimulation of bone-marrow derived 
murine macrophages with microbial agonists or cytokines mimicking in vivo situations 
allowed the characterization of two major functional and phenotypic profiles mirroring the 
Th1-Th2 polarization of T cells. Recently, computational methods analyzing at least 28 
distinct human macrophage activation programs while utilizing 299 highly standardized 
microarray transcriptome data sets expanded the current view of macrophage polarization 
(21). Reverse network engineering and the integration of database-stored knowledge 
allowed not only the identification of a common macrophage program but also distinct 
activation stimulus specific transcriptional changes, suggesting a “spectrum model” with at 
least nine significantly different macrophage activation programs. The “spectrum model” 
better accommodates for the in vivo situation of macrophages, since a plethora of stimuli are 
present in the host microenvironment, generating various possible distinct activation states 
with functional differences, reflecting the fundamental changes on transcriptional level. 
Nevertheless, previous publications describe in detail important mechanisms and involved 
factors in macrophage activation, which demonstrated valuable insights into macrophages 
independently of the recent findings in macrophage plasticity. Classically activated 
inflammatory macrophages MIFNy (formerly known as M1), targets of extensive effort to 
elucidate their activation and functional implications are generated in vitro by the stimulation 
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with TLR ligands, IFNy or TNF-α (22). These IFNy/ TNF-α associated macrophages produce 
pro-inflammatory cytokines like IL-12p40, TNF-α, IL-6 or IL-23, also promoting T helper 1 and 
T helper 17 responses (23), whereas only low levels of IL-10 are expressed. The production 
of pro-inflammatory chemokines and chemokine receptors like CCL2, CCL3, CCL4, CCL5, 
IL-8 and CCR7 attract NK and T helper 1 cells to sites of inflammation (24). On the molecular 
level, various signaling molecules, transcription factors (TFs) and other transcriptional 
regulators (TRs) form the IFNy/ TNF-α macrophage-associated activation profile. Canonical 
IRF/STAT signaling pathways are activated by IFNs or TLR signaling via STAT1 (25). IRF5 
successfully induces the expression of IL-12 and IL-23 (23). TLR4 stimulation of 
macrophages induces NF-kB signaling subsequently expressing the SOCS3 protein, which 
can inhibit IL4 activated macrophage programs by the suppression of STAT3. Interestingly, 
NF-kB signaling also activates a transcriptional program for the resolution of inflammation, 
demonstrating a negative feedback loop for the tight control of inflammatory processes 
(26,27). Thus, NF-kB is not an exclusive TF for IFNy/ TNF-α associated processes, but also 
involved in anti-inflammatory functions. IFNy/ TNF-α associated macrophages phagocytose 
microorganisms and matrix debris, mainly important in early healing phases. In the disease 
background, IFNy/ TNF-α macrophages are amongst others associated with diminished 
metastasis and increased patient survival in colon carcinomas and are even able to kill tumor 
cells in vitro (28-30). However, in septic patients the production of pro-inflammatory IFNy/ 
TNF-α macrophage associated cytokines accompanies high mortality rates (31). 
Macrophages with anti-inflammatory functions MIL4 (formerly known as M2) are in vitro 
generated by IL-4/IL-13, immune complexes or by the stimulation with glucocorticoids. They 
express anti-inflammatory mediators like IL-4, IL-10 and TGF-β (32,33) and are 
characterized by low or no expression of IL-12 and the expression of surface receptors like 
CD23, MCR1 or scavenger receptors (7). On the molecular level, IL-4/IL-13 promotes the 
activation of canonical IRF/STAT signaling pathways via STAT6 (25), while IL-10 signals via 
STAT3 and allows the subsequent expression of genes like IL10, TGFb1 or MRC1 (34,35). 
Other important promoters of IL4 activated macrophages are amongst others SOCS1, KLF4, 
PPARy or PPARδ inhibiting the STAT1/NF-kB associated IFNy/ TNF-α macrophage gene 
activation (36-39). It is important to note that differences between murine and human 
macrophages in their expression profiles were found, despite quite similar functions for 
example by the recruitment of the same cell types to sites of inflammation (40). Macrophages 
in murine models express Ym1, Fizz1, Arginase I and the chemokines CCL2 and CCL7 
recruiting eosinophils and basophils, whereas human macrophages express the chemokines 
CCL13, 14 and 17. IL4 activated macrophages promote angiogenesis, tissue remodeling and 
repair (41). Additionally, increasing evidence suggests a major role for macrophages not only 
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in peritoneal fibrosis (42) but also in tumor formation with poor prognosis and disease 
progression in breast carcinoma (43,44). 
The limitations of the M1/M2 nomenclature of macrophages is easily shown by macrophages 
from chronic inflamed tissues which belong neither to M1 nor to the M2 axis, since they 
display distinct transcriptomic changes in comparison to other activated macrophages (21). 
Chronic inflammation associated macrophages promote anti-inflammatory effects and 
strongly inhibit T cell proliferation. These macrophages are primed with GM-CSF and in vitro 
become activated by a combination of TNF-α, PGE2, and P3C (TPP) and were therefore 
described as TPP stimulated macrophages (MTPP). TNF-α, PGE2 and TLR activation was 
linked to chronic granulomatous inflammation such as in granulomatous listeriosis or 
tuberculosis (45-47). These MTPP macrophages express anti-inflammatory mediators like 
CD25, COX-2, IL10 and indoleamine 2,3-dioxygenase (IDO) which was also detected in 
human macrophages imbedded in human granulomatous structures (46,48). Furthermore, 
MTPP macrophages highly expressed CD14, CD23, CXCR7 and CD197 in comparison to 
IFNy or IL-4 activated macrophages and TFs like STAT4 or soluble effector molecules like IL-
1α were exclusively highly induced in MTPP macrophages. Additional differences on miRNA 
expression levels in comparison to MIFNy or MIL4 activation further suggested the phenotypical 
and functional difference of MTPP (21). 
In general, markers for the differentiation between stimulus-activated macrophages are still a 
matter of debate. Modern computational approaches analyzing the transcriptome of 
differentially activated macrophages may profoundly change and extend the system of 
macrophage classification to mirror more and more the complex in vivo situation and allow a 
better understanding of these innate immune cells, responsible for many functions in immune 
defense, development and even disease. 
 
1.2.1 PU.1 - A pioneer transcription factor in macrophage 
differentiation 
TRs and particularly transcription factors (TFs) play an essential role in the establishment of 
transcriptional programs. During different phases of cell development, lineage commitment 
and activation different classes of TFs are involved. Pioneer TFs like FOXA1 or GATA family 
member proteins determine the cell lineage, are one of the first factors to be expressed and 
feed forward loops further increase their presence during early development (49-52). 
Polarizing TFs are expressed due to cell-extrinsic environmental signals and further fine tune 
the regulatory landscape, thus defining the cell type. Ultimately, effector TFs mediate the 
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activation into different functional cellular subtypes caused by transient changes in the 
microenvironment.  
Pioneer TFs determine cell lineage and identity by the establishment of a core transcriptional 
program shaping the genome structure itself (53). They can bind in contrast to most other 
regulatory proteins DNA sequences even in a silent or native chromatin state and are crucial 
to make chromatin accessible for the binding of other TFs (54-56). The pivotal function of 
pioneer factors recruiting nucleosome remodeling and chromatin modifying complexes allows 
further adaption of the chromatin state at bound sites. Collectively, pioneer factors are 
proposed to act as global organizers, especially for the formation and maintenance of cis-
regulatory elements like enhancers (57). 
Enhancers are defined as DNA sequences influencing transcription in an orientation-
independent manner with variable distances to corresponding genes (58,59). They are not 
only located at intergenic genomic regions but also at intronic sites (60,61) and can contain 
multiple accessible binding sites for TFs important in development and differentiation, 
controlling cell type- and tissue-specific gene expression (57,62,63). Furthermore, specific 
coactivator proteins like mediator complexes are located at enhancers (64-66). The mediator 
protein is associated with cohesion, is essential for the interaction of DNA bound TFs and the 
RNA polymerase II enzyme and acts as a bridge between distant regulatory sites and 
promoters mediating DNA looping (67). Furthermore, other important transcriptional 
coactivators like p300 or CBP histone acetyltransferases were also associated with 
enhancers (68-70).  
The PU.1 pioneer TF, an essential regulator in the hematopoietic cell lineage, establishes the 
recruitment of other TFs to regulatory enhancer sites in murine macrophages (71-73). PU.1-
deficient fibroblasts establish macrophage-specific nucleosome-depletion and gain open 
chromatin modifications going along with active transcription at putative macrophage specific 
promoter and enhancer sites upon PU.1 expression (71). Importantly, mice deficient for PU.1 
do not only show alterations in B and T lymphocyte formation but moreover completely lack 
monocytes and macrophages (74,75). ChIP-seq binding experiments for PU.1 and other 
important TFs like C/EBPβ or p300 correlated to different histone modification (HM) signals 
illustrates the chromatin remodeling capabilities of PU.1 in mouse macrophages and the gain 
and loss of specific enhancer marks during knockout experiments with simultaneous 
changes on nucleosome positioning (71,72). A study even intrinsically linked PU.1 binding 
and nucleosome positioning in macrophages (76). Non-active PU.1 bound sites in 
macrophages and PU.1 bound sites in cell types without PU.1 expression exhibit high 
nucleosomal occupancy. In contrast, in macrophages PU.1 binds a high fraction of putative 
active or poised enhancer sites (77). Interestingly, out of 600.000 predicted high affinity PU.1 
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binding sites only 10% are actually occupied by the PU.1 protein. These results were 
obtained from PU.1 ChIP-seq experiments performed with several human cell lines like 
Jurkat or HL60 cells. Obviously, another higher level of regulation seems to select actual 
PU.1 binding sites. A functional cooperation between pioneer TFs and secondary pioneer 
TFs or a direct DNA interaction by forming 3D structures might also be possible (78). Partner 
TFs could help access specific target sites or allow the pioneer TF to occupy DNA binding 
sites with suboptimal affinities, demonstrated by the interaction of PU.1 with IRF TFs binding 
ETS/IRF composite sites (79,80). Furthermore, partner TFs could additionally remodel 
chromatin states of pioneer factor bound sites by the recruitment of nucleosome remodeling 
enzyme complexes (81). Another issue could be the differential expression rates for PU.1 
between cell types. Lower PU.1 expression in hematopoietic progenitors induced a B cell-like 
phenotype, while higher PU.1 expression leads to a reprogramming into macrophages (75). 
PU.1 expression itself is regulated by many factors. On the transcriptional level, high IRF8 or 
PAX5 expression can down-regulate PU.1 transcription and promote B cell formation (82,83). 
A prolonged cell cycle is another mechanism to enhance PU.1 expression in macrophages in 
contrast to B cells, where shorter cell cycles and decreased Spi1 gene transcription leads to 
less PU.1 protein (84). 
Pivotal for transcriptionally active genomic sites are open chromatin positions without dense 
heterochromatin structures and only sparse nucleosome densities to enable the binding of 
regulatory factors, important parts of the transcriptional machinery. This process is amongst 
others mediated by pioneer TFs and only one aspect of cellular “epigenetic” regulation. 
 
1.3 Epigenetics 
The former meaning of “epigenetics” combined the words “epigenesis” and “genetics” to 
describe processes of cell fate commitment and lineage specification during development 
(85,86). Today, the term “epigenome” describes DNA sequence independent processes that 
modulate gene expression, amongst others DNA methylation, posttranslational modification 
of histone proteins or RNA-based mechanisms (87,88). By organizing the chromosomal 
conformation in the nucleus, chromatin is organized into sites with variable transcriptional 
activity by modulating the accessibility for the binding of TRs like TFs or RNA polymerases. 
Most importantly, epigenetics does not only augment the cellular genomic sequence with an 
additional dimension, thus increasing complexity in an order of magnitude, but also 
preserves memory on different levels particularly of past transcriptional events (89-91). The 
cellular epigenome is intrinsically linked to the structural organization of the genome and 
reflects the global patterns of transcriptional activity (92).  
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1.3.1 DNA methylation 
The methylation of cellular DNA represents one major aspect of epigenetic regulation. A high 
fraction of the human genome is methylated (60-80%) typically at CpG dinucleotides by 
enzymes called DNA methyltransferases (93). DNA methylation is essential for 
developmental processes and the depletion of DNA methyltransferases leads to neonatal 
lethality in mice (94). Previous experiments suggest enrichments of DNA methylation 
especially at sites with low transcriptional activity. Next generation sequencing technology 
revealed that methylation marks are less stable than anticipated, and can also exist at non-
CpG sites and are partially enriched at actively transcribed genes (95). Furthermore, DNA 
methylation is tightly connected to histone modifications and involved in the regulation of 
transcriptional processes (96). 
 
1.3.2 DNA structure 
Another level of epigenetic regulation addresses the basic structural subunit of DNA called 
“nucleosome”. Exactly 147 bp of DNA are wrapped around the nucleosome. Nucleosome 
subunits are connected by linker DNA fragments. ATP-dependent chromatin-remodeling 
enzymes act by sliding along the DNA, triggering conformational changes of the 
nucleosomes that enable subsequent positional changes (97). The nucleosomal positioning 
inhibits or promotes the binding of regulatory proteins by the occupation of sequence specific 
sites or inhibits the activity of RNA polymerase II (98). Histone tails of nucleosomes can also 
serve as binding sites for TRs and associated proteins. Furthermore, the genomic position of 
nucleosomes is not a random process and occurs more frequently at specific regions of 
DNA, depicting the active role of nucleosome positioning in regulatory processes (99). In 
addition, nucleosomal DNA may also support synergistic TF binding leading more efficiently 
to the displacement of nucleosomes in comparison to the presence of only one TF (100). 
The nucleosome structure is only one level of cellular architecture in eukaryotes. Higher 
order 3D structures of chromatin like the 30 nm fiber of packed nucleosomes, stabilized by 
the H1 histone protein or 700 nm condensed sections of chromosomes, enable distant loci 
on the linear DNA to interact with each other and change transcriptional activity of adjacent 
genes (101). For example, distant enhancers with hundreds of kilobases distance can 
increase beta-globin gene transcription by the interaction with its promoter established by 
chromatin looping (102). In addition, chromatin close to the lamina of the inner nuclear 
membrane seems to exist in an inactive heterochromatic state (103). This further 
Introduction 
21  
 
demonstrates the importance of chromatin 3D structure onto the regulation of transcriptional 
activity for eukaryotes genes. 
 
1.3.3 RNA mediated processes 
Besides the structural chromatin regulation, a complex system of different RNA mediated 
epigenetic mechanisms further ensures the tight control of cellular transcription e.g. for the 
regulation of development (104), environmental stress (105) and disease relevant processes 
(106). The RNA polymerase II enzyme is a major subject of regulation mediating the 
transcription of eukaryotic DNA into messenger RNA precursors (mRNA) or different non-
coding RNA species like infrastructural (ribosomal RNA, small nuclear RNA) or regulatory 
RNA (microRNA, long non-coding RNA and others) (107). The RNA polymerase II enzyme 
consists of 12 protein subunits (RPBs) highly interacting with each other and mediating 
different functions like DNA binding, stabilization and regulation of transcription (108). 
Importantly, the RPB1 protein possesses a specialized region called CTD (carboxy terminal 
domain) with up to 52 tandem heptapeptide repeats in vertebrates and is subject of extensive 
posttranslational modification (109,110). These modifications define complex patterns 
culminating in a CTD code tightly correlating the state of CTD modification to the actual 
function and activity of RNA polymerase II (111). For example, antibodies in macrophage 
ChIP-seq experiments targeting phosphorylated CTDs at the serine 5 residue recognized 
RNA polymerase II enzymes during their initiation actively transcribing DNA into RNA species 
(112), while subsequent phosphorylations at the serine 2 occur later in the transcriptional 
process, during elongation (113). After reading through the transcribed gene a phosphatase 
enzyme removes the phosphorylation when arriving at the 3’ end of the protein coding 
region. The presence and modification status of RNA polymerase II enzymes allows the 
assessment of transcriptional regulation and activity at important genomic sites. Transcription 
does not only occur at protein coding genomic sites, but also in large amounts outside of 
these regions and can lead to different classes of extragenic transcripts (112,114,115).  
Long non-coding RNAs (lncRNA) are defined by their transcript length of 200 nucleotides, 
their nuclear localization in very low amounts and their sequence conservation (116). They 
can originate from various intergenic genomic locations but were also found at intronic sites 
(117). LncRNAs are involved amongst others in functions like the regulation of allelic 
expression (118) or in developmental processes (119,120). Even disease associated 
functions were identified mainly in cancer related processes (121,122), whereas the analysis 
of the functional relevance for the majority of identified lncRNAs is still far from complete 
(123). Many possible mechanisms how lncRNAs regulate their targets include for example 
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the interaction with chromatin-modifying complexes (124), the modulation of DNA 
methylation (125) or direct effects on transcription by competing with TF binding (126).  
The relatively new concept of enhancer RNA (eRNA), a special type of lncRNAs, transcribed 
at active cis-regulatory sites arises the question, if enhancers do not only influence 
transcription by their direct interaction with TFs bound to promoters forming DNA loops, but 
also regulate transcription by RNA-mediated processes (112,127,128). These highly unstable 
transcripts are produced either unidirectional as short (< 2 kb) and non-polyadenylated RNAs 
(1d-eRNA) or bidirectional in 5’ to 3’ and 3’ to 5’ direction as longer (> 4 kb) and 
polyadenylated eRNA species (2d-eRNA) (128,129). Three functional consequences of 
enhancer transcription are supported by an increasing amount of scientific data. First, 
random collisions of RNA polymerase II with accessible enhancer sites could cause eRNA 
transcription without functional consequences, thus defined as noise (130). Second, the 
process of eRNA transcription can alter the accessibility of the chromatin template due to the 
RNA polymerase II movement and its enzymatic activities altering the chromatin structure 
(131,132). Third, transcripts can cause functional changes by direct in cis or in trans 
interactions with DNA recruiting protein complexes (e.g. chromatin remodelers) or effector 
proteins (133,134).  
Another class of extragenic RNA transcripts with lengths of approximately 22 nucleotides 
were defined as microRNAs (miRNAs). RNA polymerase II transcribes primary miRNA, which 
is subsequently processed by the Drosha and DGCR8 protein complex into a hairpin 
structure called precursor miRNA (135-138). Ran-GTP and exportin 5 transports the 
precursor miRNA into the cytoplasm, where the Dicer cleavage produces mature double-
stranded miRNA. The passenger strand is degraded, while the guide strand is integrated into 
the RISC complex (RNA-induced silencing complex) and specifically targets mRNA 
transcripts, resulting in silencing of the corresponding target gene (139-142). 
Amongst already specified epigenetic mechanisms, the posttranslational modification of 
histone proteins, also called histone modification (HM), plays a key role for the establishment 
and maintenance of cellular transcriptional programs. 
 
1.3.4 Histone modifications 
The fundamental repeated subunit of chromatin called “nucleosome” consists of 
chromosomal DNA wrapped around a histone octamer with protein subunits H2A, H2B, H3 
and H4. Posttranslational modifications at the N-terminal tails of histone proteins and the 
existence of histone isoforms display a high possible variability for nucleosomes. Especially 
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covalent modifications like methylation, acetylation and phosphorylation are well studied 
examples of over 130 possible posttranslational HMs (Figure 1) (143,144). Different classes 
of chromatin-modifying enzymes accomplish the posttranslational modification of histone tails 
(97). The “histone code” hypothesis correlates an interaction of posttranslational HMs read 
by effector proteins to functions like DNA replication, recombination and transcription 
(145,146). For example, modified histone tails can form binding sites for specific classes of 
regulatory molecules. Proteins containing bromodomains bind to histone tails with acetylated 
lysine residues, while chromodomain-containing proteins bind to methylated histone lysine 
residues. These histone binding proteins could link covalently modified histone tails to 
transcriptional regulation (147). Posttranslational HMs play also a major role in 
developmental processes and disease, e.g. in cancer progression. 
 
 
Figure 1. Schema of DNA/chromatin structure and site of histone modification 
DNA consists of basic structural units called nucleosomes and is further packed into higher chromatin 
structures and may form chromosomes. The four histone protein subunits (H2A, H2B, H3, H4) of the 
nucleosome octamer can be target of covalent HMs. Various modifications like acetylation, 
methylation, phosphorylation or others can be located at specific N-terminal amino acid residues e.g. 
on lysine 4 (K4) or lysine 27 (K27).  
In fact, several HMs could be linked to functional relevant regulatory sites in the genome and 
moreover assess their transcriptional activity. The trimethylation of histone H3 on lysine 
residue 4 (H3K4me3) was found to be mainly enriched at promoter sites in yeast, mouse and 
human cells, where transcriptional initiation takes place and important TRs like RNA 
polymerase II or TFs can bind (148-150). The simultaneous methylation of lysine residue 27 
of histone protein H3 (H3K27me3) mediated by the polycomp repressor protein complex and 
of lysine 4 (H3K4me3) allowed the identification of bivalently marked poised promoters, 
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silenced in their transcriptional activity and important for a proper and robust differentiation 
(151,152). The polycomb repressor protein family can form different multiprotein complexes 
e.g. with co-repressor BCL6 or E2F6 proteins, which modify histone or other proteins to 
silence transcription (153-155). In contrast, H3K4me3 enriched sites with a simultaneous 
acetylation of histone protein H3 on lysine residue 27 (H3K27Ac) strongly correlated with 
accessible and active promoters at cell type specific promoters, important for the induction 
and maintenance of cellular transcriptional programs (156). Enhancers, another class of 
regulatory sites can further promote gene transcription and are located up- or downstream of 
transcriptional start sites (TSS) with variable distances up to 1 Mb (157). Different states of 
enhancers were previously defined with specific HMs and correlated to the transcriptional 
activity of adjacent genes. First of all, H3K4me1 (monomethylation of lysine residue 4 of 
histone protein H3) a general histone enhancer mark is solely located at weak enhancers 
regulating transcription of moderately active genes (158,159). Active and poised enhancer 
states can be discriminated with additional H3K27Ac or H3K27me3 HMs (68,160,161). Active 
enhancers increase transcriptional rates by the interaction of bound TRs with promoter sites 
or with non-coding enhancer RNA species (eRNAs) stabilizing these interactions (102,162). 
Poised enhancers, previously in an active state during development, were silenced in 
differentiated cells and correlate well with inactive genes. These combinations of HMs were 
established in various studies as standard strategy for the genome wide identification of 
promoter and enhancer states (163-166). 
In summary, histone modifications can control transcription in an activating or repressive 
manner by changing the DNA accessibility and serve as targets for TRs (167). Additionally, 
genome wide epigenetic maps allow the delineation of unknown genes encoding for example 
for regulatory RNA species or new functional cis-regulatory sites. 
 
1.3.5 Super enhancers – A distinct class of cis-regulatory sites 
A special type of cis-regulatory regions were described recently amongst others in embryonic 
stem cells (168) and murine tissue macrophages (169). These super enhancer (SE) sites are 
not only characterized by a strong enrichment for active regulatory marks and TFs but also 
by a monomethylation of the histone protein 3 at the lysine 4 residue (H3K4me1) (170,171). 
Different approaches were used for their identification based on either mediator coactivator 
complex enrichments, essential for embryonic development and maintenance of the ESC 
state (67), or on the HM H3K27Ac present at active regulatory sites (169). Single enhancer 
positions with exceptionally high H3K27Ac signals and with distances less than 12.5 kb to 
each other are integrated into large SE regions. Due to the broad nature of SEs found at 
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genomic regions spanning tens of thousands of bases, new algorithms for their analysis were 
established and integrated into present ChIP-seq data analyzers like the HOMER program 
(72). These genomic regions were found at prominent genes encoding for key regulators 
required for cell identity in different cell types like embryonic stem cells or murine T-cells 
(172,173). In addition, SE also seem to be associated with oncogenic driver genes 
influencing the development and progression of cancer (171). Furthermore, at SE regions 
TRs are cooperatively bound in high numbers in comparison to standard enhancers. Due to 
this synergistic effects of TF binding, SEs can lose activity more rapidly with lower levels of 
regulators bound to the SE locus (174,175). The higher sensitivity of SEs for perturbation 
than typical enhancers, by the loss of key TFs like BRD4, may promote a targeted down-
regulation of adjacent genes and can represent an efficient mechanism to profoundly 
influence oncogenes. SEs play also a major role for activation-induced cytidine deaminase 
(AID) processes, responsible for the initiation of somatic hypermutations during antibody 
maturation and DNA breakage during antibody class switch recombinations (176). As an 
integral part of the epigenetic landscape, SEs regulate diverse cellular functions in many cell 
types. Additionally, they may also reflect the extracellular environment and their formation is 
influenced by extracellular signals, demonstrated in heterogeneous murine tissue 
macrophages showing common macrophage SEs but also activation state specific sites 
(169), whereas the role for SEs during the establishment of different activity states in human 
macrophages still needs to be elucidated. 
 
1.3.6 Epigenetic regulation in macrophages 
Macrophages participate in a wide spectrum of biological processes and diseases, like 
neurological dysfunctions or cancer and are capable of rapid and dramatic alterations in their 
transcriptional programs adapting to environmental stimuli (92). Interestingly, despite the 
same genome and the expression of nearly the same repertoire of TFs, macrophages 
differentiate under various conditions and fulfill various functions after their specialization into 
distinct activation states (177-179). Such specialized programs seem to be based on specific 
combinations of a small number of expressed and repressed gene subsets. Epigenetic 
changes could hold the key to balance these “substantial similarities” with “specialized 
differences” mediating transcriptome variations, which can change cellular functions and 
identity. If epigenetic mechanisms alone or in combination with secondary control 
mechanisms at accessible loci are responsible for certain macrophage activation states is 
still unknown. 
Introduction 
26  
 
Different aspects of complex epigenetic regulatory mechanisms were already subject of 
detailed scientific investigations. First of all, cis-regulatory enhancer regions are established 
and maintained in macrophages mainly by the binding of the lineage determining TF PU.1, 
essential for the macrophage cell type (75,178). Between 35.000 and 45.000 enhancers 
could be identified in murine macrophages (71,72). They are used by signal depending TFs 
to integrate a diverse array of signals with gene transcription. TFs like AP-1 or C/EBP 
strongly correlate with PU.1 bound sites in thioglycolate-elicited mouse macrophages and 
cooperatively displace nucleosome barriers, prior to the establishment of functional 
enhancers (76,180). The identity of TFs cooperating with PU.1 to mediate development or 
survival of macrophages depends on the microenvironment and corresponding macrophage 
function. Tissue macrophages for example display slightly different TF repertoires. Whereas 
microglia located in the central nervous system depend on the TFs IRF8 and SMAD 
mediating TGF-β signaling (181-183), peritoneal macrophages require GATA6 for their 
survival (184). However, different murine spleen macrophage subtypes seem to depend on 
the ETS family TF SPI-C or LXRα (13,185). 
Transcripts of active enhancer sites (eRNA) may also play an important role in the direct 
regulation of the macrophage transcriptome. For instance, Rev-Erb nuclear receptors 
repress the transcription of MMP9 and CX3CR1 genes in mouse macrophages by the direct 
binding of corresponding enhancer sites and mediate the down-regulation of eRNA 
transcripts adjacent to these genes (186). Other regulatory molecules like miRNA-155 can 
down-regulate MIL4 genes in human macrophages by targeting the IL-13Rα1 subunit (187). 
Additionally, identified genomic SE regions in murine macrophages are concomitantly 
enriched for macrophage key TFs like C/EBP and seem to regulate genes responsible for 
cell identity and macrophage specific functions (168).  
Furthermore, recently identified latent or de novo enhancers in mouse macrophages gain 
enhancer associated HMs (H3K4me1) upon macrophage activation and allow the binding of 
regulatory proteins like TFs (73,188). TLR4 stimulation leads to NF-kB activation and finally 
results in PU.1/CEBP binding, which recruits NF-kB p65 to the enhancer site. Histone acetyl 
transferase enzymes (HATs) cause the acetylation of histones and the recruitment of RNA 
Polymerase II mediating in at least some cases the transcription of eRNAs. Histone methyl 
transferases (HMTs) MLL1-4 finally lead to the stabilization of the enhancer characterized by 
the methylation of lysine 4 on histone protein 3. Importantly, latent enhancers keep their 
corresponding H3K4me1 HM signal after loss of the stimulus and upon re-stimulation, a 
faster and stronger induction of macrophages could be detected, thus providing an 
epigenetic memory of the initial stimulation. 
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The histone modification enzyme (HME) repertoire itself can identify different activation 
states of macrophages and are associated with specific macrophage functions. MLL 
enzymes do not only mediate the de novo formation of latent enhancers, but are also known 
to increase the expression of CXCL10 in human and murine macrophages after IFNy/LPS 
stimulation. CXCL10, an important chemokine in MIFNy macrophages attracts T helper 1 cells 
during inflammatory processes (7,189). Other HMEs , especially JMJD3 (Jumonji Domain 
Containing 3) and HDAC3 (histone deacetylase 3) play central roles in macrophage 
differentiation and activation (190). JMJD3 is not exclusively associated to only one 
macrophage population, is essential for the transcription of pro-inflammatory human and 
murine macrophage genes and is crucial for the activation of IL4 macrophages in helminth 
infections and responses to chitin (191-193). Both demethylases JMJD3 and KIAA1718 
cooperate to resolve H3K27me3 repressive marks at genes poised for activation, allow RNA 
Polymerase II travelling and the activation of gene transcription (194). Overall, JMJD3 allows 
the response to different external stimuli in human and murine macrophages. In contrast, 
HDAC3 inhibits the activation of anti-inflammatory IL4 macrophages by the de-acetylation of 
IL-4 induced regulatory regions and promotes MIFNy pro-inflammatory responses in murine 
models (195). In HDAC3 deficient phenotypes, macrophages show MIL4-like properties in the 
absence of external stimuli and are hyper responsive to IL-4. Furthermore, HDAC3 is 
required for the activation of STAT1-dependent inflammatory genes, assessed by defects in 
IFNβ signaling in HDAC3 knockout mouse models (196). The expression and activity of 
HMEs is affected by environmental stimuli and requires the utilization of metabolites. The 
metabolism of MIFNy switches to glycolysis, while MIL4 macrophages perform enhanced fatty 
acid oxidation and mitochondrial oxidative phosphorylation (197-199). Interestingly, the 
inhibition of these metabolic pathways can impair MIFNy or MIL4 activation. Collectively, HMEs 
remodel the epigenetic landscape of macrophages upon environmental stimuli, thus may 
play an important role as linkers between environment, metabolism and macrophage 
activation (200).  
How far in detail epigenetic processes are involved in the alteration and maintenance of 
transcriptional programs, specifically during the generation of primary human macrophage 
subsets still needs to be elucidated. 
 
1.4 Next generation sequencing technology 
Next generation sequencing (NGS) technology, an essential prerequisite for the modern high 
throughput epigenetic analysis of living cells, was developed in the early 2000s to combine 
the principle of DNA sequencing technology with a high throughput approach to massively 
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parallel sequence short DNA reads using solid phase sequencing by reversible terminators. 
In contrast to the ChIP-chip array technology, where ChIP-DNA fragments were identified by 
the hybridization to a microarray, in ChIP-seq experiments the ChIP-DNA is directly 
sequenced with higher resolution, fewer artefacts and greater coverage in a massively 
parallel fashion (201). The exponential increase of deep sequencing data set numbers 
generated with quite variable techniques required the establishment of standardized rules 
and optimized protocols to enable the integration and comparison of different data sets and 
to increase their overall accuracy and quality. For this purpose, the ENCODE and Roadmap 
Epigenomics Projects (202-204) did not only release tight quality protocols to ensure high 
quality sequencing data sets but also contributed gigantic data repositories to distribute 
thousands of NGS experiments to literally everyone. This approach allows the integration of 
data on regulatory processes to generate piece by piece a broader picture of the cellular 
regulatory landscape. Especially for cell line data sets this is already feasible, due to their 
highly abundant data availability, but it is also more and more possible for primary cells finally 
correlating epigenetic, transcriptional and translational data. 
 
1.4.1 Next generation sequencing method variations 
High throughput sequencing experiments were initially designed to identify enriched genomic 
regions for a protein of interest (ChIP-seq). The creative usage of digestion enzymes or 
different separation protocols for the isolation of specific RNA or DNA molecules multiplied 
the potential areas of application. Many aspects of cellular regulation can now be subject of 
detailed high throughput experiments, like epigenetics or transcriptional regulation. 
Three NGS methods are specialized on the analysis of cellular DNA methylation and utilize 
different working principles (205,206). (I) In MRE-seq experiments (Methylation-sensitive 
Restriction Enzyme sequencing) methyl-sensitive restriction enzymes digest genomic DNA 
and finally lead to the identification of CpG methylated genomic sites. A disadvantage of this 
method is its incomplete enzymatic digestion that can lead to less accuracy and potentially 
biased sequencing results. Other more cost efficient approaches use affinity-based 
enrichment assays to select for methylated fragments in sonicated chromatin with an 
antibody or a methyl-binding domain. These sequencing methods are called (II) MeDIP-seq 
(Methylated DNA Immunoprecipitation sequencing) or MBD-seq (Methyl-CpG Binding 
Domain sequencing) (207,208). Other approaches like (III) Bisulfite sequencing experiments 
use a chemical conversion step to distinguish methylated from unmethylated cytosines 
(MethylC-seq) (209). After the discovery of four cytosine variants including intermediate 
states (210,211) classical MethylC-seq experiments were adapted due to their inability to 
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distinguish between the four cytosines (212). Enhanced OxBS-seq (Oxidative BiSulfite 
sequencing) or TAB-seq (TET Assisted Bisulfite sequencing) protocols can now discriminate 
between cytosine variants and produce accurate single-base resolution maps, despite 
concerns like DNA damage due to chemical treatments and their dependency on the 
enzymatic activity of TET (213,214) 
The genome in eukaryotes is structured into basic nucleosome units and eventually forms 
chromosomes through a series of higher order structures. Genome-wide nucleosome 
positioning can be assessed by the enzymatic micrococcal nuclease digestion of chromatin 
(MNase-seq) which is afterwards used as input for following NGS. DNA wrapped around 
nucleosomes or occupied by TFs is protected from digestion and - after a purification step 
and the sequencing of 150 bp nucleosomal DNA segments - allows the identification of 
nucleosome protected regions. Genomic loci vary in their accessibility due to their packaging 
status which is mediated amongst others by nucleosomes and therefore promote or interfere 
with their capabilities to be bound by proteins. Transcriptionally active regulatory regions like 
promoters, enhancers, insulators and silencers are tightly correlated to open chromatin 
positions and are targets of specific transcriptional regulatory proteins. In DNase-seq (DNase 
I hypersensitive sites sequencing) experiments open regulatory regions are identified due to 
their vulnerability to DNase I enzymatic digestions. These experiments finally result after 
DNAse I enzymatic treatment in nucleosome depleted open chromatin fragments (215). 
FAIRE-seq (Formaldehyde-assisted isolation of Regulatory elements), another approach to 
analyze chromatin accessibility uses formaldehyde cross-linked chromatin as input and an 
ultrasound mediated DNA shearing is performed (216). Open regulatory sites are more 
sensitive to ultrasonic shearing and thus can be sequenced after DNA purification. Another 
approach uses transposase enzymes (ATAC-seq), which shear open chromatin regions and 
integrate primer sequences into the cleaved genomic DNA (217). The biggest advantage for 
the analysis of nucleosome-free and open positions is the global identification of regulatory 
elements and protein binding sites without prior knowledge of TRs. Interestingly, specific 
nucleosome-free regions (NFR) e.g. at promoter sites can also be identified by a 
bioinformatics approach using HM data sets like H3K4me3 (tri-methylation of lysine 4 on 
histone protein 3) independently of previously listed methods with tools like the HOMER 
program to analyze the specific HM enrichment patterns (72,218). 
For mapping higher order chromatin architectures, a variety of protocols was established. 
E.g. in all 3C (Chromosome Conformation Capture) methods formaldehyde cross-linked 
chromatin is digested with a restriction enzyme. An intramolecular ligation of DNA ends in 
close proximity to each other further allows the identification of ligation frequencies between 
two restriction fragments (one-to-one) and is finally measured by qPCR with specific primer 
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sequences (219). Variations of the 3C protocol measure the genome wide interaction 
frequency of one target site with 4C-seq experiments (Circular Chromosome Conformation 
Capture sequencing) (one-to-all), while many anchor and bait primers can identify thousands 
of interactions between targets in the 5C-seq method (Chromosome Conformation Capture 
Carbon Copy sequencing) (many-to-many) (220,221). Hi-C sequencing, the newest 
breakthrough in chromatin conformation measurements can identify possible interaction 
frequencies from an entire genome with itself in all combinations (all-to-all) (222). Chimeric 
DNA ligation junctions are selected with a biotin labeled nucleotide incorporated at the 
ligation junction and are subsequently used for NGS. The ChIA-PET (Chromatin Interaction 
Analysis by Paired-End Tag sequencing) protocol even combines the Hi-C method with the 
analysis of proteins like TFs or RNA polymerases interacting with the nuclear organization 
(223). Interestingly, Hi-C experiments identified cell type and species specific 1 Mb regions 
with high local interaction frequencies separated by boundary regions and were termed 
“topologically associated domains” (TADs) (224). TADS consist of regulatory elements like 
promoters or enhancers interacting with each other by DNA looping and can even separate 
chromosomes into higher structured compartments called chromosome territories (222). 
NGS methods were also extended to the analysis of RNA molecules (225) to quantify known 
and unknown transcripts with corresponding splice junctions (226,227), alternative splicing 
(228,229) and even single nucleotide polymorphisms (SNPs) (230). Transcriptome analysis 
by massively parallel sequencing outperforms previous techniques like Sanger sequencing 
or microarray-based methods in resolution and accuracy. In RNA-seq experiments cellular 
total RNA, mRNA with poly-A tails, even micro RNA or other small non-coding RNA species 
(miRNA-seq) serve as input material for the complementary cDNA construction followed by 
RNA library preparation and high throughput sequencing. Standard RNA-seq protocols do 
not preserve the information about which strand was originally transcribed. Newer strand 
specific RNA-seq protocols can discriminate between RNA originated from + or – strand DNA 
(231). This enhanced RNA-seq protocol enables the accurate identification of regulatory 
antisense transcripts (232) or the correct measurement of expression levels for coding and 
non-coding transcripts located at overlapping genomic positions. Derivatives of RNA-seq 
experiments also allow the analysis of nascent RNA products measuring rates of 
transcription instead of steady state RNA levels (GRO-seq, Global Run-On sequencing) 
(232). During a chemically induced transcriptional pause, labeled nucleotides are added to 
isolated nuclei and transcription is briefly resumed. Therefore, the quantity and location of 
newly transcribed RNA molecules can be identified by sequencing the labeled RNA products. 
Furthermore, RNA-seq protocols were adapted to closely monitor translational processes 
(Ribo-seq, Ribosomal sequencing) (233). Only ribosome protected mRNA is isolated and 
used for sequencing experiments to detect global ribosomal densities along mRNA 
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transcripts (234) and translational start sites (235). RNA-seq experiments are the ideal tool to 
elucidate transcriptional and translational processes on a global cellular scale. Nevertheless, 
challenging bioinformatics data analysis requires correction and normalization steps to 
correctly transform experimental data into a profound biological interpretation (236). 
Chromatin immunoprecipitation following deep sequencing (ChIP-seq) identifies genome 
wide binding patterns of proteins directly or indirectly bound to chromatin or covalent 
posttranslational modifications of histone proteins. In this method, formaldehyde cross-linked 
chromatin is sheared and DNA-protein complexes are immunoprecipitated with specific 
antibodies against a protein of interest. After the purification of ChIP-DNA, known adapter 
sequences are ligated to both ends and PCR reactions multiply the DNA amounts. Finally, 
the ChIP-seq library is sequenced and resulting sequence reads are computationally aligned 
to a reference genome for the corresponding species to find peak positions enriched for the 
protein of interest. Antibody quality plays an exceptionally high role for valid and accurate 
sequencing results and greatly influences unspecific and background signal intensities (204). 
The amount of starting material can also impact sequencing results. Especially for primary 
cells ChIP-seq experiments can be challenging and the success is not guaranteed while 
using less than 5 million cells for TF associated experiments and less than 1 million cells for 
detecting HM enrichments. Low cell protocols like ChIP-nano were adapted to overcome at 
least partially the cell number requirement hurdle using 50.000 cells or less by reducing 
sample loss, adapting shearing conditions and washing steps (237,238). Another protocol 
(ChIP-exo, exonuclease sequencing) increases footprinting resolution to nucleotide 
resolution by the 5’-to-3’ exonuclease digestion of sonicated ChIP DNA ends up to the cross-
linked protein. In general, the ChIP-seq method, can identify the genomic positions of 
histones and HMs, as well as TFs, DNA or histone modifying enzymes and other chromatin 
associated proteins. Careful experimental design and data analysis is required to minimize 
false-positive and background signals negatively affecting the correct identification of sites 
enriched by a protein of interest in ChIP-seq experiments. 
 
1.4.2 Technical considerations for ChIP-seq experiments 
ChIP-seq experiments can provide detailed genomic data on many regulatory levels in living 
cells and their design depends on the scientific question and chosen experimental protocol. 
Nevertheless, due to the complexity of experimental design, sequencing and data analysis 
multiple sources of variance need to be considered to allow a precise and correct biological 
data interpretation. First of all, the chromatin structure itself influences the performance of 
shearing experiments creating sites of variable fragility which depends on the hetero- or 
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euchromatin status, thus rendering euchromatic DNA more vulnerable to shearing (239). 
Under consistent shearing conditions using a highly efficient and standardized ultrasonic 
shearing device e.g. from Covaris with the same shearing protocols for target and control 
samples, the effects of this hurdle can be sufficiently abrogated. Incomplete protein digestion 
with the proteinase K enzyme could lead to biases due to the differential solubility of nucleic 
acids and proteins during phenol-chloroform extraction, which is still a widely used method 
during ChIP-seq experiments (240). Moreover, PCR over-amplifications due to inefficient 
amounts of immunoprecipitated ChIP-DNA is especially a problem while using low-cell 
protocols and can further create false-positive signals (241).  
The choice between two different ChIP-seq approaches can additionally introduce variance. 
The X-Chip method uses formaldehyde to tightly fix proteins to corresponding genomic 
positions, which allows the study of non-histone proteins directly or even indirectly bound to 
DNA (242,243). A possible disadvantage is the inefficient antibody mediated precipitation due 
to potential masking of antibody epitopes during fixation and may require higher numbers of 
PCR cycles for sufficient DNA amplification. One positive aspect of X-ChIP experiments is 
the minimal chromatin rearrangement during ChIP-seq procedures. However, the N-ChIP 
method uses chromatin in its natural state without a fixation step and is specifically designed 
for proteins with strong DNA interactions e.g. histone proteins (244). In this protocol the 
chromatin shearing can be for example performed by an enzymatic digestion using the 
MNase enzyme (Microoccal nuclease) (245). N-ChIP is normally not suitable for non-histone 
proteins, shows more pronounced sequencing bias than sonication and protein 
rearrangements could occur during chromatin preparation. (246). An over-digestion of 
chromatin can be controlled by thoroughly assessing optimal temperature and duration of 
MNase treatments. Positive aspects of N-ChIP experiments are e.g. the increased mapping 
resolution after MNase digestion by removing linker DNA more efficiently compared to an 
ultrasound mediated shearing. Furthermore, the generation of specific antibodies is normally 
performed with not-cross-linked peptides or proteins and is therefore more predictable for 
natural chromatin and can lead to a very efficient immunoprecipitation.  
Mentioned examples of technical and biological variances create different kinds of false-
positive ChIP-seq tag (short sequence reads) signals and need to be clearly discriminated 
during peak calling from biological relevant and specific ChIP-seq peak data (Figure 2). The 
antibody performance is critically important for successful ChIP-seq experiments and 
methods like immunoblotting or ChIP-string can assess their specificity and affinity 
(204,247,248). The amount of background noise and non-specific peak signals are inevitably 
connected to antibody quality. They can bind non-specifically with the constant FC region to 
DNA and beads or bind specifically by a cross-reaction to irrelevant epitopes introduced 
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during immunization. Especially for experiments with low enrichments of TF proteins the 
proper identification of significant peaks remains difficult (249). Another type of false-positive 
sites called “hyper ChIPable” regions were recently described in yeast and are characterized 
by huge amounts of non-specific ChIP enrichments for proteins like RNA polymerase II or 
various TFs, irrespective of protein origin (250). Even artificial proteins like GFP were bound 
to these regions in high amounts. These transcriptional active euchromatic sites are also 
vulnerable to DNase I cleavage. Hyper-ChIPable regions seem to display a general 
characteristic of the ChIP procedure per se. DNA from highly transcribed and open regions 
without a densely packed nucleosomal structure could promote stronger electrostatic 
interactions with antibodies or beads used during ChIP experiments. The ChIP antibody 
could also non-specifically interact with RNA polymerase II or III bound at these sites. 
 
 
Figure 2. Schematic overview of variances influencing ChIP-seq data files. 
Sources for true- or false-positive ChIP-seq signals with corresponding graphical schema of raw tag 
signals and called peak positions marked with black bars. Figure has been previously published as 
part of manuscript “Optimization of transcription factor binding map accuracy utilizing knockout-mouse 
models” by myself as first shared author (Krebs, W.*, Schmidt, S.V.*,” et al.). 
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True-positive and biological relevant ChIP-seq signals can be identified and separated from 
false-positive signals like background, non-specific and hyper-ChIPable signals or signals 
created by other technical variances, by the usage of ChIP-seq control data sets (204,251). 
For the first type of possible control sheared “input” chromatin is used, which cannot display 
the ChIP enrichments for specific binding sites of a protein of interest. Input chromatin allows 
an estimation of chromatin distribution and bias, but lacks the integration of variances 
occurring during the chromatin immunoprecipitation (ChIP). In a “mock” ChIP reaction, also 
called “IgG” control, an unspecific control antibody with the same immunoglobulin class than 
the target ChIP antibody reacts with irrelevant antigens on sheared chromatin. IgG controls 
mimic a ChIP experiment more closely than Input DNA but could recover not enough DNA 
amounts to create ChIP-seq libraries with sufficient complexity, thus introducing significant 
amounts of bias. A third type of control utilizing protein knockout (KO) experiments was until 
now only sparsely used in ChIP-seq experiments, combines the positive effects of input and 
IgG controls and simultaneously compensates for some of their negative properties. KO 
controls undergo the same experimental procedures as the ChIP-seq sample, thus 
representing the same bias. KO associated immunoprecipitations also normally result in 
sufficient amounts of ChIP DNA in comparison to the IgG control to produce control libraries 
with enough complexity to finally discriminate true- and false-positive sites without 
introducing additional bias. More importantly, KO controls could identify hyper-ChIPable 
regions in contrast to input controls and could exclude these highly expressed false positive 
sites from the analysis (250). 
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2. Objectives 
The next generation sequencing technology, a very useful but complex method to gain 
insights into a plethora of scientific biological questions evolved in an astonishing way the 
last couple of years concerning data analysis strategies as well as in experimental methods. 
Thus, specific guidelines were recently published to ensure the comparability and 
reproducibility of ChIP-seq experiments (204). The ENCODE consortium did not specifically 
focus on knockout (KO) models and sparsely performed previous experiments concentrated 
more on the aspect of induced biological changes after the KO of a protein of interest in 
comparison to the WT situation. Therefore, it was speculated that KO experiments could be 
used as ChIP-seq control experiments, especially due to the known disadvantages of 
described IgG and Input chromatin controls to improve ChIP-seq data analysis (251).  
These observations raised several questions: Can the standard ChIP-seq data analysis 
benefit from knockout controls used in the KO Implemented Normalization method (KOIN) 
method? In which extent influences KOIN false-positive signal ratios and more importantly 
the biological interpretation of ChIP-seq data? These questions were addressed with the 
establishment of KOIN utilizing six ChIP-seq data sets from mice, either generated with 
different antibodies or under different stimulatory conditions and with the assessment of the 
results in comparison to the standard ChIP-seq analysis. 
In addition, in respect to the newly described spectrum model of human macrophage 
activation (21), the underlying complex mechanisms for their differential transcriptional 
programs need to be further elucidated. Previous observations in murine and human 
macrophages connecting epigenetic changes and transcriptional regulation already revealed 
useful insights into macrophage biology (62,157,161,252). An adapted approach for 
differentially activated primary human macrophages could further expand the knowledge of 
the underlying regulatory mechanisms for macrophage specialization. 
Different questions arose in this matter: Is there a common macrophage core signature also 
visible on the epigenetic level? How extensive are the epigenetic differences for activated 
human macrophages? Do super-enhancers play a role in macrophage activation? Are 
important TRs differentially regulated on the epigenetics level? Four differentially activated 
primary human macrophages were generated to detect their epigenetic activity states at 
promoter, enhancer or super-enhancer positions with the analysis of ChIP-seq data sets for 
four histone modifications (HM) in different combinations (H3K4me1, H3K4me3, H3K27Ac, 
H3K27me3). The HM data was subsequently correlated to RNA-seq expression data to find 
answers for the previously described questions. 
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3. Materials 
 
3.1. Chemicals and Reagents 
Agencourt AMPure XP beads Beckman Coulter, Brea, USA 
BSA New England Biolabs, UK 
CFSE  Sigma-Aldrich, München, DE  
Complete protease inhibitors Hoffmann-La Roche, Basel, CH 
dATP New England Biolabs, UK 
Dimethylsulfoxid Sigma-Aldrich, München, DE  
dNTP solution New England Biolabs, UK 
Dynabeads protein G Invitrogen Life Technologies, Karlsruhe, DE  
Dynabeads® M-450  InvitrogenLifeTechnologies,Karlsruhe, DE  
EDTA Calbiochem, San Diego, USA 
EGTA Calbiochem, San Diego, USA 
Ethanol  Roth, Karlsruhe, DE  
Ethylendiamintetraacetat Sigma, St Louis, USA  
Fetal calf serum Invitrogen LifeTechnologies,Karlsruhe, DE  
Formaldehyde 16% (wt/vol) Thermo Scientific 
Glutamax  Invitrogen Life Technologies, Karlsruhe, DE  
Glycerol Calbiochem, San Diego, USA 
Glycine Calbiochem, San Diego, USA 
Glycogen Roche Diagnostics GmbH, Mannheim, DE 
HEPES buffer Calbiochem, San Diego, USA 
Ionomycin  Sigma Aldrich, Taufkirchen, DE  
Klenow enzyme New England Biolabs, UK 
KOH solution Sigma Aldrich, Taufkirchen, DE  
Lithium chloride Sigma Aldrich, Taufkirchen, DE  
MicroBeads CD14+  MiltenyiBiotech, Bergisch Gladbach, DE  
MNase enzyme Sigma Aldrich, Taufkirchen, DE  
NEB buffer 2  New England Biolabs, UK 
N-Lauryl-sarcosine Sigma Aldrich, Taufkirchen, DE  
NP-40 Calbiochem, San Diego, USA 
Pancoll  PAA Laboratories GmbH, Pasching, AT  
PBS  PAA Laboratories GmbH, Pasching, AT  
PEG-8,000  Sigma Aldrich, Taufkirchen, DE  
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Pfu Ultra buffer Agilent Technologies, USA 
Pfu Ultra II fusion  Agilent Technologies, USA 
Propidium Iodide  Sigma Aldrich, Taufkirchen, DE  
Prostaglandin E2  Sigma Aldrich, Taufkirchen, DE  
Proteinase K Invitrogen LifeTechnologies,Karlsruhe, DE  
QIAzol®  Qiagen, Hilden, DE  
Quick ligase  New England Biolabs, UK 
Quick ligation buffer New England Biolabs, UK 
Rnase A Hoffmann-La Roche, Basel, CH 
RPMI 1640 PAA Laboratories GmbH, Pasching, AT  
SDS Calbiochem, San Diego, USA 
Sodium acetate Roth, Karlsruhe, DE  
Sodium chloride Roth, Karlsruhe, DE  
Sodium deoxycholic acid  Calbiochem, San Diego, USA 
Sodium hydroxide Merck, Darmstadt, DE  
T4 DNA polymerase New England Biolabs, UK 
T4 ligase buffer New England Biolabs, UK 
T4 polynucleotide kinase New England Biolabs, UK 
Trichloroaceticacid  Merck, Darmstadt, DE  
TRIS (hydroxymethyl)-aminomethane  Roth, Karlsruhe, DE  
Tris buffer Calbiochem, San Diego, USA 
Triton X-100 Calbiochem, San Diego, USA 
Trypanblue  Merck, Darmstadt, DE  
Tween-20 Calbiochem, San Diego, USA 
Water, molecular biology grade Sigma Aldrich, Taufkirchen, DE  
 
3.2. Cytokines 
rh GM-CSF Immunotools, Friesoythe, DE 
rh IL-4 Immunotools, Friesoythe, DE 
rh IFNy Immunotools, Friesoythe, DE 
rh TNF-α Immunotools, Friesoythe, DE 
Pam3Cysk4 Invivogen, San Francisco, USA 
PGE2 Sigma Aldrich, Taufkirchen, DE  
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3.3. Antibodies 
ChIP antibodies 
Antigen Host IgG Type Company 
H3K27Ac Rabbit Polyclonal Abcam, Cambridge, UK 
H3K27me3 Rabbit Polyclonal Merck Millipore, Billerica, USA 
H3K4me1 Rabbit Polyclonal Abcam, Cambridge, UK 
H3K4me3 Rabbit Monoclonal Merck Millipore, Billerica, USA 
PU.1 Rabbit Polyclonal Santa Cruz Biotechnology, Dallas, USA 
RNA-Pol II Rabbit Polyclonal Santa Cruz Biotechnology, Dallas, USA 
 
Antibodies for flow cytometry 
Antigen Fluorophore Company 
CD11c PE BD Biosciences, Heidelberg, DE 
CD14 APC BD Biosciences, Heidelberg, DE 
CD14 Pacific Blue Biolegend, San Diego, USA 
CD19 FITC BD Biosciences, Heidelberg, DE 
CD206 APC BD Biosciences, Heidelberg, DE 
CD23 FITC BD Biosciences, Heidelberg, DE 
CD25 FITC BD Biosciences, Heidelberg, DE 
CD3 FITC Biolegend, San Diego, USA 
CD56 PE BD Biosciences, Heidelberg, DE 
CD86 APC Biolegend, San Diego, USA 
 
 
3.4. RT-PCR primers 
Primers were designed with the Beacon Designer software and oligonucleotides were 
ordered from Sigma-Aldrich (Taufkirchen, DE). Semi-quantitative real time PCR experiments 
were performed with listed primers to validate performed ChIP-seq experiments. Primers 
were either designed to target sites with known associated HM enrichments as positive 
controls (pos.) or negative sites without corresponding target HM (neg.). 
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Target Gene Sequence 5' to 3' Purpose 
GAPDH_1 tactagcggttttacgggcg H3K4me3 pos. / H3K27me3 neg. 
  tcgaacaggaggagcagagagcga H3K4me3 pos. / H3K27me3 neg. 
Bmp2 ctcagcactccgcatttg H3K27me3 pos. / H3K4me3 neg. 
  ctcccatccaacgcttag H3K27me3 pos. / H3K4me3 neg. 
GAPDH_2 gccttgctcttgctactc H3K4me1 pos. 
  gcctgcctggtgataatc H3K4me1 pos. 
GAPDH_3 atctcagtcgttcccaaagtc H3K27Ac pos. 
  gtgatcggtgctggttcc H3K27Ac pos. 
Chr5_Intergenic_region gaacaactggatgggacaaac H3K4me1 neg / H3K27Ac neg. 
  acacgaatggaaccttatatctg H3K4me1 neg / H3K27Ac neg. 
 
3.5. Plastic ware 
0,2 - 2 ml Eppendorf tubes Eppendorf GmbH, Hamburg, DE 
1.7 ml siliconized tubes Sigma Aldrich, Taufkirchen, DE 
Falcon 15 ml Greiner bio-one, Frickenhausen, DE 
Falcon 250 ml 
Corning Life Sciences, Tewksbury, 
USA 
Falcon 50 ml Greiner bio-one, Frickenhausen, DE 
LS columns 
Miltenyi Biotech, Bergisch Gladbach, 
DE 
Microtube, AFA fiber Covaris, Woburn USA 
Nunclon™ 24-well tissue culture plate Thermo Scientific, Rockford, US 
Nunclon™ 48-well tissue culture plate Thermo Scientific, Rockford, US 
Nunclon™ 6-well tissue culture plate Thermo Scientific, Rockford, US 
Parafilm Pechiney, Chicago, US 
Pipette filter tips, 10, 200, 1000 μl Starlab GmbH, Hamburg, DE 
Pipette tips, 10, 200, 1000 μl Greiner bio-one, Frickenhausen, DE 
Pipettes 2, 5, 10 and 25 ml Greiner bio-one, Frickenhausen, DE 
Pre-Separation Filters 
MiltenyiBiotech, Bergisch-Gladbach, 
DE 
Slide-A-Lyzer 3.5K dialysis cassette Thermo Scientific, Rockford, USA 
Sterile filter 22 μm Sartorius, Hannover, DE 
Syringe 50 ml Braun, Melsungen, DE 
 
Methods 
40  
 
3.6. Equipment 
Auto MACS pro separator  MiltenyiBiotech, Bergisch Gladbach, DE  
Bandelin Sono Plus Bandelin, Berlin, DE 
BD LSR II Flow cytometer  BD Biosciences, Heidelberg, DE  
Bioanalyzer Agilent Technologies, Santa Clara, USA 
BioDoc Analyze Biometra, Jena, DE 
cBot Illumina, Eidenhoven, NL  
Centrifuge Type 5415  Eppendorf GmbH, Hamburg, DE  
Centrifuge Type 5424  Eppendorf GmbH, Hamburg, DE  
Centrifuge Type 5810R  Eppendorf GmbH, Hamburg, DE  
Covaris S220 LGC Genomics, Berlin, DE 
Eppendorf Concentrator Plus Eppendorf GmbH, Hamburg, DE  
HiScanSQ system  Illumina, Eidenhoven, NL  
HiSeq 1500 Illumina, Eidenhoven, NL  
Incubator Binder B series  Binder, Tuttlingen, DE  
Incubator Binder C series  Binder, Tuttlingen, DE  
LightCycler 480 PCR system  Roche diagnostics, Basel, Switzerland  
Magnet MACS Multi Stand  MiltenyiBiotech, Bergisch Gladbach, DE  
Magnet MPC-S  DynalBiotech, Oslo, NO  
Mikroskope SM-LUX  Leitz, Wetzlar, DE  
NanoDrop  2000 Thermo Scientific, Rockford, USA  
Neubauer chamber  Carl Roth Karlsruhe, DE  
Odyssey® Infrared Imaging System  LI-COR Biosciences, Bad Homburg, DE  
Orbital shaking incubator  Stuart, Sttafordshire, UK  
pH-meter  Knick, Berlin DE  
Pipette boy  IBS Integra Biosciences, CH  
PowerPac HC Power Supply  Bio-Rad Laboratories, München, DE  
Roller Mixer SRT 1  
Stuart, Staffordshire, UKMettler-Toledo, 
Zwingenberg, DE  
Shaker (type 3011)  GFL, Burgwedel, DE  
Tapestation Agilent Technologies, Santa Clara, USA 
Water bath Memmert, Schwabach, DE 
 
3.7. Buffers and media 
A-base addition buffer (XChIP) 
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6 µl 10x NEB buffer 2, 0.1 µl dATP (100 mM), 10.9 µl nuclease free water 
Adapter ligation buffer (XChIP) 
 
29 µl 2x DNA quick ligase buffer 
End Repair Buffer (XChIP) 
 
6.7 µl 10x T4 DNA ligase buffer, 0.67 µl BSA (10 mg/ml), 0.67 µl dNTP mix 
(10 mM), 16.96 µl nuclease free water 
LiCl buffer (NChIP) 
 
0.25 M LiCl, 0.5 % NP-40, 0.5 % sodium deoxycholate 
MACS buffer  
 
1 x PBS supplemented with 0.5 % BSA, 2 mM EDTA, pH=7.2 sterile-filtered 
MNase digestion buffer (NChIP) 
 
50 mM Tris-Cl (pH 7.6), 1 mM CaCl2, 0.2% Triton X-100, 5 mM sodium 
butyrate, protease inhibitor cocktail (working concentration), 0.5 mM PMSF 
MNase stop buffer (NChIP) 
 
10 mM Tris-Cl (pH 7.6), 10 mM EDTA 
PBS (NChIP) 
 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
RIPA buffer (NChIP) 
 
10 mM Tris-Cl (Ph 7.6), 1 mM EDTA, 0.1 % SDS, 0.1 % sodium 
deoxycholate, 1 % Triton X-100 
RIPA-NaCl buffer (NChIP) 
 
0.3 M NaCl added to RIPA buffer 
TE buffer (NChIP) 
 
10 mM Tris (pH 8.0), 1 mM EDTA 
TE/Triton X-100 buffer (NChIP) 
 
0.2 % Triton X-100 added to TE-buffer 
 
3.8. Kits 
Bioanalyzer high sensitivity DNA kit Agilent Technologies, Santa Clara, USA 
ChIP-seq sample preparation kit Illumina, Eidenhoven, NL  
KAPA SYBR FAST Roche LightCycler 
480 2X qPCR Master Mix 
KAPABiosystems, Wilmington, USA 
 
Maxima SYBR Green qPCR Master Mix Fermentas, GmbH, DE 
Multiplex sequencing primer kit Illumina, Eidenhoven, NL  
NextFlex ChIP-Seq Barcodes - 48 Bioo Scientific, Austin, USA 
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QIAquick PCR Purification Kit Qiagen, Hilden, DE 
QIAquick Gel Extraction Kit Qiagen, Hilden, DE 
Tapestation DNA high sensitivity kit Agilent Technologies, Santa Clara, USA 
Truseq DNA sample preparation kit v1/v3 Illumina, Eidenhoven, NL  
Truseq RNA sample preparation kit v3 Illumina, Eidenhoven, NL  
Truseq SBS Kit v1/v3 Illumina, Eidenhoven, NL  
 
3.9. Software 
Beacon Designer PREMIER Biosoft, Palo Alto, USA 
Bowtie 0.12.8 Ben Langmead, Cole Trapnell, USA 
Circos 0.65 
Martin Krzywinski, Canada’s Michael 
Smith Genome Sciences Centre, CA 
Cluster 3.0 Michael Eisen, Stanford University, USA 
CorelDRAW X6 Corel Corporation, Ontario, CA 
DESeq2 package (R-package) 
Michael I Love, Harvard School of Public 
Health, USA 
Eland 1.8 (NGS Alignment) Illumina, Einhoven, NL 
Endnote X5 Thomson Reuters, Carlsbad, USA 
FACSDiva BD Biosciences, Heidelberg, GER 
Flowjo 7.6.2 Tree Star, Ashland, USA 
GenomeStudio Illumina, Einhoven, NL 
HOMER 4.3 Chris Benner, UCSD/Salk Institute, USA 
Integrative Genomics Viewer Broad Institute, Cambridge, USA 
Java Treeview 3.0 Alok Saldanha, GPLv2 License 
LightCycler 480 SW 1.5 Roche applied sciences, Basel, CH 
MACS 1.4.2 
Yong Zhang, Tao Liu, Xiaole Shirley Liu 
Lab, USA 
Microsoft Office Microsoft GmbH, Unterschleissheim, DE 
Partek genomics suite Partek, St Louis, Missouri, USA 
Python 2.6.9 
The Python Software Foundation, 
Delaware, USA 
R 2.15.0 - Programming language 
Ross Ihaka, Robert Gentleman, GNU 
General Public License, USA 
Samtools 0.1.18 Heng Li, BSD License/MIT License 
SigmaPlot 12.0 Systat Software GmbH, San José, USA 
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TopHat2 
Daehwan Kim, University of Maryland, 
USA 
 
3.10. Next generation sequencing data sets 
All utilized next generation sequencing data sets are available for download from various 
sources and are listed in Table 1. 
Table 1. Utilized next generation sequencing data sets 
ChIP-seq data set name Source GEO ID 
GATA3 (WT) http://www.ncbi.nlm.nih.gov/geo/ GSM523224 
GATA3 (KO) http://www.ncbi.nlm.nih.gov/geo/ GSM742022 
SRF (WT) http://homer.salk.edu/homer/data/index.html - 
SRF (KO) http://homer.salk.edu/homer/data/index.html - 
PU.1 (WT) http://www.ncbi.nlm.nih.gov/geo/ GSM538003 
PU.1 (KO) http://www.ncbi.nlm.nih.gov/geo/ GSM537999 
ATF3Unstim (WT) http://www.ncbi.nlm.nih.gov/geo/ GSM1334036 
ATF3Unstim (KO) http://www.ncbi.nlm.nih.gov/geo/ GSM1334037 
ATF3HDL (WT) http://www.ncbi.nlm.nih.gov/geo/ GSM1334038 
ATF3HDL (KO) http://www.ncbi.nlm.nih.gov/geo/ GSM1334039 
ATF3HDL+CpG (WT) http://www.ncbi.nlm.nih.gov/geo/ GSM1334040 
ATF3HDL+CpG (KO) http://www.ncbi.nlm.nih.gov/geo/ GSM1334041 
ATF3LPS 0-120min. (WT) http://www.ncbi.nlm.nih.gov/geo/ GSE36104 
HM H3K4me3 (Mb) http://www.ncbi.nlm.nih.gov/geo/ GSM1146439 
HM H3K4me3 (MIFNy) http://www.ncbi.nlm.nih.gov/geo/ GSM1146440 
HM H3K4me3 (MIL4) http://www.ncbi.nlm.nih.gov/geo/ GSM1146441 
HM H3K4me3 (MTPP) http://www.ncbi.nlm.nih.gov/geo/ GSM1146442 
HM H3K27me3 (Mb) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27me3 (MIFNy) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27me3 (MIL4) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27me3 (MTPP) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27Ac (Mb) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27Ac (MIFNy) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27Ac (MIL4) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K27Ac (MTPP) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K4me1 (Mb) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K4me1 (MIFNy) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K4me1 (MIL4) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM H3K4me1 (MTPP) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
HM murine tissue MФ http://www.ncbi.nlm.nih.gov/geo/ GSE63339 
RNA-Seq (Mb) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
RNA-Seq (MIFNy) http://www.ncbi.nlm.nih.gov/geo/ GSE36952 
RNA-Seq (MIL4) http://www.ncbi.nlm.nih.gov/geo/ GSE36952 
RNA-Seq (MTPP) http://www.ncbi.nlm.nih.gov/geo/ GSE66595 
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Datasets for the analysis of 7 human tissues (5.2.7) are contained within Release 9 of the 
Human Epigenome Atlas (http://www.epigenomeatlas.org). In addition, 7 murine tissue 
macrophage datasets (5.2.8) are available under the main GEO accession number 
GSE63341, with the subseries accession numbers GSE63339 and GSE63340 for ChIP-seq 
and RNAseq experiments. 
Data was either used in the Fastq file format or as SRA files (GEO). SRA files required an 
additional conversion step into the FastQ file format (see Methods section 4.8.1). 
 
4. Methods 
Buffy coats from healthy donors were obtained from the Institute for Experimental 
Hematology and Transfusion Medicine of the University Hospital Bonn following protocols 
accepted by the institutional review board at the University of Bonn (local ethics vote no. 
045/09). Informed written consent was provided for each specimen according to the 
Declaration of Helsinki. 
 
4.1. Isolation of monocytes 
Peripheral blood mononuclear cells (PBMCs) were isolated in a Pancol density gradient by 
centrifugation at 250g for 25 minutes at room temperature. The interface containing the 
PBMCs was collected, washed twice with PBS and resuspended in 3 ml of MACS buffer. The 
fraction of white blood cells was incubated for 20 minutes in 200 µl CD14+ magnetic beads to 
isolate CD14 positive monocytes with the magnetic assorted cell sorting technique (MACS) 
according to the manufacturer’s protocol. LS columns were prepared in a MACS separation 
magnet and pre-separation filters were additionally used to exclude cell aggregates or fat 
pellets from downstream experiments. The white cell fraction was washed after bead 
incubation and transferred into the separation filter on top of the LS column. With the 
application of three times 3 ml of MACS buffer CD14+ cells moved through the LS column 
and were hold in the magnetic field, while CD14 negative cells were washed through the LS 
column into a collection tube. After magnet removal, collected CD14+ cells were counted and 
their purity was assessed. Stainings with CD14, CD11c, CD19 (B-cells), CD56 (NK-cells) and 
CD3 (Lymphocytes) antibodies were performed to identify impurities with CD14 negative 
cells following fluorescence activated cell sorting (FACS) analysis. Successful monocyte 
isolations with purities above 95% were used for further experiments. 
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4.2. Generation and activation of human monocyte derived 
macrophages 
Isolated monocytes were cultured in RPMI1640 medium supplemented with 10 % fetal calf 
serum (FCS) and 500 U/ml of recombinant human granulocyte macrophage colony- 
stimulating factor (rh GM-CSF). The cell concentration was adjusted to 2x106 cells/ml and 
maintained in 3 ml volume per well in 6-well plates for 72 h at 37°C and 5 % CO2. 
Unstimulated macrophages (also called baseline macrophages, Mb) were harvested and 
aliquots were seeded out in RPMI/10% FCS medium with the addition of 500 U/ml rh GM-
CSF. Treatments with different cytokines and chemicals for additional 72 h generated three 
macrophage activation states activated under different conditions described in Table 2 and 
Figure 3.  
Table 2. Cytokines and chemicals used for macrophage activation 
Macrophage activation state Stimulation Dose 
MIL4 rhIL-4 500 U/ml 
MIFNy rhIFNγ 200 U/ml 
MTPP rhTNF-α 800 U/ml 
  Pam3CSK4 1 µg/ml 
  PGE2 1 µg/ml 
 
Additionally, the expression of typical activation state specific surface proteins was validated 
by FACS analysis using CD14, CD23, CD25 and CD86 antibodies as described previously 
(21,253). For further details, see Methods section 4.4. Activated macrophages were further 
processed for ChIP-seq and RNA-seq experiments for 3 independent donors.  
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Figure 3. Workflow for primary human macrophage generation and differentiation.  
Isolated PBMCs were positively selected for CD14 with the MACS technique. Monocytes were 
cultured with rh GM-CSF for 72 h to generate unstimulated baseline macrophages (Mb). These 
macrophages were further in vitro activated under different stimulatory conditions into classically 
(MIFNy) or alternatively activated (MIL4) macrophages in addition to macrophages induced under chronic 
inflammatory conditions (MTPP) by TNF-α, prostaglandin E2, and the TLR2 ligand P3C (TPP). Figure 
has been previously published as part of manuscript “The transcriptional regulator network of human 
inflammatory macrophages is defined by open chromatin” by myself as first shared author (Schmidt, 
S.V.*, Krebs, W.*, Ulas, T.* et al. 
 
4.3. Generation of murine bone-marrow derived 
macrophages 
Bone marrow-derived macrophages (BMDMs) involved in ATF3 ChIP-seq experiments were 
generated by Dominic De Nardo and Larisa Labzin (Institute of Innate Immunity, University 
Hospitals, University of Bonn, Germany). The detailed method and analysis was described 
previously (254). In brief, BMDMs from 6- to 8-week old wildtype (WT) C57BL/6 and ATF3 
deficient knockout (KO) mice were obtained by culturing bone marrow cells for 6 days in 
DMEM supplemented with 40 ng/ml rh M-CSF, 10% (vol/vol) FCS and 10 μg/ml Ciprobay-
500 (R&D Systems). BMDMs were stimulated with 2 mg/ml HDL for 6 h (HDL condition) or 
with 2 mg/ml HDL for 6 h with additional treatment of 100nM CpG for 4 h (HDL + CpG 
condition). A third aliquot of cells was left untreated in medium (Unstim condition). Generated 
BMDM cells were subsequently used to perform cross-linked ATF3 ChIP experiments 
following deep sequencing. 
 
4.4. Flow cytometry 
For the quantitative and qualitative analysis of surface marker expression on macrophages, 
between 1x105 and 5x105 cells were resuspended in 100µl blocking buffer (PBS + 20 % 
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FCS) incubated for 10 min. at 4°C and stained with 1-5µl of antibody (used antibodies see 
Materials section 3.3) coupled to fluorochromes for 20 min. at 4°C. Next, cells were washed 
twice with 2 ml of PBS and pelleted by centrifugation at 300g for 8 minutes. After the 
supernatant was discarded, the cell volume was adjusted to approximately 300µl with PBS 
and measured on a flow cytometer FACS LSR II (Becton Dickinson, USA). Signal events 
were gated according to the expected size and granularity of living macrophages. Between 
10.000 and 50.000 events in the final gates were recorded. Cell viability was assessed by the 
addition of propidium iodide (PI; 1µg/ml) to the cells directly before measurement to detect 
DNA not protected by an intact cell membrane, thus allowing the estimation of cell death 
ratios. The frequency emission overlap of fluorochromes in a multi-color setup made a 
compensation step necessary. Single stainings for each fluorochrome used with anti-IgG1k 
coated polystyrene beads made the clear assignment of fluorochrome light signals in the 
multi-color setup possible. Finally, raw data was exported as .fcs files and analyzed with the 
FlowJo Software. 
 
4.5. Semi-quantitative real time PCR 
The semi-quantitative real time PCR method was applied as validation for successful ChIP 
experiments using the Maxima SYBR Green/Fluorescein qPCR Master Mix kit (Fermentas) 
with volumes according to manufacturer’s instructions listed in Table 3. 
 
Table 3. qRT-PCR reaction mix 
Type Amount 
Maxima SYBR Green qPCR MM (2x) 12.5 µl 
Forward primer (10µM) 0.75 µl 
Reverse primer (10µM) 0.75 µl 
Water 10 µl 
ChIP DNA (Diluted 1:5) 1 µl 
 
 
Each qPCR reaction mix was loaded at least as duplicates into a 96 well plate and results 
were generated with the LightCycler 480 II System (Roche) with the standard 
temperature/time program recommended by the manufacturer listed in Table 4. 
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Table 4. Standard RT-qPCR program 
Type Temperature, °C Time Cycles 
Initial denaturation 95 10 min. 1 
Denaturation 95 15 sec.  
Annealing 60 30 sec. 40 
Extension 72 30 sec.  
 
The relative PCR enrichment of positive (Pos) against negative (Neg) target sites were 
calculated according to the ΔΔCT method with the following formula and ChIP validation 
results were visualized as the ratios of specific ChIP antibody values (S) to unspecific IgG 
antibody values (IgG) also called as relative enrichment of ChIP antibody against unspecific 
IgG antibody: 
∆𝐶𝑡 = 𝐶𝑡(𝑆) − 𝐶𝑡(𝐼𝑔𝐺) 
∆∆𝐶𝑡 =  𝐶𝑡(𝑃𝑜𝑠) − 𝐶𝑡(𝑁𝑒𝑔) 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒  𝑒𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡 =  2−∆∆𝐶𝑡 
 
4.6. Isolation of RNA following RNA-sequencing 
RNA isolation procedure and necessary downstream steps were performed by Michael Kraut 
and Laura Bohmann. RNA isolation, quality tests and RNA sequencing experiments were 
carried out according to previously published protocols (255). 
In brief, 5x106 cultured macrophages were lysed in TRIZOL (Invitrogen). Total RNA was 
subsequently extracted according to the manufacturers’ protocol (RNeasy kit, Qiagen) and 
quality assessments were performed. Ratios of the absorbance at 260 nm and 280 nm were 
detected using a Nanodrop 2000 Spectrometer (Thermo Scientific). Furthermore, the 
integrity of the 18/28 S RNA bands was visualized with a denaturing agarose gel. Only total 
RNA meeting the quality criteria with low degradation of 18/28 S RNA bands was used to 
perform the library construction with the Illumina TruSeq RNA sample preparation kit 
according to manufacturer’s descriptions.  
In brief, purified mRNA originating from 5-10 µg of total RNA purified by the usage of poly-T 
oligo-attached magnetic beads was fragmented with divalent cations in fragmentation buffer 
(Illumina). Random oligonucleotides were used as a starting point bound to mRNA for the 
reverse transcriptase enzyme SuperScript II to conduct first strand cDNA synthesis. The 
second strand cDNA synthesis was realized by the DNA Polymerase I and RNase H enzyme. 
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Newly created cDNA overhangs were repaired into blunt ends with exonuclease/polymerase 
enzymes and an A-base was added to DNA 3’ ends. Afterwards, Illumina PE adapter 
oligonucleotides were ligated to both ends of the cDNA molecules. A library size selection for 
preferentially 200 bp cDNA fragments was performed with 2 % (w/v) agarose gels and 
fragments were purified using the QIAquick gel extraction kit (Qiagen). A 15 cycles PCR 
reaction amplified the adapter ligated cDNA molecules with PE1.0 and PE2.0 PCR primers 
(Illumina). PCR products were purified with the QIAquick PCR purification kit (Qiagen). The 
measurements of quality and quantity for constructed cDNA library was carried out on a 
Bioanalyzer 2100 (Agilent) with the Agilent high sensitivity DNA assay kit. The validated 
cDNA library pieces were immobilized on a glas flow cell (Illumina) and clusters were 
generated out of each single strand cDNA molecule within the cBot machine (Illumina).  
Finally, the constructed library was sequenced in a paired-end 100 bp sequencing run for in 
total 208 cycles on the HiScan SQ system (Illumina) with reagents from the TruSeq SBS kit 
v3 (Illumina). With the CASAVA v1.8 software (Illumina) base calling and data conversion 
was performed by Jil Sander. TopHat2 (256) was utilized for the alignment against the hg18 
reference genome (257) and the transcript information for each gene was extracted using 
Partek Genomics Suite v6.6. Subsequently, the annotated data was normalized with the 
DESeq2 package (http://dx.doi.org/10.1101/002832), a plugin for the statistical software R 
v3.0.2 (258). For visualization purposes, normalized read counts below 1 were set to 1 
(flooring) to allow the usage of logarithmic scales during the comparison of differentially 
activated macrophages. Genes with normalized RNA-seq values ≥ 10 were defined as 
expressed. Independent sequencing samples were created for 3 donors. 
 
4.7. ChiP following deep sequencing 
Chromatin immunoprecipitation following next generation sequencing (ChIP-seq) is a 
powerful tool to identify the location of DNA binding proteins or HMs associated with specific 
regions of the genome. This method combines a chromatin immunoprecipitation using 
specific antibodies against a protein of interest or a HM to isolate the corresponding bound 
DNA pieces with a next generation high throughput sequencing approach to finally identify 
the base pair sequences of unknown ChIP DNA fragments (201).  
ChIP experiments were performed with two different approaches, either using chromatin 
fixated with formaldehyde to tightly bind proteins to corresponding genomic positions (X-
ChIP) or chromatin in its natural state without a fixation step (N-ChIP). Each method 
possesses its own advantages and disadvantages described in the introduction (1.4.2). 
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ChIP-seq experiments were conducted for three independent donors and pooled prior to 
peak calling and downstream data analysis. HM data sets yielded in average 28 million 
ChIP-seq reads from 12 to 56 million reads for individual macrophage activation experiments 
 
4.7.1. Native ChIP (N-ChIP) 
The generation of H3K4me3 HM data sets was performed by adapting a previously 
published native ChIP protocol (244) and is published on the Gene Expression Omnibus 
(GEO) platform under accession number GSE47188 (21). In brief, 2x107 primary human 
macrophage cells were used from each activated macrophage population for native ChIP-
seq experiments. Cell lysates were sheared with 0.3 units MNase enzyme (Sigma Aldrich) for 
10 minutes at 37°C into even multiple pieces of 180 bp (mono-, di-, trinucleosome DNA). 
After an additional ultrasonic step (Bandelin), analysis of the resulting DNA fragment length 
was verified in an agarose gel after the shearing of the chromatin. A dialysis was executed 
with dialysis cassettes (Thermo scientific) exchanging the MNase shearing buffer with RIPA 
buffer. During the ChIP experiments rabbit monoclonal anti-trimethyl histone antibodies 
(Millipore) bound to protein G magnetic beads (Life Technologies) or unspecific isotype 
controls (Millipore) were used to isolate chromatin pieces modified with three methyl groups 
added to lysine 4 on histone protein 3 (H3K4me3). After several washing steps with low and 
high salt buffers, the de-cross-linking and protein digestion was carried out overnight. Finally, 
the DNA was purified with silica-membrane-based spin columns included in the Qiagen 
MinElute kit (Qiagen). A qPCR validation step was performed to calculate the DNA 
enrichment signals for target relative to control ChIP DNA using specific or unspecific isotype 
control antibodies (described in section 4.5) 
The ChIP-Seq Sample Preparation Kit (Illumina) and the Multiplexing Sample Preparation 
Oligonucleotide Kit (Illumina) were used with 10 ng ChIP-DNA following the manufacturer’s 
instructions to create multiplex sequencing libraries. Briefly, purified DNA ends were repaired 
using PNK and Klenow enzyme, followed by treatment with Klenow exo minus polymerase to 
add an A base to the 3′ end used for the adaptor ligation. With a size selection step by an 
agarose gel, DNA fragments with approximately 220 bp size were excised and eluted with 
the QIAquick Gel Extraction kit (Qiagen). After subsequent adapter ligation, an amplification 
was performed for 5 cycles with PCR primers 1.1 and 2.1 (Illumina). An additional 13 cycles 
PCR further amplified DNA and integrated an index sequence for each library using specific 
multiplex PCR primers (Illumina). In a last step, library DNA was purified and 8 pM of single 
stranded library was loaded onto a glass Flow Cell (Illumina).  
Methods 
51  
 
Finally, a 57 bp single read multiplex sequencing run was performed on the Illumina 
HiScanSQ/HiSeq 1000 systems resulting in DNA sequences with the length of 50 base pairs. 
These sequences were demultiplexed with CASAVA software (Illumina) and further 
processed with bioinformatics methods described in section 4.8.2. 
 
4.7.2. Cross-linked ChIP (X-ChIP) 
A previously published high-throughput low cell X-ChIP protocol was adapted to create ChIP-
seq data sets for the HMs H3K4me1, H3K27ac, H3K27me3, also including ChIP-seq library 
construction procedures (238). All experiments were performed in 96-well plate format with 
multichannel pipettes to minimize technical errors and maximize speed for optimal protein 
stability. In brief, chromatin was in the first step cross-linked for ChIP reactions to bound 
proteins with 1 % formaldehyde (Sigma Aldrich) for 10 minutes. Cell nuclei from 0.5x106 
lysed cells were isolated and chromatin was subsequently sheared for 45 min. into 
approximately 200 bp pieces with the Covaris S220 ultrasound system (Covaris Ltd.). 
Chromatin size verification was performed with the Bioanalyzer 2100 or Tapestation system 
(Agilent). Polyclonal rabbit ChIP antibodies were bound for 1 hour at RT to protein G 
magnetic beads (Life Technologies) for the subsequent detection of three different HMs 
H3K4me1 (Abcam), H3K27Ac (Abcam) or H3K27me3 (Millipore). Additionally, unspecific 
polyclonal rabbit IgG antibody (Millipore) was used to create IgG control data sets for the 
assessment of successful ChIP experiments. Antibody-bead-complexes were subsequently 
bound to chromatin in an overnight reaction. Washing steps with different salt buffers 
removed unspecific antibody-protein complexes. Chromatin de-cross-linking and 
RNA/protein digestions for 4 hours allowed the DNA purification with AMPure XP SPRI beads 
(Beckman Coulter). Isolated ChIP-DNA was measured with the Bioanalyzer 2100/Tapestation 
(Agilent) to record concentration and size. An additional qPCR validation measuring specific 
ChIP DNA signals relative to unspecific IgG control signals allowed the assessment of 
successfully performed ChIP experiments with high relative enrichments for target against 
control samples.  
ChIP-seq library construction was conducted with 0.5 ng ChIP DNA or sheared chromatin 
prior to ChIP experiments (Input control) as starting material. ChIP DNA ends were repaired 
to blunt ends and an A-base was added to their 3’ ends. Sample volumes were evaporated to 
4 µl to optimize efficacy of the ligation step, while using less DNA ligase enzyme in 
comparison to the described standard protocol. The ligation was performed with Illumina 
sequencing compatible NEXTflex adapter oligonucleotides (Bioo Scientific) in concentrations 
of 0.6 µM and incubated for 15 min. at 25 °C. A SPRI beads cleanup (Beckman Coulter) 
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removed unbound adapter oligonucleotides and a 14 cycles PCR amplification step further 
increased the ChIP-seq library DNA amount. Another SPRI beads cleanup did not only 
exclude remaining PCR primers, but also allowed a size selection and resulted in ChIP-seq 
DNA library sizes between 100 and 500 bp. The double sided SPRI beads size selection was 
conducted with different volumes of water to PEG containing SPRI buffer, which enables the 
binding of different DNA sizes to the AMPure XP beads, thus mediating a size selection. 
Concentration and molarity of purified library DNA was assessed with the KAPA qPCR 
system for Roche LightCycler 480 (Kapabiosystems) and the Bioanalyzer/Tapestation 
(Agilent Technologies). Approximately 11 pM of single stranded library DNA was loaded onto 
the Hiseq 1000 sequencer (Illumina). Multiplex single read runs for 51 cycles and additional 6 
index sequence cycles were performed with the TruSeq SBS reagents kit v3 and the Truseq 
cluster generation kit v3 (Illumina). Generated 50 bp sequence data was demultiplexed with 
Casava (Illumina) to separate data according to the used samples and was further processed 
with bioinformatics methods described in section 4.8.2. 
 
4.8. Bioinformatics data analysis 
 
4.8.1. Conversion of published data sets  
Data sets were downloaded as SRA files from the GEO database (see Materials section 
3.10. This file format does not only allow an efficient storage of ChIP-seq data concerning 
file-sizes, the data can also be reconverted into multiple file formats like fasta, fastq or sam 
as needed (http://www.ncbi.nlm.nih.gov/books/NBK158900). The SRA Toolkit program was 
downloaded and used according to the manufacturer’s recommendations to perform the 
conversion process (http://www.ncbi.nlm.nih.gov/Traces/sra/?view=software). The following 
command was used for the conversion of SRA files into FastQ files: 
fastq-dump <downloaded file> > <filename.fastq> 
 
4.8.2. Alignment to reference genome assembly 
During the alignment step of ChIP-seq data, DNA sequences were mapped with an aligner 
algorithm to the recent reference genome to identify ChIP protein enriched genomic regions. 
The alignments were performed with the program Bowtie with the following command (259): 
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./bowtie -t -q -e 70 -l 28 -n 2 --best --maxbts 125 -S -p 8 <reference genome> <ChIP-seq-
file.fastq> <aligned-ChIP-seq-file.sam> 
With this command, bowtie uses the first 28 base calls for the alignment and accepts up to 
two mismatches with a Phred score sum of smaller than 70. Bowtie also reports not only the 
uniquely alignable sequences fitting to exact one genomic position, but also the best fitting 
genomic site for short sequences matching to more than one genomic position. 
The input FastQ files do not only contain sequences of the ChIP-seq reads, but also list the 
quality values for each called base. With this information, the aligner tries to find the genomic 
position where the unknown DNA sequence belong to and thus the ChIP protein of interest 
was bound with a high probability (201,260). All ChIP-seq FastQ files either created from the 
author (see Methods section 4.7), converted from SRA files (see Methods section 4.8.1) or 
downloaded from other websites (see Material section 3.10) were aligned to the UCSC 
mouse (mm9) or UCSC human (hg18) reference genomes. TF data sets used in section 5.1 
were aligned to the mouse mm9 reference genome, while all HM data sets used in section 
5.2 were aligned to the human hg18 genome.  
 
4.8.3. Peak Calling 
Subsequently to the alignment of ChIP-seq data to the reference genome, regions with 
significant enrichment for ChIP-seq tags (short sequences reads) were identified by a peak 
calling step. In general, a peak caller takes several properties into account to separate 
background signals from true-positive signals. First of all, the ratio of treatment to control 
ChIP-seq tag counts at enriched regions is an important value for peak calling. Statistical 
calculations like bionomial or poisson distribution models further improve the probability of 
finding true-positive peak positions, due to their correction for regional bias in tag density, 
copy number or amplification variations (201,261,262).  
The peak calling for results depicted in section 5.1 were performed with MACS (Model-based 
Analysis of ChIP-Seq) v1.4.0/v2.0.1 (15), specialized on the identification of sharp peaks in 
standard ChIP-seq experiments with the following options: -g 1.87e9 -s 51 --bw 150 -w --
single-profile -p 1e-4 --on-auto. In brief, WT peaks used in the standard method (described in 
section 5.1.1) were called with aligned ‘.bam’ files as input using MACS v1.4.0. Genomic 
positions with bimodal signal enrichments were defined as peak regions, with strand and 
anti-strand tags enriched upstream and downstream of TF binding. MACS shifted sense and 
anti-sense tags to a peak midpoint and used shifted tags as significant peak position signals 
under a poisson distribution model with the parameter (λlocal WT).  
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λlocal WT = max(λBG WT, λ5kWT, λ10kWT) 
MACS determined the maximum background signals λlocal WT either from the whole WT data 
set (λBG WT) or from 5 or 10kb regions centered to the peak midpoint (λ5k, λ10k). Called WT 
peaks fitted to the poisson distribution model with p-values smaller than 0.04. 
 
During KOIN calculations, MACS used aligned ‘.bam’ files from WT experiments as 
“treatment” file and aligned ‘.bam’ files from KO experiments as separate “control” to 
calculate background signals. Similar peak calling steps were performed according to the 
standard method described before. The sum of called WT peaks with p-values smaller than 
0.04 (poisson model) are based on the parameter λlocal KO. 
λlocal KO = max(λBG KO, λ1kKO, λ5kKO, λ10kKO) 
MACS estimated the maximum background signals with the parameter λlocal KO either from the 
whole KO data set (λBG KO) or from 1, 5 or 10kbp regions centered to the peak middle points 
(λ1kKO, λ5kKO, λ10kKO). Next, “treatment” and “control” files were swapped in a second peak 
calling to identify “negative” KO peaks present in the KO data set. KO peaks with poisson p-
values smaller than 0.04 were described by the parameter λlocal WT. λlocal WT was defined as 
estimated maximum background signal in the WT data set. This is calculated by MACS either 
from the whole data set (λBG WT) or at different regions with 1, 5 or 10kb length around the 
peak summit (λ1kWT, λ5kWT, λ10kWT).  
λlocal WT = max(λBG WT, λ1kWT, λ5kWT, λ10kWT) 
Non-specific peaks which were simultaneously present in the groups of WT and KO peaks 
were excluded for further analysis in the first two steps of the KOIN method. Finally, the sum 
of corrected peaks after the KOIN method only contained significant WT peaks as described 
in the following formula: 
Corrected peaks (KOIN method) = WT peaks  ( KO peaks ∩ WT peaks) 
Peaks with fold changes < 2 for normalized WT tag counts compared to KO tag counts were 
filtered out to increase peak specificity. With the module “annotatePeaks.pl” included in the 
HOMER program, ChIP-seq tags were finally counted and total tag count normalized to WT 
and KO data sets with the -d option (command: annotatePeaks peak-file.bed mm9 -size 
given -d peak-file-tag-directory/). Fold changes (FC) between normalized tag counts for WT 
compared to KO data sets were subsequently calculated. P-values were adapted from the 
standard value 0.05 to 0.04 to reduce the number of enriched regions to a level allowing 
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statistical analysis with the GREAT tool. A command line-based description file for linux 
systems is available online to perform the KOIN correction during peak calling with the 
MACS program (https://github.com/LIMES-NGS/KOIN-pipeline). 
In parallel, peak calling for primary human macrophage data sets for HM data was performed 
with comparable steps using the HOMER program (72). In HOMER the histone style option 
was used with peak sizes of 1000 bp and with minimal peak distances of 2500 bp for an 
optimal HM analysis, especially for broad ChIP-seq peaks. Input samples were utilized as 
control files during peak detection. Significantly called peaks were defined by a four-fold 
enrichment in treatment data sets over input tag counts and passed a false discovery rate of 
1e-3 or better under a statistical Poisson model.  
 
4.8.4. Peak annotation and tag distributions 
MACS or HOMER called peak positions were annotated, concerning their genomic location 
on the reference genome mm9/hg18. The perl script “annotatePeaks.pl” included in the 
HOMER program identifies the center of each peak region and finds the closest TSS of a 
known annotated Refseq gene and finally connects this gene name to the identified peak 
position. Annotation data also allowed the generation of global peak distributions, describing 
the exact location for called peaks in relation to the known genomic function like intronic, 
exonic, intergenic and others. 
Heatmaps centered to peaks of interest were created with HOMER using the 
“annotatePeaks.pl” script with the heatmap option (-ghist). During KOIN analysis (section 
5.1), 10 bp sliding windows were utilized to calculate ChIP-seq raw signals 2 kb up- and 
downstream of peak middle points. For the second results part (section 5.2) 500 bp windows 
were used for the assessment of ChIP-seq signals and 12 kb regions were depicted and 
centered to each peak site. For both approaches ChIP-seq signals were normalized to 107 
total tag numbers. Subsequently, the program Java-Treeview (v1.1.6.r4) visualized the 
HOMER output data as heatmaps. 
For the visualization of genomic example sites with corresponding ChIP-seq raw data signals 
the integrative genomics viewer (IGV) was utilized (263). The normalization of ChIP-seq tag 
counts to 107 total tags allowed the direct comparison of WT and KO or activated 
macrophage data sets, independently of total tag sizes generated for each experiment. 
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4.8.5. De novo motif enrichment analysis 
The de novo motif discovery was performed by HOMER with the”findMotifsGenome.pl” 
script. For TF peaks in the first part of the herein presented results (section 5.1), sequences 
100 bp up- and downstream of peak centers were used as input, while for HM enriched sites 
(results section 5.2) sequences 500 bp up- and downstream of peak centers were utilized. 
Approximately 50000 random background sequences were used as controls with the same 
GC% content as the target sequences. An auto-normalization step removed imbalances in 
the short oligos between target and background sequences. Next, enriched sequences were 
identified in a global search with up to two allowed mismatches and most enriched motifs 
were optimized in their motif probability with a sensitive local optimization algorithm by 
scoring each oligo in the data to the probability matrix. Finally, enriched motifs with lengths of 
8, 10 and 12 bp were identified and scored according to their cumulative binomial p-values. 
Corresponding positional weight matrices (PWMs) were visualized for each respective 
experiment together with the found motif.  
Statistical p-values were converted into positive integer numbers with the formula -log10 (motif 
p-value) and displayed as heatmaps with Partek genomics suite (v6.6) (results section 5.1). 
The percentages of target sequences with corresponding binding motif, determined by the 
standard method or the KOIN method were compared and depicted with horizontal aligned 
bar plots. For each motif, the percentage defines the number of ChIP-seq tags with a positive 
match for the particular motif among all tags used for the motif predictions. Multiple motif hits 
at a given tag site are possible.  
Motif ratios for top 5 enriched motifs were called with HOMER, independently for WT and KO 
data sets. Numbers of motif occurrences in WT data were divided by the numbers found in 
KO data sets, after their normalization to total peak counts in respective WT or KO data sets. 
Higher motif abundance in WT compared to KO data sets are defined as positive FC values. 
Vice versa, higher ratios in KO compared to WT data sets are depicted with negative values. 
 
4.8.6. Gene ontology enrichments 
Peak sites were associated to the nearest TSS of known RefSeq genes using HOMER 
(4.8.4). For the first results section (5.1), gene names associated to peaks within ±1000 bp of 
known TSS or inside gene bodies were used as input for the Cytoscape program (v2.8.3) 
(264) Gene set enrichment analysis (GOEA) was performed with the BiNGO plugin (265). 
For statistical significant results, the false discovery rate threshold (FDR) was set to 0.001. 
Output files for WT and KO data sets were visualized as differential network with the 
Cytoscape plugin Enrichment Map (v1.2). For the detailed options a Jaccard coefficient cutoff 
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was set to 0.001 and a FDR corrected Q-value of 0.01 was used. GO-terms in clusters were 
marked and named according to their main functions, categorized by the Cytoscape plugin 
Word cloud. Only subnetworks with more than four elements were visualized. A GOEA 
analysis for gene groups with and without KOIN correction including distal loci was 
performed with the Genomic Regions Enrichment of Annotations (GREAT) tool (v2.0.2) (266) 
at default parameters. Within this analysis, functions for sets of non-coding cis-regulatory 
genomic regions and TSS-associated regions were assessed. Results were listed in the 
respective figure according to their (-log10) binomial p-values, simultaneously statistical 
significant for the hypergeometric test as well. 
In results section 5.2, genes with H3K4me3 HM peaks within ±2500 bp around known 
RefSeq TSS were used for the assessment of epigenetic promoter states, while genes with 
associated H3K4me1 enhancer peaks with distances between 2.5 kb and 100 kb away from 
the next RefSeq TSS were utilized for the identification of their epigenetic enhancer status. 
These genes were used as input for the Cytoscape program upgraded by the plugins 
BiNGO, Enrichment map and Word cloud to perform a differential GOEA analysis. For the 
final resulting GO-terms statistical filters were set to 0.001 for the FDR corrected q-value and 
subnetworks with at least 2 GO-terms were shown. 
 
4.8.7. Identification of “Hyper-ChIPable regions” 
Top 25 TF peak positions with extraordinary high ChIP-seq signals in comparison to all called 
peaks were identified and listed according to their normalized tag counts. Only peak sites 
located in at least two data sets were used for further inspection with the UCSC genome 
browser (http://genome.ucsc.edu). Loci were defined as “hyper-ChIPable”, if the following 
criteria were visible: (1) Putative regions display additional enrichments for unrelated DNA 
binding proteins currently available at the ENCODE database (described below), (2) 
characterized as DNAse I hypersensitive sites, (3) showed high RNA polymerase II binding 
and (4) showed enrichments for various HMs including H3K4me1, H3K4me3 and 
H3K27me3. Using the UCSC genome browser, putative “hyper-ChIPable regions” were 
visually analyzed for all six data sets (https://genome.ucsc.edu/ENCODE). In case the 
investigated regions showed high signals for all above mentioned criteria beyond the 
viewable default scaling, the region was defined as “hyper-ChIPable”. The following data sets 
were used: TF binding sites (Caltech TFBS; LICR TFBS; PSU TFBS; Stan/Yale TFBS), 
Histone modifications (Caltech Histone; LICR Histone, PSU Histone; Stan/Yale Histone), 
DNAse I hypersensitive cleavage sites (PSU DNaseI HS; UW DNaseI DGF; UW DNaseI 
HS). 
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4.8.8. Epigenetic promoter and enhancer class identification 
Promoter analyses were focused on H3K4me3 enriched regions 2500 bp up- and 
downstream of known RefSeq TSS. Accessible promoters (Pa) displayed both H3K4me3 and 
H3K27Ac signals, while poised promoters (Pp) gained repressive H3K27me3 HM marks. The 
integration of different HM data sets was performed with the HOMER program using the 
“mergePeaks” module. Promoter sites were defined as positively enriched for H3K27Ac or 
H3K27me3 signals, if a direct overlap between enriched genomic positions to H3K4me3 
peaks was detected. Macrophage promoters were defined as activation specific, if H3K4me3 
peak sites were exclusively found in only one macrophage activation state or in case the 
H3K4me3 HM signals were at least two times higher in one activation state than the 
H3K4me3 tag counts in the others. 
The identification of putative enhancer sites according to H3K4me1 enrichments required the 
initial removal of promoter sites enabled by a coordinate data file, listing sites ± 2500 bp up- 
and downstream of known RefSeq TSS. The intersection of promoter related positions in the 
coordinate data file with H3K4me1 enriched sites were excluded as promoter sites from the 
enhancer analysis. Strong enhancers (Es) defined by H3K4me1 and H3K27Ac signals 
lacked repressive H3K27me3 signals. Weak enhancers (Ew) were only enriched for 
H3K4me1 signals, whereas poised enhancers (Ep) gained additional repressive H3K27me3 
marks. Specific enhancers were exclusively enriched for H3K4me1 in only one macrophage 
activation state or showed at least two times more H3K4me1 signals in one macrophage 
activation state compared to the others. 
The super enhancer (SE) identification was performed according to methods described in the 
first SE publication (168) with HOMER, applying the SE option (-style super) within the peak 
calling module “findPeaks”. First, HOMER calls H3K27Ac peaks according to standard 
procedures and stitches peak sites with distances less than 12.5 kb together into SE regions. 
Second, H3K27Ac signals for each SE region are determined by the total normalized ChIP-
seq reads in target minus input data sets. Finally, SE regions are sorted by their signal 
scores (y-axis) after normalization to the highest signals and to the number of putative total 
enhancer regions (x-axis). The results are plotted as line graph. SE regions are located past 
the point, where the slope of the line graph is greater than 1 (see example plot Figure 35B). 
Subsequently, peak positions for different promoter and enhancer classes with corresponding 
normalized ChIP-seq raw data were displayed as heatmaps (detailed description in methods 
4.8.4) 
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4.8.9. Correlation of gene expression to enhancer and promoter 
classification 
Promoter and enhancer peak positions were annotated to known RefSeq gene symbols as 
described in the Method section 4.8.4. In addition, average RNA-seq (n=3) or array-based 
(n=3) expression data was subsequently connected to the same gene symbols, allowing a 
correlation of peak positions and expression data. Only enhancers with peak distances 
between 2.5 kb and 100 kb to the nearest TSS were used for the analysis. If more than one 
enhancer or promoter class correlated to one gene, for example due to multiple enhancers 
located in the proximity of a gene, the following weighting ensured a clear classification to 
only one epigenetic promoter and enhancer state:  
Promoters: Pa > Pp 
Enhancers: Es > Ew > Ep 
If not stated otherwise all genes with expression values above the following cut offs were 
defined as expressed: 
RNA-seq > 10 (linear scale) or > 2.3 (ex scale) or > 3.3 (log2 scale) 
Array-based > 150 (linear scale) or > 5 (ex scale) or > 7.22 (log2 scale) 
Dashed lines in the figures correspond to these cut off values. Statistical significance 
between expression values for activated macrophages was assessed by the Wilcoxon rank-
sum test. 
 
4.8.10. Generation of co-regulation networks for transcriptional 
regulators and macrophage core signature genes 
The generation of co-regulation networks for macrophage core signature genes was 
described in a previous publication (21). In brief, transcriptional information was used to 
perform a reverse network approach on GM-CSF stimulated baseline macrophages further 
stimulated with 28 different conditions with the ARACNe software to compute the interactions 
of important macrophage genes. 10% of resulting common macrophage genes with the 
highest values of predicted interactions (869 genes) were used for the correlation to 
established promoter and enhancer classifications. The network visualization was created 
with the Cytoscape program.  
Methods 
60  
 
A list of TR (transcriptional regulator) genes for human and murine transcriptional regulators 
encompassing TFs, co-factors, RNA-binding proteins (RNBPs) and chromatin remodelers 
was created originating from the TFCat database (267). Subsequent co-regulation networks 
based on variable Pearsons’s correlation coefficients were created for these important TR 
genes using expression data as input for the BioLayout Express3D program, described 
previously (21,268). For the visualization of TR-TR pairs and their correlation coefficients the 
Cytoscape program was utilized using a force-directed layout. Additional information like 
transcriptional fold changes calculated against a group mean value or corresponding 
epigenetic information for corresponding TR genes was mapped onto the co-regulation 
network. Networks were generated not only for differentially activated human macrophages, 
but also for human tissues and murine tissue macrophages to identify corresponding 
important TRs.  
All presented co-regulation networks are also accessible online at VisuTranscript 
(http://www.s-khb.de/visutrans/content/index_eng.html). 
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5. Results 
This thesis was designed to elucidate in its first chapter (5.1) the importance of false-positive 
binding signals falsifying the analysis and interpretation of next generation sequencing data 
sets for transcriptional regulators and transcription factors (204,250,251). A novel 
bioinformatics strategy called KOIN (knockout implement normalization) utilizes protein 
knockout experiments during the ChIP-seq data analysis to significantly and efficiently 
correct for false-positive signals derived from unspecific binding of ChIP-seq antibodies. The 
analyses of different ChIP-seq data sets were generated and online available data sets from 
other scientific publications with various bioinformatics tools were utilized to verify the 
improvement of KOIN onto the biological interpretation of TF ChIP-seq data. 
In the second part of this thesis (chapter 5.2) various ChIP-seq experiments analyzing HMs 
in different macrophages were performed to gain insights into the epigenetic status of 
primary human macrophages activated under different stimulatory conditions. As HMs allow 
the classification of important genomic regulatory sites like promoters and cis-regulatory 
elements (enhancers) into different activation states describing the present chromatin status 
of these loci (156,160,167). The chromatin structure itself can be separated into condensed 
and inactive or open and active sites. This dynamic change of chromatin status at specific 
genomic sites is one of the major regulatory mechanisms for the transcription of cellular 
genes. ChIP-seq and RNA-seq data were merged into correlation networks of central TRs to 
get information about the co-occurrence of certain HM states or the presence of SE markings 
to the transcriptional activity of stimulus specific and common macrophage genes. 
Additionally, RNA-seq and HM ChIP-seq data sets from murine tissue macrophages under 
homeostatic conditions or cells originating from different tissues were used to perform 
epigenetic classifications of gene loci and comparisons of expression data for important TR 
genes in detailed co-regulation networks with four activated macrophage states analyzed in 
detail. 
 
5.1. Knockout mouse models - A tool for the optimization of 
TF ChIP-seq experiments 
Chromatin immunoprecipitation experiments following deep sequencing (ChIP-seq) require 
tight quality controls and outstanding antibody binding properties concerning binding 
specificity and efficiency to their protein targets to allow a precise data analysis and biological 
interpretation, while minimizing false-positive signals (204). Two different types of controls 
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were established in the past for ChIP-seq experiments (204,251), sheared chromatin (Input 
control) or chromatin eluted from antibodies with unspecific binding properties with a similar 
immunoglobulin classification as the specific ChIP antibody (IgG control). Both types of 
control data sets possess positive and negative aspects discussed in the introduction 
(section 1.4.2) (204). However, knockout experiments were underestimated in its value as 
essential ChIP-seq control until now. In fact, knock out experiments could better differentiate 
between false- and true-positive ChIP-seq signals and at the same time minimize negative 
factors of previously mentioned controls. During the analysis and normalization of ChIP-seq 
data sets knockout data were implemented. This correction step during ChIP-seq peak 
calling was termed “Knockout Implemented Normalization” (KOIN) and was published within 
the scope of this thesis (269). Figures shown in section 5.1 are part of this scientific 
publication. 
 
5.1.1. Bioinformatic processing during “Knockout implemented 
normalization method” (KOIN) 
Specific computational steps were necessary to utilize protein knockout (KO) experiments for 
the classical analysis (204) of ChIP-seq data sets (Figure 4). In the first step, next generation 
sequencing data sets from wild-type experiments (WT) and KO experiments for the 
corresponding WT protein were aligned to the human reference genome to find the target 
genomic position for each generated ChIP-seq sequence. Next, peak sites significantly 
enriched for WT ChIP-seq signals were identified during peak calling with the peak caller 
MACS. During the peak identification, the KO data set enabled the differentiation of false- 
and true-positive peaks. False-positive corrected peak files were afterwards further enriched 
for highly specific peaks with normalized tag counts at least two fold higher in WT compared 
to KO data sets. Finally, downstream data analysis was performed with different approaches 
like binding motif predictions or gene ontology enrichments. Details for conducted 
bioinformatics calculations are described in the methods section (4.8). 
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Figure 4. Flowchart depicting the 
generation of false-positive corrected peak 
files (KOIN method). 
All necessary calculation steps and 
input/output files are displayed to generate 
false-positive corrected KOIN peak files. 
The aligned WT and KO data sets (step 1) 
were used as input to perform peak calling 
with MACS (step 2). In this step false-
positive peaks were filtered out. Peak files 
were further filtered to increase peak 
specificity (step 3) using only peaks with at 
least two fold higher normalized tag counts 
for WT against KO experiments. In step 4 
possible downstream data analysis options 
are mentioned ranging from peak 
annotation, connection of identified gene 
names to biological functions or to binding 
motif enrichment calculations. 
 
 
For the evaluation of KOIN advantages in comparison to the standard analysis six ChIP-seq 
data sets were utilized to compute the global binding properties of the ATF3, GATA3, SRF 
and PU.1 proteins (72,254,255,270) (Figure 5, 3.10). The alignment was performed in both 
approaches (standard or KOIN) with Bowtie following the same protocols, whereas during 
the peak calling with MACS non-specific signals were identified and filtered out, following the 
KOIN protocol. Non-specific peak regions included high ChIP-seq tag counts in WT and KO 
data sets similarly, which possibly demonstrated unspecific binding capabilities of the utilized 
ChIP antibody (204). Improvements of KOIN in ChIP-seq analysis were compared in parallel 
to commonly used downstream data analysis methods using HOMER or Cytoscape. 
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Figure 5. Schema of ChIP-seq data analysis using either the KOIN method or the standard 
method. 
Six different data sets were used to perform the KOIN method (green) with wild type (WT) and 
knockout (KO) data sets, whereas for the standard method only WT data sets were utilized. In both 
approaches next generation sequencing data sets were aligned to the reference genome and peak 
calling was performed with MACS. KOIN allowed a discrimination between specific and non-specific 
signals, in contrast to the standard peak calling. ChIP-seq signals enriched peak positions were 
annotated using the HOMER program. For downstream data processing motif enrichment and a 
comparative gene ontology enrichment analysis was performed for both methods. The corresponding 
results were compared. 
In conclusion, standard ChIP-seq analysis and the KOIN method differed only in one step 
facilitating the implementation of KOIN to the standard ChIP-seq data analysis. During the 
peak calling procedure non-specific peak sites could be excluded from downstream analysis 
utilizing KO ChIP-seq data sets. 
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5.1.2. KOIN identifies and excludes false-positive ChIP-seq signals 
False-positive binding signals are inevitable in ChIP-seq experiments (204). Due to the 
binding properties of antibodies, not only specific bindings with high affinities to target 
antigens occur, but also non-specific bindings against irrelevant antigens or unspecific 
binding to the constant FC region. For the illustration of the amount of non-specific antibody 
binding, dot plot visualizations were created, plotting normalized tag counts for WT and KO 
data sets of uncorrected (grey color) and KOIN corrected (red color) peak positions found for 
the four analyzed TFs (Figure 6). The KOIN method identified significant numbers of false-
positive peaks especially in the data sets for SRF and GATA3 proteins with respective 
percentages of 80 % and 78 % of false positive signals. Surprisingly, the correction rates for 
the ATF3 protein were dependent on the stimulatory conditions (unstimulated, stimulated with 
HDL, stimulated with HDL and CpG) ranging from 43 % to 79 %. In contrast, the KOIN 
correction slightly increased the already high peak numbers of the PU.1 data set (see section 
5.1.3). 
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Figure 6. Independent ChIP-seq experiments reveal false-positive signals after KOIN 
calculations.  
ChIP-seq tag counts for SRF, GATA3, PU.1 and ATF3 WT and KO data sets were visualized as 
dotplots with log2 scale normalized to 107 total tag counts. ATF3 data sets were stimulated under 
different stimulatory conditions as indicated. Peaks identified with the standard method were plotted in 
grey color whereas KOIN corrected peaks were overlaid as red dots into the same plots. Jitter was 
added to prevent excessive overlaps of data points and to improve the visualization. KOIN corrected 
(red) and uncorrected standard peak numbers (grey) were plotted additionally to the false-positive 
peak rates (in percent) to the right. 
 
Illuminating the question, whether the false-positive peak signals were enriched at specific 
functional genomic sites, annotations of peaks to the reference genome were performed, 
thus enabling a functional categorization of peaks into intergenic, intronic and promoter 
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regions (Figure 7). SRF and GATA3 experiments showed similar fractions of KOIN corrected 
peaks between 18 % and 24 % irrespective of the genomic peak position. As mentioned 
before, KOIN corrected peak numbers differed in the four ATF3 data sets in dependency on 
the stimulatory conditions. A high specificity of promoter peaks was detected with 50 % and 
63 % for KOIN corrected peaks in ATF3 control experiments without stimulation or stimulation 
with HDL and CpG, while intergenic and intronic sites displayed similar rates of false-positive 
signals. Monocytes stimulated with HDL displayed only minor changes between intergenic 
(53%), intronic (63%) and promoter (69%) peak numbers after KOIN correction. KOIN 
correction increased PU.1 enriched sites for true-positive peak numbers up to 15 % 
irrespective of the analyzed intergenic, intronic, or promoter sites (see section 5.1.3). 
 
Figure 7. Genomic annotation 
of KOIN corrected and 
uncorrected peaks reveal a 
high distribution of false-
positive peaks to various 
genomic positions. 
A comparison of peak numbers 
between standard peaks (blue) 
and KOIN corrected peaks 
(green) was performed according 
to their genomic positions. 
Statistics for peaks located at 
promoter (Prom), intronic (Int) and 
intergenic (Inter) positions are 
shown as bar charts. The 
percentages of true-positive 
peaks which remained after KOIN 
correction were included as green 
numbers. 
 
 
In addition to visualizing global numbers of KOIN corrected peaks, pile-up heatmap 
visualizations relative to peak centres were created to evaluate the false-positive signal 
strength before (standard method) and after the KOIN correction process (Figure 8a). WT 
and KO data sets were depicted ± 2000 bp from peak centres. As an example, the HDL and 
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CpG stimulated ATF3 data set showed distinct false-positive signals after the standard 
method in the KO data set (blue box), whereas these signals could be completely abrogated 
with KOIN correction (green box). Even in ChIP-seq experiments with high specificity like the 
PU.1 data set, KOIN successfully removed false-positive peak positions completely (Figure 
8b). 
 
 
Figure 8. False-positive signals are depleted by KOIN correction in TF ChIP-seq data sets. 
Pile-up heatmaps of ChIP-seq tag densities were created using 10bp sliding windows for total tag 
normalized data (normalized to 107 total tag counts). Tag densities are centred ± 2kb to peak 
midpoints and are displayed for (A) ATF3 under the stimulatory influence of HDL and CpG as well as 
for (B) PU.1 visualized for both WT and KO samples before (blue) and after (green) KOIN correction. 
 
An additional validation for the positive removal of false positive ChIP-seq signals was 
performed with a publicly available ChIP-seq data set, which was generated with the same 
ATF3 antibody (247). Two genomic sites (CD36 and CDK8) were visualized as examples 
(Figure 9). The validation data set (GSE36104) (3.10) called significant ATF3 peaks, marked 
by black boxes. In contrast, after KOIN correction significant ATF3 peaks remained at the 
CD36 locus but not at the CDK8 gene, which was simultaneously enriched for WT and KO 
signals. KOIN correction obviously allowed the differentiation of putative false-positive and 
true-positive peaks. 
 
Results 
69  
 
Figure 9. Representative 
genomic positions for 
true-positive and false-
positive ChIP-seq peaks 
differ in KO signal 
intensities. 
Representative ChIP-seq 
reads in the introns of 
true- and false-positive 
ATF3 binding sites. Black 
bars indicate significant 
peaks identified by MACS 
with p-values ≤ 10-4. An 
independently generated 
ATF3 data set (247) was 
used to visualize 
previously called 
significant peaks (black 
bars) called by the 
standard method. 
 
 
Collectively, ChIP-seq data sets demonstrated variable numbers of false-positive peak 
signals. Some data sets contained high numbers of false-positive signals, whereas others 
like the PU.1 data set exhibited only marginal unspecific sites. In all cases, KOIN 
successfully identified and completely removed these non-specific signals. 
 
5.1.3. Altered signal-to-noise ratios can increase peak numbers 
In most cases, the KOIN method reduced the number of significant peaks in comparison to 
standard peak calling strategies correcting for non-specific tag signals. Surprisingly, KOIN 
also increased peak counts (9 %) in the PU.1 data set in comparison to the standard method 
and called 6037 new peaks (Figure 6, Figure 7 and Figure 8b). This effect of KOIN was 
visible due to lowered background signals, since KOIN concomitantly lowered the peak 
calling threshold. In highly specific data sets like PU.1 with only low numbers of false-positive 
peaks, decreased peak calling thresholds also lead to increased numbers of significant 
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peaks with lower tag counts. In sum, more new peaks with slightly lower tag counts were 
called as significant, compared to false-positive peaks which were lost during KOIN. 
Reduced background signals also improved statistical p-values determined during peak 
calling. WT and KOIN corrected p-values were visualized as dot plot (Figure 10). The 
apparent shift of KOIN/standard p-value ratios for called peaks to the upper left corner 
demonstrated the improvement of p-values during KOIN. Furthermore, the orange dots 
emphasized the newly called peaks with lower tag counts and higher but still significant p-
values, whereas few grey dots visualized the KOIN excluded regions. 
Taken together, KOIN even improved data analysis for highly specific antibodies by the 
reduction of noise, thereby identifying more significant binding regions, previously excluded 
as false-negative sites. 
 
Figure 10. KOIN 
correction improves 
signal-to-noise ratios 
and corresponding 
statistical significance 
for KOIN peaks. 
P-values for PU.1 peaks 
called with the standard 
method by MACS (x-
axis, -log10 (p-value)) 
are plotted against the 
p-values for 
corresponding KOIN 
corrected peak 
positions (y-axis, -log10 
(p-value)). Significantly 
called peaks marked in 
red were called with and 
without KOIN correction. False-positive peaks lost after KOIN correction are marked in grey and 
orange peaks were exclusively called after application of KOIN correction. 
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5.1.4. Effect of KOIN on “hyper-ChIPable regions” 
Recently, a special type of false-positive sites was described in yeast known as “hyper-
ChIPable regions” (250). These highly expressed euchromatic regions are not only 
vulnerable to DNAse I cleavage due to the absence of densely packed DNA to nucleosomes, 
but are also highly enriched for RNA Polymerase II allowing extremely high transcriptional 
activity. Other unrelated DNA-binding proteins or certain HMs can also be present at these 
sites. The potential of “hyper-ChIPable regions” to occur in other species as well influencing 
the ChIP-seq data analysis and interpretation justified a detailed analysis. For this task, loci 
with exceptionally high normalized ChIP-seq tag counts were identified, which were found in 
at least two out of six data sets. These sites were afterwards filtered concerning the above 
mentioned criteria using multiple previously published high quality ENCODE data sets to 
identify “hyper-ChIPable regions”. In fact, up to 18 „hyper-ChIPable regions“ were detected in 
the six analyzed ChIP-seq data sets highlighting the point that they could occur in most 
ChIP-seq data sets (Figure 11). More importantly, detected “hyper-ChIPable regions” were 
excluded by KOIN correction. To confirm the successful removal, the top 25 called and KOIN 
corrected peaks did not reveal “hyper-ChIPable” criteria. 
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Figure 11. Examples of Hyper-ChIPable regions with highly enriched ChIP-seq signals.  
Three examples for “hyper-ChIPable example regions” were visualized for six representative ChIP-seq 
TF data sets (SRF, GATA3, PU.1 and ATF3 generated under different stimulatory conditions). 
Histograms of WT and KO ChIP-seq signals are depicted in different colors. In KOIN corrected data 
sets “hyper-ChIPable regions” are absent. 
The herein presented findings suggested that “hyper-ChIPable regions” not only exist in 
yeast but also in other species. More importantly, the KOIN correction curated TF ChIP-seq 
data from “hyper-ChIPable regions” beyond the correction for tag signals from other 
unspecific binding events. 
 
5.1.5. Increased identification of ChIP protein specific binding 
motifs after KOIN correction 
The analysis of TF-binding motifs is a possible approach to evaluate the accuracy of ChIP-
seq data (204,271). In highly specific TF ChIP-seq data a significant enrichment for TF 
binding sites is observed. In ChIP-seq data with high fractions of false-positive binding sites 
the binding motif for the specific target protein is not enriched or can only be found with low 
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statistical significance. The effect of KOIN was determined by the measurement of binomial 
p-values and counts for motif enrichments in WT, KO and KOIN corrected data sets (Figure 
12). First of all, HOMER calculated a high and statistical significant enrichment of the SRF, 
GATA3 and PU.1 binding motifs in WT and KO data sets. Additionally, Jun-AP1 and AP1 
motifs were highly enriched in ATF3 data sets. As both TFs build heterodimers together with 
the ATF3 protein, they are also enriched at the same DNA regions as ATF3 (272). The 
amount of PU.1 positive peaks remained unchanged, possibly due to the high specificity of 
the PU.1 data, whereas in all other ChIP-seq data sets the KOIN correction strongly 
improved relative numbers of important binding motifs. Especially in SRF data KOIN 
improved the SRF binding motif occurrence from 15 % to 45 %. 
 
 
Figure 12. TF motif analysis is significantly improved after KOIN correction. 
Top 10 TF binding motifs which were significantly enriched in SRF, PU.1, GATA3 and ATF3 data sets 
after KOIN correction were visualized and sorted according to their significance p-values. The 
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horizontally aligned bar plots describe the percentage of target sequences with corresponding TF 
motifs in each data set after KOIN correction (blue) or without KOIN correction (green). Graphical 
versions of positional weight matrices (PWM) for each motif are plotted to the right and KOIN motif p-
values are depicted in heatmaps on the left side of each bar (white to red color). 
 
Independent motif enrichments were also conducted solely with available ChIP-seq KO data 
and visualized as horizontal bar plots (Figure 13). In general, poorly enriched KO motifs 
lacked the main motifs of the respective TF as described before. Despite the sporadic 
enrichment of motifs at KO called peaks like the AR-halfsite motif in the GATA3 data set, the 
white colored heatmaps clearly illustrated the poor statistical significance of resulting 
enrichment scores suggesting putative false-positively called binding motifs. 
 
 
Figure 13. Absent enrichment for specific TF motifs in uncorrected KO data sets. 
Percentages of target sequences with the corresponding top 10 enriched motifs exclusively at KO 
peak sites were ranked according to their enrichment p-values for six representative ChIP-seq data 
sets and depicted as horizontally aligned bar plots. Scales for p-values and percentages were used 
according to scales in Figure 12. 
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For further validation of the performed motif predictions, ratios of main motifs for 
independently analyzed WT and KO ChIP-seq data sets were plotted as bar charts (Figure 
14). Fold change ratios were calculated for the top 5 motif counts in WT against KO peaks. In 
SRF and PU.1 data sets corresponding main motifs were found in the WT data set and 
enriched with high fold changes in comparison to KO data. Not only GATA3 but also other 
GATA TF family members were enriched with high fold changes exclusively in WT and not in 
KO data, due to high similarities in their core binding sequence (motif sequences, Figure 12). 
For ATF3 data sets the similarities in core sequences and the previously mentioned 
heterodimer formation with ATF3 caused an enrichment of Jun-AP1, AP1 and Bach2 ratios in 
WT data sets.  
 
 
Figure 14. Enriched WT motifs are exclusively found in WT data sets compared to KO results.  
Motif count ratios for the top 5 enriched motifs were depicted in WT (black) against KO (white) peak 
files. Motif counts were normalized to total peak counts and the ratio of WT against KO motif counts 
was calculated as fold changes. WT specific motifs exhibit positive ratio values and motifs with higher 
abundance in KO data sets show negative ratios. 
 
In summary, motif binding predictions were altered by false-positive peaks in uncorrected WT 
data sets. The removal of false-positive sites drastically increased the percentages of peaks 
positive for the corresponding main TF motif. Additionally, comparisons for the top 5 enriched 
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motifs in WT against KO data sets illustrated the false-positive binding capabilities of ChIP 
antibodies and the enrichment of unrelated motifs without the target protein. 
 
5.1.6. KOIN significantly enhances biological interpretation of TF 
ChIP-seq data  
KOIN identified and significantly reduces false-positive binding signals as demonstrated in 
previous results (269) and in this thesis. The effects of the correction process onto the 
biological interpretation of ChIP-seq data was evaluated with a Gene Ontology Enrichment 
Analysis (GOEA) which connects gene groups with ChIP-seq enriched peak positions to 
known biological functions. The SRF data set was used as an example. GOEA analysis 
before and after KOIN correction was performed to investigate the improvement of biological 
interpretation by KOIN. Genes enriched for strong SRF binding within a 2 kb window 
centered to TSS or within the gene locus itself were utilized to create a differential network 
visualization for enriched GO-terms using BiNGO and EnrichmentMap plugins of Cytoscape 
(Figure 15). From 13 major subnetworks which were enriched in the WT SRF data set, two 
subnetworks were excluded (s7, s12) due to false-positive binding signals (blue edge and 
black border colors). Furthermore, only 5 (s16, s18, s20, s27, s28) out of 15 minor 
subnetworks remained after the KOIN correction process for false-positive curated genomic 
positions (green edge and red node colors). Therefore, KOIN correction curated the data set 
associated biological processes from irrelevant functions for the SRF protein and enriched 
significantly highly relevant biological processes the SRF protein is known for to participate in 
(255,273).  
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Figure 15. GO-term enrichment analysis for promoter regions is significantly improved after 
KOIN correction. 
Gene Ontology Enrichment Analysis (GOEA) was performed for genes marked by SRF protein binding 
signals 1kb up- and downstream from their TSS. Results are visualized as networks for 1510 genes 
before KOIN correction (black node borders: GO-terms, blue edges: GO-term relations) and 327 
genes after the correction process (red nodes: GO-terms, green edges: GO-term relations). The 
remaining true-positive GO-terms for SRF bound genomic regions after the KOIN correction are 
depicted as red nodes with black borders. The binomial FDR corrected p-value cutoff was set to 
<0.001. The analysis was performed with Cytoscape and the plugins BiNGO and Enrichment Map. In 
green color marked corrected GO-terms were also found in GREAT GOEA analysis in Figure 16. 
 
The improvement of GOEA was validated by the GREAT tool (Genomic Regions Enrichment 
of Annotations Tool) which allows the integration of known GO-terms also for distant 
regulatory sites far away from any promoter region into the biological interpretation of ChIP-
seq peak signals (Figure 16) (266). GREAT utilizes stringent filter criteria by the application of 
not only hypergeometric but also binomial statistical models to predict meaningful biological 
processes for proximal and distal regulatory sites. In agreement with previous results found 
for GO-terms enriched at promoter regions (Figure 15) GREAT identified known SRF 
functions like “actin cytoskeleton dependent processes” (274) or “leukocyte activation in 
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immune response” (255). Other not related SRF functions like “mast-cell activation” or 
“cellular response to lithium ion” were excluded by KOIN.  
 
 
Figure 16. KOIN also improves GOEA analysis at cis-regulatory genomic regions. 
Enriched GO-terms for cis-regulatory and non-coding genomic regions were calculated with the 
GREAT tool. Statistical stringency for significantly enriched terms was set to a FDR corrected p-value 
threshold of 0.05 using binomial and hypergeometric tests simultaneously. For the visualization the 
binomial p-value (-log10(p-value)) of enriched GO-terms with (green) or without (blue) KOIN correction 
was used. 
In summary, the herein presented results show that two independent tools for connecting 
ChIP-seq enriched genomic positions to known biological functions highly benefit from KOIN 
corrected data sets. Functional SRF relevant biological processes were correctly identified 
for KOIN corrected data, while false-positive GO-terms were excluded. Uncorrected data 
dilutes the true interpretation of ChIP-seq bound regions and could lead to overestimations 
concerning irrelevant biological functions. 
 
5.2. Epigenetic changes during activation of primary 
human macrophages 
The activation model for human monocyte-derived macrophages was recently extended 
beyond the established M1/M2 axis model to a multi-dimensional model, integrating a 
multitude of specific macrophage activation states equivalent to their multiple origins and 
employed stimulatory cues (21). The described macrophage plasticity with the establishment 
of different activation states displaying specialized functions, requires profound changes on 
the transcriptional level. Complex regulatory networks ensure the efficient and tight control of 
transcriptional processes. Amongst others, the epigenetic regulation of HMs can profoundly 
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alter the chromatin landscape and may also play a critical role as platform for the recruitment 
and binding of TR proteins, like TFs (167). Specific combinations of HMs can not only identify 
important regulatory regions like promoters or cis-regulatory sites in human and mouse, but 
can also predict the transcriptional activity at certain loci and their chromatin packaging 
status (68,148,151,156,158). Four different activation states of monocyte-derived primary 
human macrophages were used as an in vitro model for pro-inflammatory immune activation 
(21) to assess their chromatin landscapes. Four histone modifications were assessed 
(H3K4me1, H3K4me3, H3K27Ac, H3K27me3) in respect to the histone code hypothesis 
(145,146) and previously described adapted methods to identify regulatory regions of 
interest, including promoter and enhancer sites in up to three activity states for each defined 
genomic site. This epigenetic information correlated to transcriptional data from RNA-seq or 
microarray expression data demonstrated in detail the importance of epigenetic regulatory 
processes at promoter and enhancer sites during the activation of primary human 
macrophages and further elucidate underlying molecular mechanisms of their functional 
commonalities and differences. 
The herein presented results (section 5.2) are also in most instances part of a scientific 
publication (275). 
 
5.2.1. ChIP-seq validation procedures 
In preparation of ChIP-seq experiments human monocytes were differentiated into baseline 
macrophages (Mb) and were further activated into MIFNy, MIL4 and MTPP macrophages. GM-
CSF was used as primary differentiation stimulus in the in vitro model to mimic an 
inflammatory milieu, often characterized by elevated systemic levels of GM-CSF (276). The 
complete activation of different macrophage populations was validated by the expression of 
typical macrophage marker proteins, like CD14 for Mb and other activation specific surface 
proteins like CD86 (MIFNy), CD23 (MIL4) and CD25 (MTPP) described previously (Figure 17) 
(21,253).  
 
Figure 17. FACS analysis of surface marker expression in activated macrophages. 
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Typical macrophage surface markers used for the discrimination between certain activation states 
(CD14, CD86, CD23, CD25) were quantified by flow cytometry for unstimulated (baseline), IL4, IFNy 
and TPP stimulated macrophages. Results are depicted as mean fluorescence intensity (MFI). 
*p<0.05 (Student’s t-test) 
 
Chromatin of each macrophage population was sheared in an ultrasonic Covaris S220 into 
approximately 150 bp fragments and the exact length distributions were measured with the 
Agilent Bioanalyzer (Figure 18A). Suitable DNA fragments between 100 and 500 bp were 
purified by paramagnetic beads (Agencourt) during the library construction, while fragments 
with differing sizes were excluded. ChIP-seq experiments were performed as described in 
the methods section. The relative enrichments of known HM marked positions were 
quantified via semi-quantitative real time PCR for target experiments in comparison to DNA 
fragments enriched unspecifically with control IgG antibodies. Relative enrichments between 
256 and 1024 folds for target against control DNA were detected for HM positive sites, 
whereas negative control regions displayed only minimal enrichments (Figure 18B). 
 
 
 
Figure 18. Quality controls for successful ChIP experiments. 
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(A) Representative gel electrophoresis result for cross-linked chromatin sheared for 45 minutes with 
chromatin sizes depicted in bp on the x-axis and fluorescence units on the y-axis. Additionally, optimal 
size for ChIP-seq library construction was marked with blue lines (Region 1). Lower and upper DNA 
markers are located at 35 and 10500 bp. (B) Relative qPCR enrichments of histone enriched known 
positive and negative sites are depicted as fold changes against background controls (IgG). Results 
represent the mean ± standard deviation of at least three independent experiments and were 
performed for four different ChIP-seq data sets: H3K4me3 (red), H3K4me1 (orange), H3K27Ac (blue), 
H3K27me3 (violet). 
 
5.2.2. Optimization of next generation sequencing library 
construction  
Prior to ChIP-seq library construction experiments with primary human macrophages, jurkat 
cell DNA (Human T cell lymphoblast-like cell line, Clone E6-1) was isolated and sheared to 
assess the minimal necessary amount for efficient ChIP-seq library construction. These 
experiments were especially necessary due to the limited amount of isolated CD14 positive 
human monocytes per blood donor to establish the different macrophage activation states. 
For the library construction, between 10pg and 10ng chromatin was used as input starting 
material to construct 7 multiplex ChIP-Seq libraries. Constructed libraries were sequenced on 
a HiScan SQ machine (Illumina). Computational steps like demultiplexing and alignment to 
the reference genome were performed. Finally, sequencing results in form of tag counts 
normalized to total counts for each experiment were compared in circos plots for each 
chromosome to assess the optimal chromatin amount to cover the brought variety of 
genomic positions during ChIP-seq library construction and subsequent sequencing (Figure 
19). 
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Figure 19. Sequencing results for ChIP-seq libraries constructed with variable amounts of DNA 
input material. 
Normalized tag counts for 7 multiplex ChIP-seq libraries were visualized as circos plots and sorted 
according to their library construction starting material (10, 2, 1, 0.5, 0.2, 0.1, 0.01 ng DNA from Jurkat 
cells). Circos plot depicts normalized tag counts on chromosome 12 from position 0 to 5.3 million bp. 
 
Despite manufacturer’s specifications (Illumina) to use 1µg DNA as starting material for ChIP 
sequencing, 0.5-1ng of DNA for the library construction already displayed a broad distribution 
of tag signals for the example position on chromosome 12. Lower amounts of DNA lead to 
tremendously decreased sequencing signal resolutions, because of absent ChIP DNA pieces 
during library construction for various loci. In addition, over amplifications of ChIP-seq signals 
for specific DNA regions on chromosome 12 were observed for libraries constructed with 
10pg input DNA. These signals are inevitable, if only low amounts of DNA are available and 
can falsify subsequent analysis steps.  
Based on the above described optimization, 0.5-1 ng of sheared chromatin isolated from 
human macrophages was utilized for all following ChIP-seq library constructions described in 
the methods section. In addition, representative size distributions of constructed libraries 
Results 
83  
 
indicated correct sizes between 250 and 450 bp as recommended from the manufacturer 
(Illumina) for the optimal performance of next generation sequencing experiments (Figure 
20). 
 
 
Figure 20. Representative size distribution of macrophage ChIP-seq library. 
Representative DNA size distributions of successfully constructed ChIP-seq libraries (Agilent 
Bioanalyzer). The x-axis represents the chromatin size in bp, while the y-axis depicts fluorescence 
units of measured DNA fragments labelled with an intercalating dye. Lower and upper DNA markers 
are located at 35 and 10500 bp 
 
Applied pipelines for the following downstream analysis of next generation sequencing data 
included the separation of data sets (demultiplexing), the alignment of unknown sequenced 
pieces to the human reference genome and the identification of regions significantly enriched 
for ChIP-seq signals (peak calling) finally determining locations of specific HM signals. 
Furthermore, the usage of 0.5-1 ng of sheared chromatin ensured the correct ChIP-seq 
library construction. 
 
5.2.3. Epigenetic classification of specific promoter and enhancer 
states during human macrophage activation 
Transcriptional processes and their regulation are tightly connected to changes on 
epigenetics level. Exogenous signals can regulate transcriptional processes by the 
modification of histone proteins not only at promoter but also at enhancer sites (73,277). 
Histone proteins, targets of different posttranslational modifications play a major role in these 
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changes and act as linkers to integrate amongst others chromatin organization, TF binding 
and transcription. In which extend HMs lead in primary human macrophages to their 
specialization adapting to environmental cues still needs to be elucidated, especially in 
primary human macrophages. 
Previous publications lead to the genome wide identification of transcriptional regulatory sites 
like promoters or enhancers and the definition of activity states by the combination of 
different posttranslational HMs (Figure 22) (148,158,159). Accessible and poised promoters 
(Pa/Pp) as well as strong, weak and poised enhancers (Es, Ew, Ep) could shape the 
transcriptome of differentially activated primary human macrophages.  
 
 
Figure 21. Definition of epigenetic states at promoter and enhancer sites. 
Combinations of four HMs (H3K4me3, H3K4me1, H3K27Ac, H3K27me3) define the activity states of 
promoters (accessible Pa, poised Pp) and enhancer regions (strong Es, weak Ew, poised Ep). 
 
Activation-signal-specific changes of the epigenetic landscape in human inflammatory 
macrophages were defined following two rules: First, specific loci were at least two times 
higher enriched for H3K4me3 or H3K4me1 total tag counts than the input control datasets. 
Second, tag signals for a specific H3K4me3 or H3K4me1 locus were increased at least two 
times in the respective activation state in comparison to the other activated macrophages. 
430 activation state specific accessible promoters were identified (Figure 22A) by following 
the defined criteria during global analysis. Heatmaps clearly visualized the concomitant 
enrichments for H3K4me3 and H3K27Ac HM signals for Pa sites (Figure 22B). Pa numbers 
reflected the activation state of differentially activated macrophages with low numbers in Mb 
and increasing numbers in macrophages stimulated with different molecules (MIFNy, MIL4, 
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MTPP) with highest numbers in pro-inflammatory MIFNy. In contrast to Pa sites, in total 459 Pp 
were marked with H3K4me3 and repressive H3K27me3 signals, while lacking the active 
H3K27Ac HM modification. Highest numbers of Pp in MIL4 could suggest the importance of 
promoter inactivation, necessary for the IL4-induced transcriptional program. MTPP 
macrophages showed almost equal numbers for Pa and Pp, different to MIFNy with higher 
numbers for Pa. Another interesting observation was the mutually exclusive enrichment of 
active H3K27Ac marks and repressive H3K27me3 HM at accessible and poised promoters. 
 
 
Figure 22. Activation state specific epigenetic promoter states in human macrophages. 
(A) Numbers of macrophage activation specific promoter sites. (B) Heatmaps of normalized histone 
ChIP-seq tag counts at macrophage activation specific genomic positions for defined promoter states. 
Pa sites show simultaneous H3K4me3 and H3K27Ac signals, while Pp are characterized by H3K4me3 
and H3K27me3 HM signals. Heatmaps were centred to H3K4me3 peaks and ChIP-seq signals were 
determined in 500 bp windows 6 kb up- and downstream of peak middle points. (Mb/blue, MIFNy/yellow, 
MIL4/green, MTPP/red) 
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Promoter or enhancer sites need to be accessible for TRs and in an open chromatin state to 
allow actual gene transcription. In macrophages, the pioneer TF PU.1 is essential for the 
opening of closed inactive chromatin sites and mediates with the co-binding of other 
secondary TFs thereby enabling the transcription of corresponding genes (75,278,279). 
Previous publications assessed PU.1 binding mainly at cis-regulatory enhancer sites in 
macrophages, but PU.1 binding motifs are also present at promoter sites. In fact, in 
differentially activated macrophages approximately half of the Pa sites contained the PU.1 
consensus motif (Figure 23A), except for Pa sites in Mb which showed even higher PU.1 
motif rates of 71%. This finding could hint to the hypothesis that PU.1 binding is not a 
prerequisite for the activity of stimulus-specific macrophage promoters. Additionally, genes 
with Pa sites revealed gene ontology (GO) terms like “immune response”, “chemotaxis” or 
“inflammatory response”, correlating well with known functions as exemplified for MTPP. 
 
Figure 23. PU.1 frequencies at 
stimulus specific accessible MTPP 
promoters and GO-terms related to 
typical macrophage functions. 
(A) Percentages of accessible 
promoters enriched for the PU.1 
consensus motif in differentially 
activated macrophages. Positional 
weight matrix of PU.1 motif is depicted 
in the upper right corner. (B) Gene set 
enrichment analysis (GOEA) for 108 
genes marked as accessible 
promoters (Pa) in TPP activated 
macrophages (MTPP). Corresponding 
p-values and corrected p-values were 
listed to the right (hypergeometric test, 
Benjamini & Hochberg correction). 
 
The correlation of epigenetic promoter states to RNA-seq data allowed the assessment, if 
HM promoter markings have an effect on transcriptional activity of genes in primary human 
macrophages. Indeed, a significant increase in transcriptional activity was detected in all 
macrophages activated by the indicated stimuli, when genes with accessible or poised 
promoterss were compared (Figure 24A). Furthermore, genes with specific accessible or 
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poised promoter marks were specific for the corresponding macrophage activation state 
(Figure 24B). MTPP macrophage genes marked with Pa were significantly increased in their 
expression values in MTPP in comparison to other macrophage activation states and showed 
stronger enrichments for H3K4me3 and H3K27Ac in comparison to decreased levels in other 
macrophages, especially for the HM H3K4me3 (Figure 22B). Poised promoter genes were in 
general drastically reduced in their expression values in comparison to accessible promoters, 
already stated previously. However, the less pronounced decrease in the expression rates for 
Pp in MTPP in comparison to other activation states could be present due to the higher 
H3K4me3 signals in MTPP almost diminished in the other macrophages. Comparable specific 
results were detected for the other three activated macrophages (data not shown).  
 
 
Figure 24. Boxplots of expression values for genes marked with stimulus specific accessible 
and poised promoters. 
(A) Boxplots of RNA-seq expression values for genes marked with macrophage activation state 
specific accessible or poised promoters. Dashed line represents cut-off values for genes without gene 
expression. (B) RNA-seq expression values for MTPP genes associated with specific accessible or 
poised promoters in all four macrophage activation states. (Mb/blue, MIFNy/yellow, MIL4/green, 
MTPP/red). *p < 0.05, **p < 0.01, ***p < 0.001 (wilcoxon rank sum test) 
 
Cis-regulatory enhancer sites, crucial for transcriptional regulation and maintenance act as 
platforms bound by TFs and other proteins and can mediate DNA looping to subsequently 
stimulate promoter activation and gene transcription (58,59,67). In addition, recently defined 
“latent enhancers” in murine macrophages suggested that exogenous signals can shape the 
epigenetic landscape (249). Therefore, three activity states of enhancers (strong, weak and 
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poised enhancers) were defined by the combination of three HM signal enrichments (Figure 
21). In total 2024 Es, 15754 Ew and 2390 Ep sites specific for the macrophage activation 
states were identified (Figure 25A). Heatmaps illustrate HM signal combinations for Es with 
H3K4me1 and H3K27Ac signal enrichments, solely H3K4me1 for weak enhancers and a 
combination of H3K4me1 and H3K27me3 for poised enhancer sites (Figure 25B). 
Interestingly, Ew represented in numbers the largest group of defined enhancer states and 
thus could suggest their importance in shaping the activation associated transcriptome to 
induce stimulus-specific macrophage functions (68,160,280). Especially the MIFNy 
macrophage with the highest numbers of Es could also demonstrate the strong impact of 
dominant inflammatory signals on the activity of regulatory sites and their chromatin 
organization. Lower Es numbers in MTPP, despite the inflammatory signals during activation 
could once more reveal negative feedback loops, due to the chronic inflammatory setting. 
MIL4 macrophages showed increased numbers of Ep sites, which is in line with previously 
described high numbers for Pp, emphasizing the importance of repressive mechanisms for 
anti-inflammatory macrophages. For answering the question if stimulus-specific enhancers 
require PU.1 presence for their activity PU.1 binding predictions were performed. 12 % to 54 
% of described Es sites were positively marked with the PU.1 consensus motif, while Ew 
sites were slightly reduced in PU.1 frequencies (12 % - 32 %) (Figure 25C). Previously 
published results for mouse macrophages stated comparable results for the enrichment of 
the PU.1 motifs at H3K4me1 positive enhancer sites (157). These findings suggest - in line 
with previous results (281) - that the presence of PU.1 is not always required for stimulus-
specific enhancers and that additional regulators are involved. TF binding predictions 
revealed significant enrichments for motifs like PU.1 in Mb, IRF1 in MIFNy, STAT6 in MIL4 (data 
not shown) and FOSL2 in MTPP. Exemplarily, the top five enriched motifs for MTPP were 
shown including enrichment p-values for expressed TFs at MTPP-specific enhancer regions 
(Figure 25D). 
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Figure 25. Identification of specific epigenetic enhancer states and corresponding PU.1 
frequencies in four macrophage activation states 
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(A) Numbers of specific enhancer sites in differentially activated macrophages. (B) Normalized ChiP-
seq tag counts of genomic positions for strong (Es), weak (Ew) and poised (Ep) enhancers plotted as 
heatmaps. All enhancers share the H3K4me1 signals, while Es are marked with additional H3K27Ac 
and poised enhancers with H3K27me3, respectively. Heatmaps were centred on H3K4me1 peak 
signals and assessed in 500 bp windows 6 kb up- and downstream of the peak midpoints (C) 
Frequencies for PU.1 positive enhancer sites at Es and Ew depicted for all four macrophage activation 
states in percent. Absolute gene numbers were plotted to the right. (Mb/blue, MIFNy/yellow, MIL4/green, 
MTPP/red) 
 
To assess a correlation of the epigenetic enhancer status at a genomic locus to the actual 
transcriptional activity of adjacent genes, RNA-seq data were combined to enhancer states 
of known genes (Figure 26). Genes in the vicinity of Es sites demonstrated high expression 
levels, while genes with Ew were in comparison to Es significantly down-regulated in MIFNy 
and MIL4 and showed comparable tendencies in the other activation states. In contrast, Ep 
enriched sites were strongly correlated to genes with low transcriptional activity.  
 
Figure 26. RNA-seq expression 
values of genes marked with 
activation specific enhancers. 
Boxplots of RNA-seq expression 
values for genes marked with 
macrophage activation specific 
enhancers with strong (Es), weak 
(Ew) or poised (Ep) status. 
Dashed line represents the cut off 
for expressed genes. (Mb/blue, 
MIFNy/yellow, MIL4/green, MTPP/red). 
*p < 0.05, **p < 0.01, ***p < 
0.001(wilcoxon rank sum test) 
 
Two examples for genomic sites with MTPP specific Pa or Es sites and high expression values 
in RNA-seq data were visualized (Figure 27). Normalized HM tag counts were explicitly 
enriched at marked positions with at least two times higher tag counts in MTPP compared to 
other macrophage activation states. The example genes IL2RA and CXCL1 neighboring 
specific MTPP promoter and enhancer regions were highly expressed, specifically in MTPP 
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macrophages and were also previously linked to chronic inflammation in macrophages 
(21,282). 
 
 
Figure 27. Visualization for 
representative sites in MTPP with 
activation specific accessible 
promoter and strong enhancers. 
Normalized ChIP-seq signals for 
different histone modification data sets 
(H3K4me3, H3K4me1, H3K27Ac and 
H3K27me3) are shown for an 
accessible promoter (left panel, IL2RA) 
or a strong enhancer (right panel, 
CXCL1). Locations of enriched ChIP-
seq signals defining corresponding 
promoter or enhancer states are 
marked with red boxes. Corresponding 
RNA-seq expression values for MTPP 
signature genes are depicted as box 
plots below the genomic visualization 
window.* p < 0.05 (wilcoxon rank sum 
test). (Mb/blue, MIFNy/yellow, 
MIL4/green, MTPP/red) 
 
 
 
Ongoing gene transcription is determined by the combination of promoter and enhancer 
activity. Hypergeometric probability tests, comparing pairs of gene groups marked by 
different epigenetic classes of promoters and enhancers, allowed the estimation of their 
relationships. Hypergeometric p-values smaller than 0.05 define a positive correlation 
between gene groups (Figure 28A). A strong correlation of Pa to Es and Ew and of Pp to Ep 
was detected especially for MIL4 and MTPP. In MIFNy, positive correlations between mentioned 
sites were less pronounced but still significantly detectable. Low correlations of Pa and Pp in 
Mb and Pp in MIFNy to corresponding enhancer sites could be caused by the relatively small 
Results 
92  
 
numbers of specific promoter sites (< 50) (Figure 22A). To assess the influence of 
combinations for promoter and enhancer markings at corresponding macrophage activation 
specific genes onto transcriptional activity, expression values for Pa genes with and without 
Es or Ew marks were compared (Figure 28B). Genes with additional marks for Es or Ew 
displayed elevated median expression levels in all macrophage activation states. Accessible 
and active promoters with already expressed genes (expression above dashed line) were 
especially increased by numbers in activated macrophages (MIFNy, MIL4, MTPP) due to the 
putative interactions with Es. 
 
 
Figure 28. Correlation analysis of promoters and enhancers with different epigenetic activity 
markings. 
(A) Pairwise correlations (Hypergeometric test) between gene groups marked with macrophage 
activation specific promoters (accessible Pa, poised Pp) and enhancers with different epigenetic 
activity states (strong Es, weak Ew, poised Ep). (B) RNA-seq expression values for genes marked 
with an Pa alone or with simultaneous Es or Ew markings are depicted as box plots for four 
macrophage activation states. (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red). *p < 0.05 (wilcoxon rank 
sum test) 
 
Collectively, macrophage activation specific genes with different epigenetic promoter and 
enhancer states were identified. These genes may shape the transcriptome of activated 
macrophages and mediate their specialization to fulfill different functions upon stimulation. 
The expression values of genes marked with Pp or Ep were significantly attenuated, while Pa 
genes with or without additional enhancer markings revealed high transcriptional rates in 
most cases. Mentioned exceptions could implicate additional regulatory mechanisms by fine 
tuning the activation-specific macrophage transcriptomes.  
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5.2.4. Epigenetic core program in differentially activated 
macrophages 
Despite the specific differences of activated macrophages on epigenetic level, a high fraction 
of similarities was previously found for macrophages with different origins and stimulated 
under different conditions (21). Recent computational reverse engineering approaches 
utilizing 28 differentially activated human macrophages allowed the definition of a so called 
“macrophage core signature”, describing actively transcribed macrophage genes important 
for their identity.  
Adapting the idea of a “macrophage core signature” for the regulation on epigenetic level, the 
HM status of promoter and cis-regulatory sites for macrophage activation states was 
assessed and sorted for genomic sites with common activity states. 7427 common 
accessible promoters (Pa common) and 1247 common poised promoters (Pp common) could be 
identified and were visualized as heatmaps (Figure 29A). Furthermore, a group of common 
enhancers was identified in all four macrophage activation states and subdivided into 3731 
strong enhancers (Es common) and 467 poised enhancers (Ep common) (Figure 29B). Additionally, 
3110 weak enhancers (Ew common) were found. Common Pa and Es were defined as 
“common histone core signature” (CHCS), found in activated macrophages. Previous results 
comparing murine macrophages, neutrophils and monocytes corroborate the demonstrated 
strong overlap in the usage of accessible promoters in contrast to strong enhancers (157). 
The CHCS seems to be predominantly characterized by a vast number of promoters and to a 
lesser extent by cis-regulatory sites thereby capable of the establishment and maintenance 
of a common macrophage program. 
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Figure 29. Common accessible and poised promoters in activated macrophages. 
Heatmapss of normalized ChiP-seq tag counts for genomic positions with common (A) accessible 
(Pacommon) and poised (Ppcommon) promoters or common (B) strong (Escommon) and weak (Ewcommon) 
enhancers in four macrophage stimulatory conditions. Heatmaps were centred on (A) H3K4me3 or (B) 
H3K4me1 peak signals and assessed in 500 bp windows 6 kb up- and downstream of peak middle 
points. (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red) 
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To verify, that genes with accessible or poised promoter state are expressed similarly in all 
investigated macrophage activation states or are absent, RNA-seq experiments were 
performed for activated macrophages. Expression values of genes with common Pa are 
plotted in comparison to genes with common Pp marks as boxplots for each macrophage 
activation state separately (Figure 30A). Promoters with common active HM signals were 
significantly higher expressed compared to genes with poised promoter sites. Comparable 
calculations were performed for genes with common enhancer marks found in all 
macrophage activation states (Figure 30B). Genes adjacent to cis-regulatory enhancer sites 
with Es correlated to increased expression values, while genes marked with Ew and Ep were 
significantly down-regulated. Interestingly, genes with poised promoter states were in a lower 
degree down-regulated in their expression in comparison to genes with a poised enhancer in 
their vicinity. In case CHCS genes are particularly important and moreover specific for 
macrophages, higher frequencies for PU.1 motifs at CHCS sites should be visible at 
corresponding promoter and enhancer sites, since PU.1 as macrophage lineage determining 
factor would initiate chromatin remodeling processes and permit the accessibility of gene loci 
(Figure 30C). Indeed, 89 % of Pa sites and 96 % of strong enhancers contained the PU.1 
consensus motif, indicating a macrophage specific transcriptional regulation for the 
corresponding genes. 
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Figure 30. Expression values and PU.1 frequencies of common macrophage promoter and 
enhancer sites. 
RNA-seq expression values depicted as boxplots for genes associated with common (A) Pa and Pp or 
with common (B) Es and Ep sites in all four macrophage activation states. ***p < 0.001 (wilcoxon rank 
sum test). (C) Percentages of PU.1 motif positive accessible promoter (Pa) or strong enhancer (Es) 
sites common in all four macrophage activation states. Absolute gene numbers and PU.1 consensus 
motif were plotted to the right (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red) 
 
Furthermore, a GO-term enrichment analysis of CHCS genes with common Pa sites and 
common Es marks was combined into one network with promoter data visualized in network 
nodes, while enhancer data was depicted in corresponding node borders (Figure 31). GO-
terms were grouped according to their relationship of biological functions and resulted in 28 
sub-clusters. The network revealed a significant correlation of CHCS gene functions to 
“housekeeping” functions, like “metabolic process”, “cell cycle” or “macromolecule catabolic 
process”. 
 
Results 
97  
 
 
Figure 31. Differential Gene Ontology Enrichment Analysis of CHCS genes marked with 
common Pa or common Es. 
GO-term associated functions of common macrophage genes marked with an accessible promoter 
(red border color) or strong enhancer (black nodes) are depicted as networks. Specific terms for 
network modules with strong correlations to each other are marked with numbers and listed to the 
right. 
 
For a detailed analysis of the macrophage specificity for the defined CHCS gene signature, 
microarray data sets of other immune cells were utilized. CHCS expression values for all cell 
types were plotted as boxplots and compared to expression values in Mb. Statistical 
significant differences were found not only for Mb genes with accessible promoters (Figure 
32A) but also for Mb genes in the proximity of Es compared to non-myeloid cell types (Figure 
32B). Interestingly, Mb showed no statistical significant difference in CHCS expression values 
to monocytes or the other three activated macrophage groups (MIFNy, MIL4, MTPP), probably 
due to their strong relationship to each other as macrophage precursors or different Mb 
activation states. 
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Figure 32. Expression values of common macrophage genes with similar epigenetic status at 
regulatory sites compared to other cell types of the immune system. 
Boxplots of RNA-seq expression values for common macrophage genes associated with (A) 
accessible promoters and (B) strong enhancers in various primary cell types from peripheral blood. **p 
< 0.01, ***p < 0.001 (wilcoxon rank sum test). (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red, 
Mono=monocytes, DC=immature dendritic cells, NK=natural killer cells, TC=T cells, BC=B cells) 
 
The establishment of a general macrophage phenotype depends on the activity of DNA 
binding proteins like TFs. A motif binding prediction analysis revealed the enrichment of DNA 
binding proteins located at accessible promoters (Figure 33A) or strong enhancer sites 
(Figure 33B) for CHCS genes. Top 10 motifs for proteins expressed in all macrophage 
activation states included the macrophage pioneer factor PU.1 overrepresented not only at 
common Pa but also at common Es sites (71,72). These results corroborated the performed 
PU.1 enrichment analysis described above (Figure 30C). Beyond PU.1, other motifs for TFs 
like ELK4, GABPA and ELK1 were significantly enriched at common Pa sites. These TFs 
were described to cooperate with the serum response factor (SRF) to regulate cytoskeletal 
gene expression in macrophages (255,274). Additionally, ETS family members like FLI1, 
ELF1 and ETS1 were also enriched and can interact with PU.1 to regulate macrophage 
development (283,284). At sites with marks for common Es, TFs like FRA1, FOSL2 (FRA2) 
and AP-1 were identified. Interestingly, these TFs play important roles in putative negative 
feedback loops suppressing exaggerated inflammatory responses, demonstrated previously 
for example for the TF BCL6 (285-287). 
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Figure 33. Motif enrichment analysis of common Pa and Es sites found in four activated 
macrophages. 
Motif enrichment analysis for (A) accessible promoters or (B) strong enhancer sites found in all four 
macrophage activation states. Corresponding p-values (hypergeometric test) and positional weight 
matrices (PWMs) for top 10 enriched motifs were additionally plotted. 
 
With the hypothesis that commonly expressed CHCS genes are best characterized by 
accessible promoters, previously defined major hub genes of the multi-dimensional model of 
human macrophage activation (21) should also be characterized by permissive histone 
modifications at their promoters. Therefore, a network representation of previously defined 
macrophage core signature genes (869 top 10 % highly connected major hub genes) was 
overlaid with CHCS information of Pa and Es/Ew enrichments (Figure 34). More than 94 % of 
major hub genes were tagged with a common accessible promoter, while only 27 % of gene 
names overlapped with genes adjacent to common strong or weak enhancers. The strong 
overlap for common Pa (CHCS data) with central macrophage genes identified by 
independently performed in silico predictions further demonstrates the importance of 
epigenetic data for the identification of central genes of a common macrophage program. 
Lower overlaps for CHCS enhancer data could indicate a minor role for cis-regulatory 
elements in common macrophage programs described before. Intriguingly, the previously 
built common macrophage network was based on 28 different macrophage stimulatory 
conditions, but epigenetic data of only four macrophage activation states already matched to 
a major extent to common macrophage genes. 
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Figure 34. Network 
visualization for the 
epigenetic status of 
regulatory sites in 
common macrophage 
core signature genes. 
The epigenetic status of 
promoter and enhancer 
sites is depicted as 
network visualization for 
869 important regulatory 
macrophage genes: Pa 
(red node colour)/ Es/Ew 
(orange border colour)/ 
no mark (white border or 
node colour).The node 
size specifies the degree of connectivity between depicted common macrophage genes. 
 
In conclusion, accessible and poised promoters as well as enhancers common for all 
investigated macrophage activation states were identified and especially Pa correlated well 
with previously described macrophage core signature genes. Common promoter and 
enhancer sites were enriched for the macrophage pioneer TF PU.1 and other TFs related to 
important macrophage functions. CHCS genes were expressed in all differentially activated 
macrophages and participated in gene ontology terms for general housekeeping functions 
but more importantly for specific biological processes associated to macrophages. The 
collected data supports the hypothesis that the epigenetic regulation mediated by the 
common histone core signature is fundamentally linked to the macrophage phenotype. 
 
5.2.5. Influence of super enhancers onto macrophage activation 
Recently, special regulatory genomic regions called “super enhancers” (SE) were described 
in immune cells like murine macrophages or embryonic stem cells (169,170). Their main 
characteristics are defined by very strong enrichments for activating H3K27Ac HM signals 
and remarkably high numbers of TF binding sites. Additionally, SE regions consist of multiple 
numbers of classically defined enhancer sites with distances less than 12.5 kb to each other 
(Figure 35A). They were proposed to play important roles in disease initiation and 
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progression and regulate cell type-specific gene transcription and thus establishing cell 
identity. 
In activated human macrophages between 417 and 806 SE regions could be identified 
(Figure 35B). As exemplified for MTPP cells, 417 SEs were discriminated from classical 
enhancers by their disproportionally high H3K27Ac signals. Genomic MTPP sites at SE 
regions were first sorted according to their total region size, starting with the biggest SE 
regions with 134.853 bp length and then visualized as heatmaps depicting their normalized 
H3K27Ac tag counts (Figure 36C). Broad H3K27Ac signals distributed over all SE areas 
further validated their identity in comparison to surrounding regions with significantly lower 
H3K27Ac levels. SEs in other macrophages (Mb, MIFNy, MIL4) were identified and validated 
accordingly. 
 
 
Figure 35. Identification of super enhancers in activated macrophages. 
(A) Schematic overview of common and stimulus specific super enhancers (SE). (B) Identification of 
SE sites (grey box) at enhancers with extraordinary high H3K27Ac HM signals, exemplified for SEs 
found in MTPP. Total SE counts for four activated macrophage activation states are listed in upper box. 
(C) Heatmap of normalized H3K27Ac tag densities at genomic SE sites found in MTPP sorted 
according to their total region size in bp (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red) 
 
In differentially activated macrophages, common and specific SEs could be located. 200 
common SE regions were identified in all four macrophage activation states (Figure 36A). 
Histograms of normalized ChIP-seq raw data were visualized for one example of a common 
SE with high gene expression values in all four investigated macrophage activation states 
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(Figure 36B). This example of a gene locus defined by high H3K27Ac signals showed 
additionally strong H3K4me1 HM signals defining it as enhancer site. The SE adjacent gene 
CCR1, which encodes a chemokine receptor is critical for macrophage immune functions 
and was expressed in all four macrophages (288). Unique SE sites present in only one 
macrophage activation state demonstrated a high variability in their numbers (Figure 36A). 
Highest numbers of activation specific SE were especially identified in Mb and MIFNy. A 
correlation to mRNA expression of genes with specific SE further demonstrated the capability 
of SE to promote transcription of adjacent genes beyond the expression levels of genes with 
Es or Ew in their proximity. For example, MTPP genes with SE markings in their vicinity 
displayed significantly higher expression values in comparison to genes marked with Es or 
Ew, (Figure 36C). These results state a strong impact of SE on overall macrophage gene 
expression. 
 
 
Figure 36. Super enhancer characterization. 
(A) Bar chart for numbers of common and activation specific SE found in differentially activated 
macrophages. (B) Example for a genomic site identified as common macrophage SE visualized as 
histograms with normalized HM signals for four different HM data sets (H3K4me3, H3K4me1, 
H3K27Ac, H3K27me3). Expression values for the XCR1 and the super enhancer associated CCR1 
gene in human macrophages are plotted to the right. (C) Boxplots for expression values of genes 
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marked by the different enhancer types (SE, Es, Ew) in MTPP. ***p < 0.001 (wilcoxon rank sum test). 
(Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red) 
 
Performing a GO analysis on the group of SE marked genes in MTPP, GO-terms for 
macrophage relevant functions like “response to cytokine stimulus”, “wound healing” and 
“phagocytosis” were enriched (Figure 37A). Focusing on the smaller groups of genomic sites 
marked with activation state specific SEs occured at least partially near genes which 
contribute to activation specific macrophage functions (Figure 37B). For example, IFI30 is 
constitutively expressed in antigen-presenting cells mediating lysosomal functions (289). NMI 
is induced by IFNy stimulation and is responsible for STAT-mediated transcription, LIPA 
mediates lipolysis and the alternative activation of macrophages (290) and CXCL1 promotes 
inflammatory processes (291). Yet GO-term analysis on activation specific SE could be 
limited in its interpretations due to the low number of activation specific SE (Figure 36A). 
 
 
Figure 37. Correlation of gene ontology terms to genes with SE marks. 
(A) Top 10 enriched GO-term functions for genes marked with SEs in MTPP. (B) Word cloud 
visualization for exemplified macrophage related genes associated to SEs. (Mb/blue, MIFNy/yellow, 
MIL4/green, MTPP/red) 
 
All shown examples of expressed activation specific macrophage genes possessed an 
activation specific SE (Figure 38). In some cases, specific SE sites over spanned not only a 
single gen locus (LIPA) but were also located over several genes (IFI30) and displayed a 
broad enrichment for H3K27Ac signals. Moreover, a simultaneous enrichment for H3K4me1 
signals was observed thus confirming their enhancer character. 
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Figure 38. Visualization of genomic loci for macrophage activation state specific SE loci. 
Normalized HM signals are visualized for four different data sets (H3K4me3, H3K4me1, H3K27Ac, 
H3K27me3) at macrophage activation specific SE sites (IFI30/Mb, NMI/MIFNy, LIPA/MIL4, CXCL1/MTPP). 
Corresponding H3K27Ac signals are marked for each macrophage population with coloured boxes. 
Expression values for genes at macrophage specific SE sites are depicted at the bottom. *p < 0.05, 
***p < 0.001 (wilcoxon rank sum test). (Mb/blue, MIFNy/yellow, MIL4/green, MTPP/red) 
 
In summary, a special type of regulatory region called “super enhancer” was identified in 
activated human macrophages. Genes in proximity to common and specific SE sites 
displayed strongly increased expression values. Furthermore, a partial overlap with known 
macrophage functions in MTPP and markings at macrophage associated genes in all four 
activation states were detected. These results suggested the involvement of SE in the input-
signal specific induction of gene expression in inflammatory macrophages. 
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5.2.6. Epigenetic regulation of central macrophage transcriptional 
regulators in human 
For the establishment and specialization of macrophage specific transcriptional programs, 
TRs are essential key components. Different classes of TRs mediate various functions like 
chromatin remodelers (e.g. histone methyl-transferases), pioneer factors (e.g. PU.1), 
transcriptional inhibitors mediating protein complex formation (e.g. NCOR2) or TFs. The 
expression of these regulatory proteins is influenced by epigenetic modifications, thus the 
analysis of HM signals at central TR loci could shed light on the regulation of TR expression 
during macrophage activation. 
A previously published multi-dimensional model of macrophage activation allowed the 
definition of a distinct set of TR genes (21). In brief, GM-CSF derived macrophages (Mb) 
were activated by 28 different stimulatory conditions to mimic inflammatory conditions (Figure 
39A). 485 macrophage TRs were identified to be expressed at least in one of the 29 
stimulatory conditions. Co-regulation network analysis allowed the creation of visualizations 
for 297 highly interconnected TR genes, which are to be considered as central key factors for 
macrophage identity and were termed as “macrophage activation TR network”. In this 
network each node represents one specific TR with connections to other co-regulated TRs. 
Surprisingly, almost all promoters (93%) of central TRs participating in macrophage activation 
were marked by an accessible promoter state already in untreated Mb (Figure 39B, C). In 
addition, the vicinity of central TRs was occupied for more than 69% by strong or weak 
enhancers (Figure 39D). Concomitantly, TRs with accessible promoters and/or strong/weak 
enhancer markings showed expression levels above background level, while only a small 
subset of these TRs showed relatively low expression levels (Figure 39E, F). These results 
could support constitutively permissive histone modifications at TR loci independently of their 
transcriptional activity in Mb. 
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Figure 39. Epigenetic landscape of transcriptional regulators in baseline macrophages. 
(A) Schema for the computational generation of co-regulation networks including 297 important 
activated macrophage TRs (transcriptional regulators) (21). Distribution of (B) accessible (Pa) and 
poised (Pp) promoter marks or (C) strong (Es), weak (Ew) or poised (Ep) enhancers in baseline 
macrophages for TRs being part of the generated macrophage activation TR network. (D) TR network 
visualization for baseline macrophages (Mb) with overlaid epigenetic information for accessible 
promoter states (Pa). (E, F) Microarray expression data for 287 TRs depicted as scatter plots in 
baseline macrophages (Mb) and sorted for (E) accessible (Pa) and poised (Pp) promoter states or (F) 
for strong (Es), weak (Ew) or poised (Ep) enhancer states. Mann-Whitney rank sum test (E) or 
Kruskal-Wallis One Way ANOVA on ranks with pairwise multiple comparisons according to Dunn’s 
Method (F) were used for statistical calculations (*p<0.05, ***p<0.001, cutoff for expression: 7.2). 
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To answer the next question, if the activation-specific regulation of TR expression is 
influenced by specific changes of histone modifications at TR loci, three differentially 
activated macrophages were used. As observed for previous Mb results, a large majority of 
TR promoters for all activation conditions showed an accessible state (>93%, Figure 40A) 
with simultaneous strong/weak enhancer markings for a high fraction of TR loci (>69%, 
Figure 40B). The expression levels for these macrophage activation associated TR genes 
with accessible promoters or strong enhancers were once more significantly higher than for 
TR genes with poised promoters or weak/poised enhancer markings (Figure 40C, D). 
Permissive histone modifications seem to dominate not only the epigenetic TR landscape of 
Mb but also play an important role in activated macrophages under inflammatory conditions 
independently of their transcriptional activity. 
 
 
Figure 40. Promoter and enhancer mark distributions for transcriptional regulators in activated 
macrophages. 
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Distributions of (A) accessible (Pa) and poised (Pp) promoter marks or (B) strong (Es), weak (Ew) and 
poised (Ep) enhancer marks visualized as bar charts for TRs being part of the macrophage activation 
TR network in IFNy (yellow), IL4 (green) and TPP (red) activated macrophages. (C, D) Microarray 
expression data for 287 TRs depicted as scatter plots sorted for (C) accessible (Pa) and poised (Pp) 
promoter states or (D) for strong (Es), weak (Ew) or poised (Ep) enhancer states in IFNy (yellow), IL4 
(green) and TPP (red) activated macrophages. Mann-Whitney rank sum test (C) or Kruskal-Wallis One 
Way ANOVA on ranks with pairwise multiple comparisons according to Dunn’s Method (D) were used 
for statistical calculations (*p<0.05, ***p<0.001, cutoff for expression: 7.2). 
 
A network visualization of transcriptional regulators allowed not only the direct comparison of 
transcriptional changes for activated macrophages in comparison to Mb but also the 
assessment of the epigenetic status for their promoter and enhancer sites (Figure 41A). For 
all three activated macrophages (MIFNy, MIL4, MTPP) TRs were transcriptionally regulated in a 
distinct and specific manner (Figure 41A left panel). These results demonstrate an enormous 
transcriptional regulation of TRs in an input-signal specific fashion in human macrophages. 
Compared to the noticeable changes for TRs on transcriptional level, the patterns for 
promoter and enhancer marks within the network were quite uniform (Figure 41A, middle and 
right panel) with a majority of promoters marked as accessible and enhancers with strong or 
weak HM marks. Interestingly, TRs not expressed in any of the 29 stimulatory conditions 
showed only a minority of accessible promoters (12-15%) or strong enhancer markings (12-
17%) (data not shown). To confirm the hypothesis, that the permissive histone landscape is a 
unique feature for macrophage-activation associated TRs in monocyte-derived 
macrophages, a hypergeometric statistical test was performed for different gene sets to 
analyze the significance of accessible promoter occurrences (Figure 41). Both gene groups 
either for the central nervous system (CNS) or randomly chosen genes showed fewer 
accessible promoters and thus lower statistical significances compared to the TRs in 
activated human macrophages. To further identify master regulator genes in each stimulatory 
condition, TFs with significant enriched expression in MIFNy, MIL4 or MTPP were determined 
and were predicted to bind to gene loci with an accessible promoter and strong or weak 
enhancer markings within the network. Important TF genes like STAT1 for MIFNy, IRF4 for 
MIL4 or STAT4 for MTPP were found and previously connected to corresponding macrophage 
functions (193,292,293) (Figure 41C). 
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Figure 41. Epigenetic landscape of transcriptional regulators in activated macrophages. 
(A) Network visualization of transcriptional regulators in activated macrophages (network generation 
described in Figure 39A). Left panel: RNA-seq expression values were overlaid as fold-changes (FC) 
compared to the expression values in Mb (FC with an unadjusted p-value <0.05 are marked by wider 
black border colour). Mid panel: Overlay with epigenetic data on accessible (Pa) promoters (red border 
colour). Right panel: Overlay with epigenetic data on strong (Es) or weak (Ew) enhancer marks 
(orange border colour). (B) Hypergeometric probability test for the enrichment of accessible promoters 
Results 
110  
 
(Pa) in GO-term gene sets related to the CNS (central nervous system), activated macrophages TR 
genes or a set of random genes. (C) Binomial p-values for motif enrichment calculations at promoter 
and enhancer positions, positional weight matrices and corresponding expression values were 
depicted for predicted master regulators in Mb (blue), MIFNy (yellow), MIL4 (green) and MTPP (red) in all 
macrophage conditions. One Way ANOVA tests with pairwise multiple comparison according to Tukey 
were used for statistical analysis of expression values (*p<0.05, n=3). RNA-seq and ChIP-seq data 
was derived from three independent experiments. 
 
Overall, the established networks of active TRs during human macrophage activation 
showed in general an open chromatin state at promoter loci with concomitant strong or weak 
enhancer markings, while significant transcriptional differences between used stimulatory 
macrophage conditions were visible. These results could hint to a model where the quick 
adaption capabilities of macrophages to environmental signals are tightly connected to these 
epigenetic open TR loci. Transcriptional control mechanisms like the binding of transcription 
factors, co-repressors or –activators or non-coding RNAs which restrain TR mRNA 
transcription could regulate the predominantly accessible promoters and subsequently adapt 
the macrophage transcriptome. 
 
5.2.7. Epigenetic and transcriptional regulation in human tissue-
defined TR networks 
Since human macrophage activation TR networks are characterized by an overall open 
chromatin state the question arises, if this epigenetic pattern is an exclusive feature in these 
cells. To answer this question similar histone modification networks were created for five 
human tissues (intestine, lung, ovary, heart, and muscle) (294) (Figure 43A). These datasets 
showed comparable RNA-seq statistics (data not shown), but up to 3-fold differences in their 
read numbers (Figure 42A) and called peaks (Figure 42B), probably due to their differences 
in function and location in the human body. Nevertheless, the histone distribution across the 
genome in correlation to important genomic functions demonstrated almost equal results, 
which was not only visible for the intestine and lung datasets (Figure 42C) but for all five 
human tissue datasets (data not shown).  
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Figure 42. Main features of ChIP-seq datasets for five different human tissues 
(A, B) Main features of consolidated histone ChIP-seq data (n=1) from the Road map consortium 
(294) describing (A) read counts and (B) called peak positions for corresponding histone datasets in 
five human tissues. (C) Histone modification peak distributions depicted by their localization to specific 
genomic regions for small intestine (SI) and lung tissue (Lung) datasets. 
 
After the creation of a TR network for these 5 human tissues (Figure 43A) a similar approach 
introduced for the human macrophage activation TR network was performed. In the following 
results only two example datasets for small intestine and lung tissues were visualized but the 
other three datasets showed similar results. Transcriptional differences plotted onto the 
network revealed a specific upregulation of genes in only one subcluster for each of the five 
tissues (Figure 43B, left panel). Upregulated small intestine genes e.g. CDX2 or CREB3L3 
are mainly located in the central subcluster, while important upregulated lung genes like 
TBX4 or NKX2-1 are located in the lower right network subcluster. TRs being not expressed 
in the particular tissue were located within the other not-tissue-specific subclusters in the 
network that marked the remaining tissues (Figure 43B, right panel, green nodes). 
Interestingly, genes not expressed in a particular tissue lacked the open promoter markings. 
This pattern strongly supports the hypothesis that transcriptional differences of TRs between 
tissues are epigenetically regulated and thus following previously published models(167). 
Indeed, the correlation of epigenetic promoter status and gene expression of TRs clearly 
demonstrated a dichotomous distribution with expressed TRs being defined by accessible 
promoters, while not expressed TR genes were characterized by the absence of accessible 
promoters (Figure 43C). Raw histone modification read counts on a genomic level also 
support these results (Figure 43D). For example, the CDX2 gene is not only specifically 
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expressed in small intestine cells but also shows specific open chromatin marks like 
H3K4me3 and H3K27Ac only in the small intestine dataset. 
 
 
Figure 43. Epigenetic control of transcriptional regulators in human tissues 
(A) Bioinformatics workflow for the generation of human tissue-related TR networks. (B) Network 
visualization of human-tissue related transcriptional regulators in small intestine and lung tissue 
datasets. Left Panel: Overlay with expression values depicted as fold-changes (FC) over the mean 
expression values of all five tissues included in the analysis. Right Panel: TR networks are overlaid 
with epigenetic data on accessible promoters (Pa) marked in red. Additionally, expressed TRs are 
marked in grey (RNA-seq expression values >10), while not expressed TRs are marked in green with 
black borders (RNA-seq expression values <10). (C) Human tissue related TRs were grouped into 
expressed (black bars) and not expressed (grey bars) genes and their promoter states were visualized 
as bar charts (accessible promoter (Pa), poised promoter (Pp), no H3K4me3 promoter mark (no 
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mark)). (D) Representative example position at CDX2 gene locus for a TR with tissue specific 
expression and promoter marks. 
 
In conclusion, network visualizations clearly showed that highly upregulated genes in tissue 
specific clusters were simultaneously marked with open promoters, while not expressed 
genes lacked these markings. This finding suggests that tissue-associated TRs are unlike 
human macrophages coordinately regulated on the epigenetic and transcriptional level. 
 
5.2.8. Transcriptional regulator networks in tissue macrophages  
Previously depicted data in activated human macrophages and different tissues resulting in 
quite differential pictures about epigenetic and transcriptional regulation raised the question, 
if the described open chromatin state in monocyte-derived human macrophage TR networks 
is already a feature of macrophages during tissue homeostasis. To answer this question 
previously published data of seven murine tissue macrophage populations was used to 
generate TR networks (Figure 44), since there is not sufficient transcriptome and epigenome 
data available for human tissue macrophages (157).  
 
 
Figure 44. Workflow for the generation of TR networks in murine tissue macrophages. 
Bioinformatics workflow for the generation of human tissue-related TR networks. 
 
First of all, 554 expressed TRs were identified in at least one of the 7 populations, while in 
total 321 expressed TRs were highly interconnected (Figure 45A, left panel). Interestingly, 
after the plotting of differential gene expression onto the network, each of the 6 subclusters 
was associated with highly upregulated genes for a particular tissue macrophage population. 
Previously described specific tissue TFs were located in the described tissue specific 
subclusters within the network, for example Runx3, which was previously connected to ileal 
and colonic macrophages was present in the gut subcluster (157). This was also visible for 
Results 
114  
 
other TFs like Mef2c (microglia), Gata6 (peritoneal macrophages), Rxra (Kuppfer cells), or 
Spic (spleen macrophages). In general, 2/3rd of all TRs are not specifically expressed in one 
tissue macrophage population but in any given population suggesting the importance of 
transcriptional changes in only a small number of TRs for the tissue specific transcriptional 
program. After adding epigenetic promoter information onto the network 77 to 90% of the 
specifically expressed TRs in the respective macrophage population were marked with an 
accessible promoter while only 19 to 41% of TRs being not expressed showed an accessible 
promoter state (Figure 45A, right panel, Figure 45B). Similar results were found for all 554 
TRs expressed in at least one of the seven macrophage populations (data not shown).  
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Figure 45. Epigenetic regulation of TRs in murine tissue macrophages. 
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(A) Network visualizations for transcriptional regulators in seven murine tissue macrophages (network 
generation described in Figure 44A). Left Panel: Overlay with expression values depicted as fold-
changes (FC) over the mean expression of all seven tissue macrophage datasets. Right Panel: 
Epigenetic data for accessible promoters (Pa) was overlaid in red border colours. Expressed TRs 
(RNA-seq expression values >10) were visualized in grey colour, while not expressed TR genes were 
depicted in green with black border colour. (B) Distributions of expressed (black bars) and not 
expressed (grey bars) TRs belonging to the murine tissue macrophage TR network were depicted as 
bar charts and were also grouped by their epigenetic promoter states (accessible promoter (Pa), 
poised promoter (Pp), no H3K4me3 promoter mark (no mark)). ChIP-seq and RNA-seq data originated 
from two independent experiments. 
 
In contrast, TRs not included in the network (n=358) showed clearly lower percentages with 
5-8% accessible promoter ratios (Figure 46A, upper numbers). In addition to epigenetic 
promoter state information two examples of strong enhancer datasets for microglia and 
peritoneal macrophages were also plotted to the network (Figure 46B). The highest 
percentages of strong enhancer enrichments were detected for expressed TRs within the 
network, followed by not expressed network TRs, while TRs not being part of the network 
showed the lowest enrichments for strong enhancers (Figure 46A, lower numbers). The 
genomic loci for two specific tissue TRs (Gata6 and Sall1) were chosen to further visualize 
the epigenetic regulation in murine tissue macrophages. Histone modification signals for 
H3K4me3, H3K27me3 and H3K4me1 were plotted for all tissue macrophages and depict the 
signal specificity of Gata6 for peritoneal macrophages and Sall1 for microglia (Figure 46C). 
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Figure 46. Epigenetic landscape of TR in murine tissue macrophages. 
(A) Promoter and enhancer state distributions for 358 TRs not expressed in five murine tissue 
macrophage datasets (accessible promoter (Pa), poised promoter (Pp), strong enhancer (Es), weak 
enhancer (Ew), poised enhancer (Ep), no H3K4me3 (promoter) / H3K4me1(enhancer) mark (no 
mark)). (B) Network visualizations of murine tissue macrophage related transcriptional regulators for 
microglia and colonic macrophages overlaid with epigenetic data on strong enhancers (orange border 
colour). Expressed genes are marked in grey colour, while not expressed TR genes are marked in 
green with black border colour. (C) Example positions for tissue macrophage-specific promoter 
(H3K4me3) and enhancer (H3K4me1) marks at the TF gene loci Gata6 and Sall1. ChIP-seq and RNA-
seq data originated from two independent experiments. 
 
In summary, the TR network approach revealed that tissue macrophages are defined by a 
whole cluster of co-regulated TRs and not only by the upregulation of a single TR. In 
addition, while activated human macrophage TR networks were characterized by a 
completely open promoter landscape, tissue macrophages showed a more tissue specific 
and coherent regulation of epigenetic and transcriptional activity. 
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5.2.9. Model of epigenetic regulation in human macrophages in an 
inflammatory model 
The integration of herein generated human macrophage data on epigenetic HM level during 
activation and the correlation to transcriptional level can be summarized into a working model 
of several layers of epigenetic regulation beyond the activity status of promoter or cis-
regulatory sites (Figure 47). 
 
 
Figure 47. Model for epigenetic regulation in differentially activated macrophages. 
Schema of central transcriptional regulator networks in human macrophage activation. Differentially 
activated human macrophages share a common core program with accessible promoter and enhancer 
sites marked with H3K4me3 and H3K4me1 and additional H3K27Ac HM activating signals. Activation 
state specific accessible and inactive sites are able to allow fast transcriptional regulation in case of 
environmental signals which are the basics for macrophage plasticity. Such regulatory mechanisms 
are established by several layers of epigenetic control mechanisms and an interplay between 
chromatin remodellers, repressors and transcriptional activators that allow a transcriptional 
specialization of activated macrophages. 
 
In summary, this work describes a macrophage core program which shapes the general 
macrophage transcriptome and could be responsible for the regulation of basic cellular 
functions, while specific programs could drive macrophage specialization into different 
activation states with various functions. Interestingly, besides closed sites without functions in 
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the macrophage cell type, a high abundance of accessible regulatory promoter and enhancer 
sites could keep many genomic TR sites, which control the macrophage transcriptome in a 
general open chromatin state. Thus, these highly adaptive cells can quickly adapt to 
stimulatory signals, induced by changes in the microenvironment, independently of the 
slower chromatin remodeling process. This transcriptional fine-tuning for macrophage 
specialization could be regulated on other epigenetic levels beyond chromatin remodeling, 
possibly amongst others by the binding of transcriptional repressors. 
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6. Discussion 
 
6.1. False-positive and negative signals in ChIP-seq 
experiments 
ChIP-seq experiments inevitably contain false-positive signals introduced at multiple steps of 
experimental procedures (204). The herein presented method to reduce false positive ChIP-
signals named KOIN in the first paragraph of this thesis, revealed false-positive ChIP-seq 
signals in up to 80 % of peak signals in six independent data sets. However, one data set for 
the important macrophage pioneer factor PU.1 displayed outstanding quality with minimal 
amounts of false-positive signals. Intriguingly, even in this high-quality data set the KOIN 
method increased signal-to-noise ratios and identified more significant peaks in comparison 
to peak calling without utilizing the KOIN method (Figure 10). Irrespective of the high 
variability of data set quality with various ratios of false- to true-positive signals, the KOIN 
method successfully identified and removed false-positive ChIP-seq signals (Figure 6, Figure 
8, Figure 9) and recovered false-negative peak signals. 
Interestingly, variable ratios of non-specific to true-positive signals between differentially 
stimulated ATF3 data sets were detected (Figure 6). Percentages of false-positive peaks 
were almost reduced to 50% after HDL stimulation in comparison to unstimulated 
macrophages. It still needs to be elucidated, how and to which extent the stimulation of cells 
can influence the amount of non-specific antibody binding, resulting in false-positive peak 
signals. Hypothetically, due to the strong impact of stimulation onto the chromatin landscape, 
demonstrated in mouse macrophages upon LPS stimulation, many new promoter or 
enhancer regions are in an open chromatin state and thus potentially introducing more ATF3 
binding sites leading to more specific signals (73). Additionally, increased ATF3 expression 
upon HDL stimulation (254) could further present valid antibody targets for specific ChIP-seq 
binding signals and thus increase specific to unspecific signal ratios. 
Particularly, the antibody quality has a strong impact on false-positive binding signals during 
ChIP-seq experiments. One approach called “ChIP-string” was designed to screen for 
effective antibodies against chromatin regulator proteins (248). Multiplexed ChIP-seq 
experiments with low sequencing depth were performed for every antibody and enrichments 
at approximately 500 representative loci were detected and correlated to IgG controls and 
already known chromatin states to assess the antibody quality. This approach or other 
antibody validation procedures, like immunoblotting suggested by the ENCODE consortium 
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(204) can initially help to evaluate antibody quality, aid the optimization of ChIP-seq 
experiments but cannot completely abolish unspecific antibody binding. Besides, KOIN even 
improved ChIP-seq data sets performed with high quality antibodies and is especially 
important for the identification of “hyper-ChIPable” regions, which is not possible with 
described antibody validation methods. 
Overall, the complexity of the next generation sequencing (NGS) technology requires not 
only considerate experimental procedures but also highly specific and adaptive data 
processing methods to account for a data analysis as accurate as possible with the aim to 
correct biological downstream interpretation. The increasing availability of NGS technology 
due to greatly improved cost efficiency resulted in a rapid progression of data analysis 
strategies. These efforts allowed further improvements of NGS data analysis on different 
stages of the ChIP-seq analysis pipeline, which could be in addition to KOIN beneficial for 
future ChIP-seq experiments and decreasing false-positive ChIP-seq signals. For example, 
during the first major step aligning short DNA sequences (ChIP-seq tags) to the reference 
genome to discover locations of enriched ChIP protein binding, unaligned data is normally 
excluded as false-negative sequences from downstream peak calling (295). A remapping 
procedure of not alignable sequences with the short read aligner SHRiMP demonstrated the 
enhancement of gene regulatory grids and networks for the human TAL1 gene. Other 
approaches try to utilize “multi-mappable” reads. These sequences are additionally excluded 
from ChIP-seq analysis and can be introduced for example by excessive PCR amplification 
of ChIP DNA. They match to multiple locations on the reference genome and could therefore 
falsify the peak calling procedure (271). Yet, “not-uniquely” alignable reads can contain 
biological relevant information for proteins binding to highly repetitive sequences at different 
locations on the reference genome and can further increase sequencing depths (296).  
It was demonstrated, that false-positive peak ratios can occur with high variability and are a 
common problem especially amongst “low-quality” ChiP-seq data sets. A systematic 
approach to assess and compare ChIP-seq data quality was performed previously (251). 
Between 20 % and 45 % of analyzed data sets were defined as low or intermediate quality. 
But, rigorous exclusion of all experiments failing very stringent and rigid criteria could be the 
wrong approach and could lead to the loss of important biological discoveries. KOIN could 
greatly improve the interpretation of low-quality ChIP-seq experiments and extract 
biologically meaningful data, especially when antibodies with lower binding specificities were 
used. Newly performed ChIP-seq experiments as well as already archived data could benefit 
from reanalysis with the KOIN method, as long as knockout data sets are available. 
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6.2. Correct biological interpretation requires KOIN 
correction 
One type of biological interpretation for ChIP-seq binding signals correlates for example 
signals associated to specific genes to known gene groups involved in biological functions 
included in a gene ontology (GO) database (264,265,297). This type of analysis allows a 
general evaluation of putative functions associated to the analyzed TF and its binding 
patterns. The exclusion of false-positive signals during the KOIN method had a profound 
impact not only on the enrichments of specific TF binding motifs (Figure 12), often used as 
ChIP-seq quality criterion but also on the biological interpretation of ChIP-seq data sets, 
herein exemplified for the SRF protein (Figure 15, Figure 16). After false-positive correction 
by KOIN, SRF relevant GO-terms were identified, while unspecific SRF functions were lost.  
Another type of biological interpretation utilizes the motif binding enrichments and predicts 
the cooperation of DNA binding proteins by forming putative multi-factor proteins, important 
for the corresponding analyzed cell type. The concomitant enrichment for the important 
pioneer TF PU.1 in the SRF data set at SRF binding sites demonstrated such a cooperative 
binding of TFs in the transcriptional regulation of macrophages (Figure 12) (255). Another 
example for the cooperation of PU.1 with the TF RUNX1 during myeloid differentiation at 
genomic sites like the granulocyte macrophage colony-stimulating factor receptor (GMCSFR) 
were described in murine macrophages (298). Interestingly, without a functional RUNX1 
protein, PU.1 interacts with a corepressor complex and its histone deacetylase (HDAC) 
activity can subsequently decrease GMCSFR expression. It was demonstrated in this work 
that KOIN further sharpens the results for the identification of highly specific motifs 
cooperating with corresponding ChIP proteins, mediating important biological functions. 
Additionally, the low statistical significance of motif enrichments in KO data sets (Figure 13, 
Figure 14) showed the absence of specifically enriched motifs associated with KO peak sites 
and rather depicts randomly distributed motifs over the whole human genome, detected by 
unspecific antibody bindings to irrelevant target proteins.  
Of note, in ATF3 data sets other TF motifs were identified (Jun, Jun-AP1) but not specifically 
the ATF3 motif (Figure 12). This might be caused by variations in TF binding strength based 
on modifications of the motif sequence, as it was described for the early stages of Drosophila 
development in embryonic cells (299). Another reason could be the hetero-dimerization of 
ATF3 with the Jun or AP1 protein to stabilize the ATF3 DNA binding followed by the induction 
of transcription for corresponding target sites (272). 
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In summary, the described observations like GO-term enrichments as well as TF cooperation 
predictions or other biological interpretations lead to the conclusion that the KOIN method 
performed during ChIP-seq peak calling significantly benefits bioinformatics data analysis. 
 
6.3. Knockout data sets - Optimal control for TF ChIP-seq 
experiments 
Already established controls reduce false-positive signals to a certain extent. Still, these 
established controls display several disadvantages. Input controls accurately describe the 
chromatin landscape of used chromatin material, but do not reflect bias introduced during the 
ChIP procedure. Whereas IgG controls exactly match the experimental steps of the ChIP 
samples they suffer from high variability, over-amplification and overestimation of background 
signals, leading to decreased signal-to-noise ratios and false-negative signals (251). In 
contrast, knockout samples combine both mentioned advantages – complete ChIP protocol 
bias description and the accurate display of the chromatin landscape - without the 
disadvantages of input or IgG controls. 
The ChIP-seq experimental procedures themselves can introduce variation and potential 
bias due to different complex enzymatic reactions following DNA purification. “Hyper-
ChIPable” regions are a special type of introduced ChIP-seq bias and are targets of massive 
protein binding with open chromatin states (250). These naturally occurring genomic sites are 
targets of non-specific ChIP enrichments, irrespective of the used antibody, potentially due to 
their open chromatin state allowing electrostatic or binding interactions of RNA polymerases 
or DNA to antibodies. KOIN identified 18 “hyper-ChIPable” regions in all six data sets and 
successfully removed these special type of false-positive signals (Figure 11). Importantly, 
sites with extraordinary high ChIP protein binding enrichments are of special interest for the 
interpretation of ChIP-seq results and the analysis of TF binding patterns. Without the KOIN 
method, all sites with high ChIP-seq signals are considered for data analysis, irrespective or 
their potential false-positive character.  
Another advantage of KOIN is the possible integration into other ChIP-seq pipelines, utilizing 
different peak calling algorithms. In parallel to the herein presented protocol for ChIP-seq 
analysis, KOIN was tested with a second peak calling algorithm called SICER (269,300). 
Despite the detected improvements on data analysis with SICER utilizing KO data sets, 
MACS outperformed SICER. Different peak calling algorithms influence the identification of 
ChIP-protein enriched regions and thus can have an impact on the downstream biological 
data interpretation (269,301,302). Until now, no gold standard was defined for peak calling 
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algorithms. Every peak caller has its own beneficial properties and drawbacks strongly 
depending on the type of ChIP-seq data used as input for the data analysis. For example, the 
used MACS algorithm (262) showed a good performance not only in classical ChIP-seq but 
also in DNAse-seq experiments (302) and is one of the best established algorithms until now.  
One limitation of the KOIN method is the requirement for ChIP protein knockout cells. In 
murine models, the relatively new CRISPR/Cas-mediated genome engineering approach 
allows a fast and efficient generation of knockout mouse models and is also easily adaptable 
for the usage in other mammalian cells (303,304). This technique utilizes the CRISPR 
(clustered regulatory interspaced short palindromic repeat) and Cas (CRISPR-associated) 
proteins, originally found in bacteria and archaea mediating a RNA-based adaptive immunity 
(305,306). A single guide RNA (sgRNA) is artificially constructed to direct the Cas9 protein to 
a specific genomic DNA sequence to edit the genome in an efficient and simple manner, 
introducing for example reporter constructs or mediating gene knockouts in mammalian cells. 
The generation of KO control cells via the CRISPR/Cas technique might be a way to 
establish a convincing control for ChIP-seq data sets. 
The positive effects on ChIP-seq data analysis utilizing KOIN peak calling demonstrated the 
profound influence and value of KOIN to reduce false-positive peak calls. Future studies of 
novel TFs, chromatin regulators or the recently introduced “occupied regions of genomes 
from affinity purified naturally isolated chromatin “(ORGANIC) method could greatly benefit 
from taking KOIN into account (307). The ORGANIC method uses native chromatin to 
identify direct TF chromatin interactions with high resolution, specificity and sensitivity in 
comparison to standard protocols using cross-linked chromatin. KOIN could further minimize 
bias and maximize specificity in combination with the advantages of native chromatin 
preparations, circumventing epitope masking and allowing minimal chromatin amounts as 
input.  
In conclusion, KOIN should be considered as gold standard for the analysis of TF ChIP-seq 
data, optimizing not only false-positive signal reduction amongst others by the exclusion of 
“hyper-ChIPable” regions but also significantly improving the biological interpretation of TF 
binding data. 
 
6.4. A common epigenetic core program defines the basic 
transcriptional landscape in macrophages 
In the second part of this thesis, the epigenetic changes during activation of a human 
somatic cell type, namely monocyte-derived macrophages, were studied. Macrophages exist 
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upon stimulatory cues in different stimulus specific activation states and can thereby mediate 
various functions in inflammation, immune response modulation and tissue repair (33,308). 
Strong overlaps were found in this study for the epigenetic states of many regulatory 
promoter and enhancer sites in all investigated macrophages (Figure 29, Figure 30). The 
described common regions establish a macrophage specific transcriptional program (Figure 
32) with corresponding general “housekeeping” functions (Figure 31). These high similarities 
were previously visible in different murine myeloid cells with 82 % overlap for H3K4me3 
identified promoter regions comparing macrophages, monocytes and neutrophils (157). 
Common enhancer regions were less abundant (27 %) but still present. In terms of the 
similar origin of these cells, this common signature is not surprising, while cells only differ in 
their activation stimulus. In line with these results, even mouse tissue macrophages 
originated from different organs like lung or brain seem to manifest a common macrophage 
signature (177). Additionally, PU.1 but also other TFs like ETS1, GABPA or FLI1 seem to 
maintain the common epigenetic landscape of human macrophages (Figure 33). In previous 
publications, the cooperation of PU.1 with secondary TFs of the ETS family was described in 
mouse models amongst others in macrophage cells to initiate and maintain their 
transcriptional program (255,274,283,284). Furthermore, with a previous computational 
reverse engineering approach (21) commonly found promoter and enhancer sites could be 
verified by a high overlap of previous common macrophage core signature genes with active 
epigenetic promoter and enhancer markings rendering these genes as highly 
transcriptionally active, thus demonstrating their general importance (Figure 30, Figure 34). 
 
6.5. Profound changes at promoter or cis-regulatory sites 
alter the transcriptional program in activated human 
macrophages 
In this study, 430 differentially regulated H3K4me3 promoters were found while comparing 
four differentially activated primary human macrophages, activated under different 
stimulatory conditions in a pro-inflammatory background (Figure 22). These sites are 
involved in macrophage specific biological processes, exemplified for MTPP and positively 
correlated with the transcriptional activity of corresponding genes (Figure 23, Figure 24). In 
comparison, 873 differential H3K4me3 promoters were previously found in murine 
macrophages compared to monocyte and neutrophils which are in line with found numbers in 
this study (157). These changes reflect the induced transcriptional changes on promoter 
level during the macrophage activation process. Interestingly, at least two times higher 
numbers of repressed promoters were detected in human MIL4 macrophages in comparison 
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to the other activation states. This could hint to a necessary repression of genes to prevent 
their transcriptional activity and finally to the establishment of the MIL4 phenotype with 
corresponding functions. In mouse models, comparable repressive cascades were described 
upon IL-4 stimulation e.g. for STAT6, KLF4 or PPAR proteins, inhibiting important 
mechanisms to finally repress a pro-inflammatory macrophage program (7). 
In addition, a huge number of cis-regulatory enhancer regions with approximately 20.000 
stimulus specific enhancer sites could be identified in the four investigated macrophage 
activation states (Figure 25). Their activity HM classification also positively correlated to the 
transcriptional activity of adjacent genes (Figure 26) and they outnumber the stimulus 
specific promoter regions determined before (Figure 22). The vast increase in activation state 
specific enhancer numbers indicates their extreme variability and complexity and also display 
their important role during the activation process of human macrophages as switch for 
transcriptional regulation and binding sites for signal-dependent TFs (71,72,188,309,310).  
Furthermore, comparable numbers of super enhancers (SE) as determined here for human 
macrophages were found in previously described murine macrophages (169) (Figure 35). 
SEs were located in the vicinity of activation state relevant macrophage genes with 
corresponding functions and substantially increased the transcriptional activity of these 
genes (Figure 36, Figure 37). SEs could play an important role in the regulation of 
macrophage genes, since their role in the determination of cell fate and lineage in murine 
tissue macrophages or stem cells was previously verified (169,170,311). 
This study further demonstrated the repertoire of cis-regulatory elements is shaped by 
different external and internal stimulatory events cells may undergo. Some of these important 
regulatory sites are established during cell differentiation and are directly controlled by the 
enhancer-organizing activities of lineage-determining TFs, which was demonstrated for PU.1 
in macrophages (57,71,72). Other enhancers are formed by the functional cooperation 
between stimulus-activated TFs and lineage-restricted TFs (73). These stimulus dependent 
“latent enhancers” were demonstrated in murine macrophages to form an epigenetic memory 
after stimulatory signals and to change cellular reactions upon future stimulatory cues. Latent 
enhancers, defined by a de novo formation of H3K4me1 signals upon stimulatory signals are 
still present once the stimulatory signal, which established them, is terminated. It can be 
assumed, that the largest group of differential enhancer sites, identified as specific weak 
enhancers with solely H3K4me1 signals (Figure 25) partially consist of latent enhancers with 
no direct effect on the actual transcriptional program, but are important for putative reactions 
upon future stimulatory signals. Another argument for their “latent” enhancer character could 
be the loss of PU.1 binding (Figure 25) at many of the activation specific enhancer sites. 
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Epigenetic memory was also demonstrated for other HMs like H3K27me3 in arabidopsis 
(312), H3K9me3 in murine fibroblasts and pluripotent cells (313) or H3K4me1/2 and 
H3K9me3 in Caenorhabditis elegans (314). Interestingly, not all HMs seem to be able to 
maintain long-lasting marks at corresponding genomic locations (315). Mainly histone 
methylation, like H3K4me3 at promoter or H3K4me1 at enhancer regions, was suggested to 
act as a stable mark to establish longer lasting transcriptional changes with the potential to 
establish a mechanism for epigenetic memory. 
The correlation of promoters with or without cis-regulatory elements located in their vicinity 
resulted in an increase of transcriptional activity (Figure 28B). Enhancers can increase gene 
expression by direct interactions forming chromatin loops or by indirect effects mediated by 
eRNAs (67,112,127,128). The strong overlaps for promoter and enhancer correlated gene 
names, especially for MIL4 and MTPP but also for MIFNy in a less prominent but still significant 
manner, demonstrated the influence and correlation of promoter sites and enhancer 
presence in their surroundings (Figure 28A). Interestingly, the activation of human 
macrophages seems to influence the promoter-enhancer correlation. In unstimulated 
baseline macrophages (Mb), the overlaps are less specific in contrast to the other 
macrophage populations. Despite the defined activation state specificity for described 
promoter and enhancer sites, the results could indicate the usage of Mb enhancers not only 
for Mb promoters but also for other macrophage activation states. This postulate would also 
explain the strong correlation of Ep sites in MIFNy also with Pp sites in MTPP, potentially 
reflecting their common inflammatory background and the partially shared character of these 
enhancer sites. More importantly, the method of promoter-enhancer pair identification could 
be partially responsible for these results as a potential source of variation. 
The identification of regulatory pairs for promoter and corresponding enhancer sites on a 
global scale still remains difficult. Interactions between enhancers and their target genes can 
be orientation-independent, characterized by distances with up to 1 megabase pairs and 
enhancers can even be located within the coding region of the corresponding gene (58-60). 
Furthermore, enhancers and promoters can be targets of multiple interactions, rendering the 
proper identification of promoter-enhancer pairings even more complex. Until now, the 
common approach to annotate cis-regulatory elements to corresponding regulated genes is 
established by the identification of the nearest known TSS relative to the center of the 
corresponding enhancer site. This approach is a fast and efficient solution, especially for a 
high number of enhancer regions in the proximity of TSS for known genes. But due to 
previously mentioned enhancer properties, this approach is not an optimal solution, leading 
to false-positive or negative results. For single cis-regulatory elements, the classical 
luciferase assay is still a valid method to identify corresponding target genes, but for 
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hundreds or thousands of enhancer regions a global approach with the luciferase assay 
technique is not feasible. Future genome wide solutions, which are already utilized for a 
better and more precise prediction of promoter and enhancer cooperation could be the Hi-C 
seq method (222,316). This technique allows the prediction of 3D chromatin structures in a 
genome wide manner, thus identifying promoter to enhancer interactions by forming 
chromatin loops, allowing a direct interaction of factors involved in the regulation and 
transcription of the corresponding gene locus. Another revolutionary approach to identify 
promoter-enhancer pairs could be guanine-rich nucleic acid sequences capable of forming a 
four-stranded structure through Hoogsteen hydrogen bonding, also called “G-quadruplexes 
(317). These G-rich patterns found at the boundaries of DNAse I hypersensitive promoters 
and enhancers could facilitate the formation of G-quadruplexes, thus promoting the formation 
of chromatin loops which mediate the interaction of promoter and enhancer sites (67). 
Another relatively new approach to identify actively transcribed enhancers in a broad variety 
of cell types e.g. human myeloid cells was performed by the FANTOM5 project by the 
detection of the bidirectional promoter activity of active enhancers with the CAGE (Cap 
analysis of gene expression) method and the correlation to histone modifications H3K4me1 
and H3K27Ac (318-320). 
In conclusion, several identified epigenetic promoter and enhancer differences for 
investigated macrophage activation states influence the transcriptional landscapes of these 
cells. A more complex analysis specifically for cis-regulatory elements is required to reveal 
more insights how these important sites impact the establishment of different macrophage 
activation programs by the regulation of corresponding promoter sites and the establishment 
of epigenetic memory. 
 
6.6. Specialized transcriptional control of TRs in activated 
human macrophages 
Due to the general differences found in epigenetic promoter and enhancer states in activated 
human macrophages, a detailed correlation analysis was performed for important TR 
proteins. Transcriptional regulators (TRs) like transcription factors (TFs), chromatin 
remodelers or co-factors are crucial elements responsible for changes on transcriptional 
levels and may act as cornerstones, establishing diverse macrophage programs upon 
inflammation-associated stimulatory signals in an input signal-specific manner. Astonishingly, 
co-regulation networks of TRs in differentially activated macrophages resulted in an 
overwhelming fraction of accessible sites with minimal differences between macrophage 
populations, despite clear transcriptional alterations (Figure 39, Figure 40, Figure 41). This 
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pre-defined open chromatin landscape in inflammatory macrophages could suggest that 
gene expression is solely guided by transcriptional regulatory processes mediated by input-
specific master TRs. In contrast, differential observations were made for histone modification 
states in human tissues or murine tissue macrophages originating from different tissues. 
These cells display a tight regulation of TR on epigenetic level with an accessible chromatin 
landscape for highly expressed genes and vice versa inaccessible chromatin for non-
expressed genes following a previously described general model (Figure 43, Figure 45, 
Figure 46) (167). Interestingly, peritoneal and colonic macrophages showed the highest 
numbers of genes not transcribed yet with accessible promoter markings in tissue 
macrophages, demonstrating a closer relation to the special epigenetic regulatory 
mechanisms in monocytes than other tissue macrophages. This closer connection to human 
monocyte-derived macrophages could be explained by the previously found replacement of 
these cells by monocyte-derived cells in the adulthood (321). In summary, these results 
suggest that the accessibility of the vast majority of TR loci is a special feature of TRs in 
activated monocyte-derived macrophages. This observed uncoupling of epigenetic and 
transcriptional regulation of TRs could not be found in tissue macrophages. 
Only one other example of the uncoupling of epigenetic and transcriptional control was very 
recently found in stem cells and their progenies within intestinal crypts, where cell plasticity 
was associated with broadly permissive chromatin (322). The expression of one specific TF 
was responsible to switch cell phenotypes and functions from enterocytes to secretory cells 
and vice versa, despite the similarly open chromatin landscape. Furthermore, the enormous 
plasticity of gene expression of human macrophage activation demonstrated in the 
previously introduced multi-dimensional model (21) could be a direct consequence of 
expression-dependent regulation within this specialized TR network. Other cell types with 
functional plasticity may also contain similar activation TR networks, while the majority of 
other cell types without a broad functional plasticity are precisely regulated by epigenetic 
mechanisms. 
Aside from macrophage plasticity, macrophages also need to react fast and efficient to 
environmental cues in the organism to mediate proper immune responses and other critical 
functions. It is speculated that the posttranslational HM, one important aspect of epigenetic 
regulation is a relatively slow process with multiple necessary steps until the transcriptional 
activity of corresponding genomic loci are altered (315,323). Pioneer factors open the 
chromatin landscape with or without secondary factors and recruit HM enzymes, which 
covalently modify histone proteins, leading to transcriptional initiation and elongation 
mediated by RNA polymerase II (73,324-326). Interestingly, amongst putative 
posttranslational modifications especially the methylation of histone proteins was described 
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to be a relatively slow and stable process (315). This observation could support the overall 
open promoter landscape in activated macrophages at TR regions, implicating other 
regulatory levels besides the posttranslational modification of histone residues. 
First of all, specific repressor proteins like BCL6 (B cell leukemia) or nuclear receptors 
recruiting co-repressor complexes with additional transcriptional regulatory functions can 
restrict the expression of TRs (154,287,327,328). Other repressive HM marks, which are not 
part of this study like H3K9me3 or H4K20me3 could down-regulate the transcriptional activity 
of adjacent genes (329-331). Importantly, a cross-talk between HM was demonstrated for 
example by the stronger interaction of PHF8 to H3K4me3 with simultaneous H3K9 and 
H3K27 acetylation in human cells (332). Not only the methylation of histone proteins can 
repress gene transcription, but also the ubiquitinylation of H2AK119 inhibits the elongation of 
RNA polymerase II enzymes (333). Furthermore, eRNA transcripts could greatly influence 
the TR gene expression rates by RNA-mediated repression, altering for example the 
formation of DNA loopings between enhancer and promoter sites or changing the chromatin 
structure level itself (112,127,128). Also nuclear receptors can alter eRNA transcription and 
thus down-regulate the transcription of target genes, as it has been demonstrated for the 
Rev-Erb α and Rev-Erb- β proteins in murine macrophages (186,334). In addition, a 
disruption of the interaction between acetylated histone proteins and the bromodomain and 
extra terminal domain (BET) “epigenetic reader” proteins could additionally regulate 
transcription by the elongation of RNA polymerase II. This mechanism was described to 
selectively block the expression of a subset of TLR4 induced genes in mouse models of 
endotoxic shock or for pro-inflammatory cytokine expression (335-337). BET family members 
are indeed expressed in the utilized human macrophage model in all investigated 
populations, thus underlining their importance for a fast transcriptional response in 
macrophages (data not shown). Another possible regulatory level could be the extent of 
differential TR expression between differentially activated macrophages. In case of PU.1, 
differences in protein expression lead to the differentiation of hematopoietic progenitors into 
a B cell-like phenotype or into a macrophage cell type (75). In both cases, PU.1 is expressed 
and thus an open promoter state with corresponding cis-regulatory enhancer markings could 
be assumed. The same mechanism could be true for many TR genes, allowing for rapid 
changes in expression values upon stimulatory signals, due to already open promoter 
markings, rendering slow HM changes unnecessary. 
Eventually, post-translational HMs are deposited as a consequence of TF binding. Multiple 
TFs bind in combinations or as multi-factor proteins to promoter and enhancer positions and 
play key regulatory roles in their activation (327). TF binding seems to be far more dynamic 
than the turnover of chromatin marks, which thus can extend and stabilize cellular activation 
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signals (247). In recent publications, the importance and abundance of these genomic loci 
co-occupied by multiple TFs was demonstrated in multiple cell types, mediating a complex 
regulation of transcriptional processes by their combinatorial binding (319,338-340). Possible 
candidates for important regulatory TFs in macrophages could be especially STAT TFs, 
previously demonstrated as essential proteins for the establishment of transcriptional 
programs in differentially activated macrophages. First of all, STAT1 was strongly associated 
to pro-inflammatory human or mouse macrophages important for IFNy responsive genes 
(196,293,341), while STAT6 is induced by IL-4 stimulation in human and mouse 
macrophages and critically regulates PPARy function (25,342,343). Moreover, the motif 
enrichment analysis of Pa and Es revealed the enrichment of STAT6 in MIL4 macrophages 
(Figure 25). High STAT4 expression and relevance was previously demonstrated in MTPP 
cells (21). STAT TFs were highly expressed in corresponding macrophage populations and 
were marked with Pa and Es markings (Figure 41C). These TFs could act in combination 
with other important regulatory proteins like PU.1, NF-kB or C/EBP with putative lineage 
determining functions in macrophages (92,338,344,345). In fact, multiple publications 
described the synergistic cooperation of STAT proteins with PU.1, C/EBP, NF-kB, AP-1 and 
other proteins (341,346-349). PU.1 and other lineage determining TFs may provide 
macrophages with a basic and plastic epigenomic architecture with many open and 
accessible sites, upon combination with other signals or TFs, a fine-tuning mechanism 
resulting in an optimal transcriptional output adapted to external and internal stimulatory 
signals (92). 
Collectively, the epigenetic and transcriptional regulation in macrophage activation TR 
networks is uncoupled with an overall accessible epigenetic promoter and enhancer state, in 
contrast to other tissue cells or tissue macrophages without a functional and cellular 
plasticity, where a classical model of tight epigenetic and transcriptional correlation has 
emerged. Other regulatory mechanisms like eRNAs or TF binding could fine-tune the signal 
integration-dependent transcriptional regulation of network TRs. 
 
6.7. Epigenetics - the “next generation” tool for the 
identification of regulatory genomic sites 
The exciting identification of a “histone code”, connecting specific posttranslational histone 
modifications read by effector proteins to specific biological functions in virtually all known 
cell types, concomitantly with the development of the next generation sequencing technology 
allowed the location of regulatory sites and the discrimination of their activity status with 
unprecedented precision in a genome wide manner (145,146). This was demonstrated not 
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only in multiple cell types and species for the identification of cis-regulatory elements 
(62,160,161,350), but also for the assessment of disease relevant aspects (351). For the first 
time, differentially activated human macrophages were in detail analyzed in this study, 
correlating epigenetic activity states of regulatory promoter or enhancer sites with 
transcriptional RNA-seq data. Previous chapters described fascinating common but also 
differential properties of activated human macrophages and shed light especially to the 
regulatory processes of TRs, visualized in co-regulation networks.  
The integration of collected data allowed the generation of a model, which described the 
epigenetic modification of important macrophage genes during the differential activation 
process (Figure 47). A macrophage core program defines sets of active and inactive genes 
important for general macrophage functions like the SP1 gene encoding for the TF PU.1 or 
PRDM1 (Figure 39B), while a stimulus specific active program promotes the specialization of 
the corresponding activated macrophage, like IL2RA for MTPP (Figure 27). In contrast, a co-
regulation network of important TR genes revealed an uncoupling of transcriptional and 
epigenetic regulation with a mainly accessible epigenetic landscape, which suggests other 
regulatory mechanisms in concert with accessible epigenetic HM marks in monocyte-derived 
human macrophages (Figure 41), which was discussed previously. 
Additional future approaches are needed to elucidate this interesting point to extend the 
gathered information on HM changes in macrophages and link new knowledge to loose ends 
of macrophage biology. Within this study, cells in the used macrophage models were 
stimulated for 72 hours, harvested and were subsequently used for ChIP-seq experiments. 
Between the first minutes of stimulation and at later time points, various cascades of 
coordinate regulatory mechanisms display concerted actions in macrophage differentiation. 
Future time kinetic experiments could exactly specify the time points when epigenetic 
changes occur and thus, shed more light onto their functions mediating early responses at 
genomic regions for important TFs like TNF or NFkBIA enabling late responses for the 
maintenance of the corresponding macrophage activation state (352-354). Furthermore, 
previously demonstrated transient epigenetic effects in liver development can cause stable 
changes on transcriptional level (355). Comparable transient changes on epigenetic level 
during early phases of the activation process could be lost after the complete activation of 
macrophages and can thus only be targeted with the implementation of multi-time point 
experiments (68,280). Until now, it can only be speculated, how many reversible epigenetic 
marks are established during the differential activation of human macrophages in comparison 
to stable HM marks, visible after the completion of macrophage activation. 
Other experimental approaches could further collect information about complete activation of 
human macrophages on the RNA polymerase II level. Global Run-On sequencing (GRO-
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seq) experiments, already performed for example in mouse macrophages and cancer cells 
(162,186,356) could detect nascent RNA transcripts still associated with the RNA 
polymerase II enzyme in differentially activated macrophages. These experiments could 
further specify regulatory regions with high RNA polymerase II activity in combination with 
epigenetic HM signals at promoter or enhancer locations. Additionally, resulting precise 
catalogues of eRNA transcripts could assess the relevance of these non-coding and 
relatively unstable RNA species (186) in the regulation of human macrophage genes. Thus, 
especially genes in the depicted transcriptional co-regulation networks could be regulated by 
eRNAs, positively correlating with stabilized promoter-enhancer interactions and higher gene 
expression for corresponding adjacent genes and vice versa leading to decreased 
expression values after eRNA suppression. 
In addition to future experiments which aim to gather further invaluable information about 
human macrophage biology, a few general issues should be kept in mind. For the 
characterization of human macrophages, the direct translation of data obtained from mouse 
models or from other species is a quite valuable approach, but should not be used in an 
unquestionable manner, without the consideration of important facts concerning murine and 
human macrophage biology and utilized experimental approaches (308). First, human 
inflammatory monocyte-derived macrophages are in general generated from blood 
monocytes, while murine macrophages are mostly generated from bone marrow in vitro or 
directly isolated from tissues. Moreover, differences in the production of iNOS and nitrite 
oxygen (NO) with antimicrobial functions seem to show fundamental differences in 
experiments performed with human or mouse macrophages (357-361). A similar scenario 
was described for the Arg1 enzyme. In humans it is only expressed in neutrophils, while it 
was found in both murine neutrophils and macrophages (362-364). Due to these differences, 
protein markers for specific murine macrophage states could not be validated in human 
macrophages and vice versa (365). Recent studies (21,366,367) tried to elucidate the 
similarities and differences of macrophages in human and mouse macrophage models to 
understand their core similarities but also highlight obvious evolutionary differences 
influencing their immune responses, like the IFN-regulated IRG protein with two members in 
human and approximately 18 in the mouse (368). 
In addition to the mouse-human comparability, the actual in vivo situation for human 
macrophages should always stay in focus of future research. In this study, primary human 
macrophages were used in an inflammatory model using different stimuli to create functional 
activation states to approach the in vivo situation (Figure 3). In contrast to immortalized cell 
lines, where various artificial alterations to their genetic background could render results 
generated and biological interpretations at least partially questionable. The ENCODE project 
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(204) uses computational approaches (21,156,338) and other similar efforts to standardize 
and collect NGS data sets and thus makes the correlation of different data sets on various 
levels (RNA, promoter, enhancer, histones) possible to get with individual experiments more 
and more insights into complex biological systems. In this study generated data sets 
elucidated macrophage biology and added more aspects of information for the activation of 
primary human macrophages and their epigenetic regulation to the increasing amount of 
NGS databases. Further epigenetic experiments with human tissue macrophages in 
comparison to monocytes and monocyte-derived inflammatory macrophages cannot only 
shed more light on their regulatory processes, commonalities and differences but can also 
help to study epigenetic influences in macrophages in context of human diseases. Finally, 
single cell experiments concerning the genetic variability of macrophage regulation in 
different individuals can be important for personalized medicine-approaches for future 
patients. 
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Zusammenfassung 
Makrophagen, integrale Bestandteile des angeborenen Immunsystems sind an wichtigen 
Funktionen wie z.B. bei der Immunantwort, an metabolischen Prozessen, der Gewebe-
Homöostase und an der Entwicklung beteiligt. Diese extrem heterogenen Zellen können ihre 
transkriptionelle Aktivität einer Vielzahl von stimulatorischen Signalen anpassen, um jeweils 
ihre spezialisierte Funktion erfüllen zu können. Das transkriptionelle Programm von 
aktivierten Makrophagen wird unter anderem durch transkriptionelle Regulatoren (TR) oder 
durch komplexe Veränderungen auf epigenetischer Ebene beeinflusst. Die DNS 
Sequenziertechnologie der nächsten Generation ermöglicht die Bereitstellung von 
genomweiten Analysemethoden, um mit „ChIP-seq“ oder „RNA-seq“ Experimenten die DNS-
Bindungsfähigkeiten von Proteinen im Genom oder die transkriptionelle Aktivität von 
unterschiedlich aktivierten menschlichen Makrophagen zu untersuchen. In dieser Arbeit 
wurden zwei wichtige Aspekte erarbeitet, zum einen eine methodische Verbesserung bei der 
Auswertung von ChIP-seq Daten für genomweite Transkriptionsfaktorbindungsstudien. Zum 
anderen wurde die epigenetische Regulation der Aktivierung humaner monozyten-
abgeleiteter Makrophagen erstmalig beschrieben. 
Für die Reduzierung der falsch-positiven Detektion von Proteinbindungsstellen („Peak-
calling“) im Genom bei ChIP-seq Datensätzen wurde eine neue Methode entwickelt 
(Knockout implemented normalization method = KOIN). Bei KOIN werden ebenfalls Daten 
berücksichtigt, die aus Zellen stammen, die eine Nullmutante (Knockout = KO) für das 
jeweilige Protein darstellen. Mit Hilfe von KOIN konnte der größte Teil falsch-positiver 
Signale eliminiert werden, während das Signal-Stör-Verhältnis unabhängig der 
Datensatzqualität erhöht wurde. Außerdem wurden nicht nur kürzlich entdeckte „hyper-
ChIPable“ Regionen, die mit falsch-positive Signalen assoziiert worden sind, erfolgreich 
ermittelt und entfernt, sondern die darauf folgende biologische Interpretation durch „KOIN“ 
maßgeblich verbessert. Insgesamt erzielte die „KOIN“ Methode durchweg bessere 
Ergebnisse als bisher verwendete „Input“ und „IgG“ Kontrollen, und wird hier deshalb als 
mögliche optimale „ChIP-seq“ Kontrolle für zukünftige ChIP-seq Experimente für 
Transkriptionsfaktoren – zumindest im murinen System - empfohlen. 
Bei der Aktivierung von humanen Monozyten-abgeleiteten Makrophagen wurde ein Modell 
zur Charakterisierung von Histon-Modifizierungen nach Aktivierung erstellt. Mit Hilfe dieser 
Histon-Modifizierungen kann der Aktivierungszustand von wichtigen Regler-Elementen wie 
Promotoren oder Sequenzen die die Transkription eines Gens verstärken („Enhancer“) 
erkannt werden. Diese sind für die Etablierung und Aufrechterhaltung der 
Transkriptionslandschaft von entscheidender Bedeutung. In einem Modell, das teilweise mit 
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Faktoren aus Entzündungsreaktionen etabliert wurde, sind vier verschiedene primäre 
humane Makrophagen-Subpopulationen generiert worden. Zunächst wurde ein 
gemeinsames epigenetisches Makrophagen-Kernprogramm determiniert, was vor allem 
durch eine Vielzahl von gemeinsamen Promotern bestimmt wird. Außerdem konnten Subtyp-
spezifische epigenetische Unterschiede an Promotoren, Super-„Enhancern“ und vor allem an 
einer Vielzahl von „Enhancern“ definiert werden, die auf Grund von stimulatorischen 
Signalen und einer darauf folgenden Spezialisierung der Makrophagen auftraten. 
Überraschenderweise wurden trotz transkriptioneller Unterschiede eine überraschend große 
Zahl an genomischen Bereichen mit aktiven und offenen Promotoren und partieller 
„Enhancer“ Markierung in aktivierten Makrophagen gefunden. Mit Hilfe sogenannter 
Koregulations-Netzwerke für transkriptionelle Regulatoren wurde gezeigt, dass für diese 
Klasse von Genen eine Entkoppelung von epigenetischer und transkriptioneller Kontrolle in 
Monozyten-abgeleiteten Makrophagen besteht. Die fehlende Notwendigkeit der 
epigenetischen Regulation dieser wichtigen Klasse von Genen könnte ein entscheidender 
Mechanismus sein, der der hohen Plastizität dieser Zellen als Antwort auf unterschiedlichste 
Signale aus dem Mikromilieu zugrunde liegt. Zusätzliche Mechanismen der transkriptionellen 
Regulierung wie “eRNA“, repressorische Proteine oder Wechselwirkungen zwischen Histon-
Proteinen könnten für die Feinregulierung der Transkription in Makrophagen verantwortlich 
sein. Die kooperative Bindung zwischen Pionier-Transkriptions-Faktoren wie PU.1 mit 
sekundären Transkriptions-Faktoren wie z.B. STAT Proteinen könnte, neben der Regulation 
durch Histon-Protein-Modifikationen ein wichtiges Element für die Steuerung der 
Transkription für die offenen Positionen im Genom von aktivierten Makrophagen sein. 
 
